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2 Abstract 
Children aged less than five years who are hospitalized with severe anemia have nine 
times higher risk of mortality compared to children in the community. The risk of 
dying and re-hospitalization remains high up to 6 months after discharge from the 
hospital. Causes of severe anaemia are multifactorial and vary in different settings. 
These include genetic factors and malignancies, nutritional deficiencies and 
infectious diseases such as malaria. Malaria remains a major contributor to slow 
hematological recovery, morbidity and mortality. New or recrudescent malaria 
infections after discharge negate the initial rise in hemoglobin due to on-going red 
cell destruction and red blood cell production failure. Studies have found that in 
addition to the protective effect of insecticide treated nets (ITNs), provision of post-
discharge malaria chemoprevention (PMC) using monthly doses of antimalarial 
medication to children with severe anaemia prevented as much as 31% of deaths or 
hospital readmissions. 
Using data from a prospective study that was investigating severe anaemia in children 
aged less than 5 years old in Malawi, we did a cohort analysis to compare the risk of 
death between severely anaemic children who had moderate to severe malnutrition 
and those who had severe anaemia alone (Paper I). A total of 382 severely anaemic 
children were screened and 331 enrolled of which a total of 53 children had moderate 
to severe malnutrition (exposed) and 275 did not (unexposed). During the 18-month 
follow period, 28.3% of children with moderate to severe malnutrition died, compared 
to 13.1% among children with severe anaemia alone, (IRR 2.1, CI 0.9-4.2, p=0.03). 
However, the number of hospitalizations and recurrence of severe anaemia was 
similar between the two groups [IRR 0.8 (0.4-1.4), p=0.6 and IRR 1.1 (0.3-2.8), 
p=0.8] respectively. 
We conducted a 5-arm, cluster-randomized trial among 375 hospitalized to determine 
the optimum PMC delivery mechanism by comparing community- versus health 
facility-based strategies in order to inform policy. Children, aged <5 years with severe 
anemia received 3-day monthly treatment courses of dihydroartemisinin-piperaquine 
(DP) either through community-based methods compared to health facility-based 
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methods. We found that adherence was 24% higher among children when PMC was 
delivered in the community compared to when delivered at the health facilities. In 
addition, we found that when compared to the facility-based, non-SMS arm (control 
arm); community-based delivery utilizing community health workers (CHWs) 
resulted in higher adherence [39/76 (51·3%) vs. 54/79 (68·4%); IRR=1·32, 1·14-1·54, 
p<0·001].  
With the objective of assessing the feasibility of involving community health workers 
(CHWs) in the scaling up of PMC into the Malawian health system, we conducted 
focus group discussions and in-depth interviews to explore perceptions, experiences 
and motivation of the CHWs who were involved in the PMC trial in Malawi. We 
found that CHWs were motivated to remind caregivers to administer PMC medication 
to their children mainly by altruism. However, professional, structural and community 
factors were barriers that prevented them from carrying out the assigned tasks. 
In conclusion, it is crucial to investigate and manage acute malnutrition among 
severely anaemic children, as this might be another treatable factor associated with 
high mortality. If PMC is scaled up and made into policy of treatment for children 
with severe anemia, community delivery is effective for high adherence and access. 
However, community delivery anchored in CHWs may not be feasible.
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5 Introduction 
Infant and child mortality rates are basic indicators of a country’s socioeconomic 
situation and quality of life. Since 2000, the risk of a child dying before their fifth 
birthday has halved in the Sub-Saharan African (SSA) region due  to gains made in 
vaccination coverage for specific diseases. [1] Although this is substantial, the current 
under-five mortality rates still remains too high to achieve the Sustainable 
Development Goals (SDG) target in reducing under-five mortality to at least as low as 
25 per 1000 live births. [2]  
Under-five mortality remains a significant concern in the developing world, with one 
in twelve children dying before they reach the age of five years. [1] In 2018, the under-
five mortality rate in Africa was reportedly eight times higher than in Europe. [1] The 
Malawi health and demographic survey in 2015 reported the all cause under-five 
mortality rate was 63 deaths per 1000 live births with most childhood deaths being 
related to conditions such as HIV, diarrhea, pneumonia malaria and malnutrition.[3]  
This PhD project builds on findings from studies in Malawi where severe anemia is a 
major cause of not only in-hospital mortality, but in the long-term among under-five 
children. Findings show that in malaria-endemic countries, the major etiological factor 
for severe anemia is malaria infection. [4, 5] Furthermore, it was found that provision of 
malaria chemoprevention to severely anemic under-five children for three months 
after discharge from hospital, significantly reduced the risk of all-cause death as well 
as re-hospitalization.[5] 
Anemia, malnutrition and malaria are the commonest health problems affecting 
children.[6] It has also been established that malnutrition is one of the most important 
underlying factors for childhood mortality and a major etiological factor for severe 
anemia among children aged less than five years in developing countries.[7-9] Areas 
endemic for malaria often have a high prevalence of micronutrient malnutrition and 
anemia. [10] 
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With this background, the aim of this thesis is: 1). to investigate the mortality risk 
among children with severe anemia and moderate to severe acute malnutrition, 2). to 
identify the optimal delivery strategy for malaria chemoprevention among under-five 
children with severe anemia and 3). to determine if mobilization of community health 
workers to deliver malaria chemoprevention is feasible.
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5.1 Malnutrition in children 
Childhood malnutrition is a major global health problem that significantly contributes 
to under-five morbidity and mortality. [11, 12] Malnutrition is a complex and 
multifactorial condition that results from deficiencies, excesses, or imbalances in a 
person’s intake of energy and/or nutrients. [13] Children’s nutritional status influences 
their survival, cognitive development, and lifelong health. [14-20] Stunting, or low 
height-for-age, is an indicator of overall nutritional status and an important cause of 
morbidity and mortality in infants and children.[14, 18, 21] 
5.1.1 Types of malnutrition 
Although one child can have more than one form of malnutrition, the WHO released 
new growth standards for children aged 0– 59 months in 2006 which represent the 
standards on which all WHO definitions and estimates of all forms of malnutrition are 
based. [22] Undernutrition refers to deficiencies in nutritional intakes. [23] The four 
main forms of undernutrition in children are wasting, stunting, underweight and 
deficiencies in vitamins and minerals.  
Micronutrient malnutrition refers to conditions caused by dietary deficiencies of 
vitamins or minerals and is often interlinked with all types of malnutrition. Stunting is 
an indicator of long-term and chronic intake of poor nutrition signified by a child 
being too short for his or her age. [24] Children are defined as stunted if their height-
for-age is more than two standard deviations below the WHO Child Growth Standards 
median. [22] Stunted children often suffer severe physical and cognitive damage that is 
not reversible and lasts a life-time. [25] Under-weight children are those that have 
weight for age two standard deviations below the WHO child growth standards 
median. [22] Children who are under-weight have two times the risk of dying compared 
to those without nutritional deficits in developing countries. [14, 19] 
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Wasting, also referred to as acute malnutrition results from rapid drops in food 
consumption or food quality and frequently co-exists with pathological causes. [26] 
Children suffering from wasting have weakened immunity, are susceptible to long 
term developmental delays and face an increased risk of death. [14] These children 
require urgent feeding, treatment and care to survive. [27, 28]They are two forms of 
acute malnutrition; severe acute malnutrition (SAM) and moderate acute malnutrition 
(MAM). In children aged 6-59 months of age, SAM is defined as; weight-for-height 
below -3 z-scores of the median of the WHO growth standards, visible severe wasting, 
mid upper arm circumference (MUAC) less than 11.5cm or presence of bilateral 
pitting edema. [22, 23] On the other hand, MAM is defined as a weight for height 
between -3 and -2 scores below the median of the WHO growth standards, wasting 
and a MUAC between 11.5 and 12.5 cm. [22, 23] 
5.1.2 Global burden of childhood malnutrition 
Childhood malnutrition is the underlying cause of death in an estimated 45% of the 8 
million deaths among children under the age of five years. [21] The burden of 
childhood malnutrition remains high globally, with one in 150 million children in 
2017 having any form of malnutrition. [29] The trend of nutrition indicators between 
2010 and 2019 clearly shows that the progress in reduction of childhood malnutrition 
is not sufficient to reach the World Assembly targets set for 2025 and the Sustainable 
Development Goals set for 2030. [21, 29] 
Many countries, especially LMIC suffer the major severe brunt of malnutrition. While 
only half (46%) of all under five children live in LMIC, 75% of wasted children live 
there. [29] In 2019, it was estimated that 47 million children were affected by wasting 
of which 14.3 million were severely wasted. [26] The WHO global nutritional target for 
wasting is to keep the global prevalence to below 5% by 2025. [30] However, the trend 
shows that little progress has been made since 2012 when the prevalence was 7.9% 
compared to 7.3% in 2018. [31] In 2019, more than two thirds of all wasted children 
under 5 lived in Asia and more than one quarter lived in Africa. [31] 
Severe anemia in Malawian children: Risk factors, mortality and malaria chemoprevention 
Thandile Nkosi PhD thesis  
15 
SAM or wasting is the most severe form of malnutrition which accounts for 4.4% of 
deaths among children aged less than five years. [30, 32, 33] The association between 
SAM and mortality has been well established. [34] Due to the ongoing metabolic 
imbalances in a child with SAM, there is a reduction in their capacity to regulate 
normal physiologic processes such as temperature and gastrointestinal absorption. As 
a result, children with SAM more are prone to dehydration, hypothermia, 
hypoglycemia and increased risk of infections and severe illness due to the preceding 
immunosuppression than a well-nourished child. [14, 18] Nearly one in ten children who 
are moderately and severely wasted are at risk of dying during the initial admission as 
well as after discharge from hospital. [33] Globally, over 3.6% (15.9 million) of under 
five children are both stunted and wasted which further increases the risk of dying. [31]  
5.1.3 Burden of childhood malnutrition in Malawi 
Just like in other countries, malnutrition remains a major challenge that contributes 
significantly to morbidity and mortality among under-five children in Malawi. 
Although it has been performing relatively well against other developing countries, [35] 
Malawi still experiences a significant malnutrition burden among its under-five 
population. The 2016 DHS showed that 37% of children under-five years of age are 
stunted while 12% are underweight and children younger than 18 months are most 
affected. [35]  
 
Malawi is somewhat on the right course to meet the global targets for under-five 
overweight and under-five wasting rates. As of 2015, the estimated national 
prevalence of under-five wasting was 3 %, which has decreased slightly from 4 % in 
2010 but it is much less than the developing country average of 8.9%. [35] Despite this 
positive trend towards reduction in wasting, mortality in children with severe acute 
malnutrition has remained high, with up 42% of children admitted with SAM dying in 
Malawi. [33] 
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5.1.4 Risk factors and causes of childhood malnutrition 
The pathophysiology and causes of malnutrition are complex and often linked. the 
UNICEF conceptual framework for undernutrition was developed to generally 
demonstrate the determinants of undernutrition among specific individual, household 
and environmental factors. [36] These determinants were grouped into three: 
immediate, basic and underlying causes of undernutrition. Immediate factors are 
factors related to inadequate dietary intake and exposure to diseases which leads to 
poor appetite, poor absorption, increased metabolic requirements and nutrient losses. 
[37, 38] Underlying determinants are factors that are related to inadequate access to 
appropriate diet and health and cause poor nutrition and basic determinants are 
influenced by social, economic and political factors. [36, 37]  
Diverse and safe foods in early childhood and a healthy environment; including access 
to basic health, water, hygiene and sanitation services are important for reduction of 
all forms of malnutrition. Similar to other developing countries, 69% of people in 
Malawi live on less than US$2 a day and therefore factors related to poverty are the 
main determinants of the burden of malnutrition. [39] These factors include poor diets 
and infectious diseases, lack of food, poverty, over-dependence on maize as a staple, 
high population density and population growth. [3] 
5.1.5 Prevention of acute malnutrition 
Strategies for reducing and preventing acute malnutrition should aim at optimizing 
provision of healthy diets, promotion of good health and growth in infants and 
children. In 2012, WHO adopted targets that aimed to reduce the burden of many 
forms of malnutrition. The “Comprehensive implementation plan on maternal, infant 
and young child nutrition’ includes targets on stunting and wasting among children 
under five years of age. [13] And in 2015, UN member states adopted the ambitious 
target to “end malnutrition and in all its forms” by 2030 as part of the target 2.2 of the 
SGDs in recognition of the importance of nutrition for development. [13, 31] 
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In 2007, the Government of Malawi developed the first edition of the National 
Nutrition Policy and Strategic Plan (NNPSP) to guide the implementation of a 
multisectoral nutrition response and facilitate the improvement of the nutrition status 
of all Malawians. Through the implementation of the NNPSP 2007–2011, significant 
progress was made in improving key nutritional indicators in the country. [40] The 
current Malawi National Multi-Sector Nutrition Policy 2018–2022 (MNSNP ) is in 
line with the World Health Assembly targets for 2025 and SDGs; and serves to 
redirect focus on maternal, infant, young child and adolescent nutrition, acute 
malnutrition, interventions across sectors and nutritional governance. [41, 42] 
5.1.5.1 Provision of adequate nutrition  
Preventing the development of acute malnutrition includes improving feeding 
practices among children who are particularly susceptible to malnutrition. The WHO 
minimum acceptable diet (MAD) is one of the core indicators for assessing infant and 
young child feeding and is a combination of dietary diversity and minimum meal 
frequency among children aged between 6-23 months. [43, 44] Exclusive breastfeeding 
for the first six months is recommended for improved nutritional status and disease 
prevention. [45, 46] 
 However, only about 42% of babies are exclusively breastfed globally. [31] 
Introducing appropriate complementary foods with high nutrient density and 
bioavailability of micronutrients that are prepared hygienically to children is key in 
improving uptake of optimal nutrient and prevent malnutrition but only 18 % of 
children between 6 and 2 months received a MAD in 2019. [31] Similarly and sadly in 
Malawi, only 59% of children under six months were exclusively breast fed and only 
8% met the minimum required diet for children between six and 23 months in 2015. 
[47]  
5.1.5.2 Prevention of infections  
The relationship between malnutrition and infection is described as a vicious cycle. 
Children with SAM are in a deranged metabolic and physiological state which makes 
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them more susceptible to infections and severe illness which in turn worsens the 
malnutrition. [28, 36, 48] Effective strategies for preventing malnutrition should aim at 
breaking the infection-malnutrition cycle especially those related to 
immunosuppression, diarrhea and respiratory tract infections. [49, 50] 
5.1.5.3 Appropriate management of acute malnutrition 
WHO developed the specific guidelines which are supported by available evidence 
and expertise for management of children with SAM in order to reduce malnutrition 
deaths, improve outcomes and prevent further cases of malnutrition. [51] Despite many 
countries adopting the 2013 WHO treatment guidelines for severe acute malnutrition 
into their management protocols, the post-discharge mortality has remained as high as 
31 deaths per 1000-person years in developing countries. [33, 51, 52]  
While SAM without complications is managed through the community-based 
therapeutic care centers or out-patient children with complicated SAM are admitted to 
hospital. [28, 51, 53] The standard in-patient management steps are split into three phases; 
the initial treatment phase, rehabilitation phase and the follow-up phase. The 
management steps also include stimulation of the child’s emotional sensory and 
physical development. Inpatient care involves initial stabilization phase to treat any 
immediate medical complications and careful feeding with specially formulated low-
calorie milk to allow the gut to repair.  
During the rehabilitation or transition phase, feeding with ready to eat therapeutic 
feeds (RUTF) or higher calorie milk is reintroduced to the child in preparation for 
outpatient supplementary feeding phase with dry feeds. A child is discharged from 
treatment when they have achieved a weight-for-height/length above –2 standard 
deviations of the WHO child growth standards median score or mid-upper-arm 
circumference above 125 mm and no edema for at least 2 weeks. [27] 
5.1.6 Interaction between malnutrition and anemia 
In addition to the high risk of dying, children with SAM also have significant 
comorbidities that further increase this risk. [54] The prevalence of these comorbidities 
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varies in different settings. The most significant comorbidities include infectious 
diseases such as pneumonia, acute respiratory tract infection, tuberculosis, HIV and 
micronutrient deficiencies such as anemia. [8, 9, 55, 56] Anemia and malnutrition are the 
commonest health problems that often co-exist among children aged less than five 
years old.  
In Malawi, 15.8% children with severe anemia were found to be wasted, [33] while 
67.3% of children aged between 6-59 months with severe malnutrition were found to 
be severely anemic. Another descriptive study investigating comorbidities in children 
with SAM found that the prevalence of severe anemia was 24%. [57] However, there is 
insufficient evidence of the long-term impact of having these two co-morbidities to 
guide appropriate follow up and micronutrient supplementation during rehabilitation. 
[27]  
5.2 Malaria  
Malaria is a life-threatening infection that is caused by parasites of the Plasmodium 
family and is transmitted to humans by infected female Anopheles mosquitoes. The 
five known human species of plasmodium are; P. falciparum, P. vivax, P. malariae, 
P. ovale and P. knowlesi. While P. falciparum and P. vivax are most prevalent, P. 
falciparum causes more severe disease and deaths. [58] The natural history of malaria 
involves cyclical infection where the parasites grow, invade and destroy red blood 
cells of humans and infected female Anopheles mosquitoes act as “vectors” that carry 
the disease from one human to another.  
 
5.2.1 Global malaria burden 
Despite being preventable and treatable, malaria continues to be a major cause of 
illness and death in the world. The 2019 World Malaria Report estimated that 
globally, there were 228,000,000 infected cases of malaria in 2018.[59] In the same 
year, the disease reportedly killed 405,000 people, [59] which a slight decline from the 
429,000 malaria deaths that were reported in 2015. [60] Similarly, the number of 
malaria deaths among children was estimated to have decreased by 29% since 2010 
but malaria remains a major cause of death among children. [61] 
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It is estimated that malaria takes the life of a child every 2 minutes. In 2015 alone, 303 
000 malaria deaths occurred in children aged less than five years, which is equivalent 
to 70% of the total global estimates.[61] Despite encouraging progress made by many 
countries towards attaining target 3.3 of the sustainable development goals (SDGs) 
which aims to end epidemics including malaria, the African region still carries a 
disproportionately high share of the global malaria burden. [59] According to recent 
world health organization reports, 93% of all malaria cases and 94% of all malaria 
deaths occur in Africa alone. [59] [62] 
5.2.2 Malaria epidemiology in Malawi 
In Malawi, malaria is among the top five causes of deaths with around 4 million 
malaria cases reported annually and contributing to 39% of all outpatient visits. [63] 
Children under the age of five years bear the highest burden of malaria; with an 
estimated annual incidence rate as high as 1160 episodes per 1000 children and 
accounting for nearly 40% of all hospitalizations. . [64-66] attributing an estimated 
7.84% of total deaths among this group. [6, 67, 68]  
 
Malaria transmission patterns in Malawi show seasonal variation and is largely 
determined by the annual rainfall. [69] Vector capacity is high due to plentiful rainfall, 
raised temperatures and elevated humidity all year. [70] The highest transmission areas 
are along the hotter, wetter and humidly low-lying areas, while the lowest risk areas 
fall along the highland areas. [69, 71] Anopheles funestus is still considered to be the 
primary vector species but An. gambiae s.s. and An. arabiensis are also present. [72] 
Plasmodium falciparum is the most common species which accounts for 98% of all 
infections and cause of severe disease and deaths. [69]  
5.2.3  Risk factors for malaria transmission  
Factors that influence malaria transmission are complex and related to the human host, 
the vector, and the environment. In order to adopt feasible and targeted strategies and 
interventions for malaria control, we need to understand factors that drive malaria 
transmission. The main factors that are important for malaria transmission are: 1) 
environmental factors, 2) biological factors and 3) human related factors. [73] 
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5.2.3.1 Environmental factors  
In many countries, malaria transmission is seasonal and varies at different times of the 
year particularly during or after the rainy season. Transmission is highly dependent on 
climatic factors such as temperature, humidity, altitude and amount and pattern of 
rainfall which determines the longevity and capacity of the Anopheles vector. [73] 
Rainfall provides aquatic breeding sites for mosquitoes; and high temperature, high 
humidity and low altitudes are favourable for mosquito survival and parasite 
maturation which leads to increased malaria transmission. By reducing the lifespan of 
the mosquito, the maturation of the parasite is also reduced thereby reducing 
proportion of infective bites. However, because environmental factors cannot easily 
be modified, targeted interventions that minimise contact between the mosquito and 
human and those that reduce mosquito longevity and density are important. [71] 
 
5.2.3.2 Biological factors  
Biological factors are factors that are related to the parasite, mosquito and the human 
host. The different types of the parasites influence the extent of impact of malaria. P. 
falciparum is the most common specie of plasmodium in SSA and also causes the 
most severe disease. In Malawi, where falciparum malaria accounts for 96% of 
malaria infections, the risk of severe disease is high. [72] Additionally, different 
Anopheles vectors have different behaviour and capacities which influence malaria 
transmission and insecticidal resistance of vector and parasites are major challenges 
on malaria control. [74] 
 
5.2.3.3 Human factors 
Human related factors include human activities such as access to health care, 
migration, gender, land use, socioeconomic status and use of interventions for malaria 
control. These factors influence the pattern and extent of malaria transmission. [75] 
Differences between human beings have influence on the patterns of transmission and 
the severity of malaria. Immunity to malaria develops after several exposures over 
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time and the ability to suppress the infection and survival will depend on an 
individual’s immunity.  
5.2.4 Malaria control strategies 
Since the early 2000s, malaria interventions have been scaled up in sub-Saharan 
Africa with the goal to control and eliminate the disease. [58] The WHO global malaria 
programme recommends use of four prevention tools and strategies for malaria 
control. [76] These are: prevention through deployment of vector control interventions 
of 1) insecticide treated nets and 2) indoor residual spraying 3) use of antimalarial 
treatment for high risk populations including pregnant women and children and 4) 
malaria case management through early diagnosis and prompt, effective treatment. 
Through the coordination of Roll Back Malaria (RBM) partners, malaria is one of the 
public health priorities within the Essential Health Package (EHP) in Malawi. With its 
vision to have all people in Malawi free from the burden of malaria and a mission to 
reduce the burden of malaria to a level of no public health significance in Malawi, The 
Ministry of Health (MoH), in collaboration with other partners, developed the 
National Malaria Strategic Plan (NMSP) with three core strategies for malaria 
elimination in Malawi : 1) vector control through ITN use and IRS, 2) improved 
malaria diagnosis and treatment, and 3) intermittent preventive treatment in pregnancy 
(IPTp). [77] The implementation of these policies has been associated with a 19 percent 
point drop in malaria prevalence in children aged less than five years from 43% in 
2010 to 22% in 2017. [78, 79]  
5.2.5 Current strategies and extent of coverage 
5.2.5.1 Improved diagnosis and treatment  
For effective management of malaria, early and accurate diagnosis with a 
parasitological test and prompt treatment with appropriate antimalarial agents within 
24-48 hours of onset of malaria symptoms is key. [80, 81] Diagnosis of malaria should 
not be made by clinical symptoms alone as they cannot be reliably distinguished from 
other causes of fever. [80] Since 2010, WHO recommends parasitological confirmation 
of all suspected malaria with either light microscopy or rapid diagnostic tests (RDT) 
before treatment is administered. [80, 81] Although microscopy is the gold standard, it 
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requires competency and training to determine accurate results. [82] While RDTs do 
not offer the same high sensitivity as microscopy, they are important for prompt 
malaria diagnosis because they can be used at the bedside and do not require high 
skilled personnel. [83] Between 2010 and 2017, the percentage of children with a fever 
who received a malaria diagnostic test increased from 33% between 2010-2012 to 
59% in 2015– 2017 in SSA. [59] 
In 2011, the Malawi NMCP adopted the WHO recommendation that, parasitological 
malaria diagnostic should be done on all suspected cases. [78] [77] In the current MSP 
2017-2022 in Malawi, priority has been placed on expanding and strengthening 
diagnostic capacity and increased procurement of malaria commodities to ensure that 
prompt and effective case management is provided and that there is reduction in the 
presumptive use of antimalarial medications. [84] In the 2017 Malaria Indicator Survey 
(MIS), 38% of children aged less 5 years with reported fever had blood collected from 
either the finger or heel for testing (used as proxy for diagnosis) compared to 32 % in 
2014. [78] 
Without effective treatment, severe malaria infection is always fatal. Due to evidence 
of growing malaria parasite resistance, the government of Malawi changed its malaria 
treatment drug policy for first line treatment for uncomplicated malaria from 
chloroquine monotherapy to sulfadoxine-pyrimethamine (SP) in 2003, and from SP to 
artemisinin combination therapy, [19] with artemether–lumefantrine (AL) in 2007. [84] 
The current second-line is oral artesunate- amodiaquine. Parenteral artesunate is used 
for complicated malaria while oral quinine is reserved for management of malaria in 
pregnancy in the first trimester. [77]  
MoH continues to focus on improving and expanding availability of appropriate 
malaria management to health facilities and community through community 
mobilization, supportive supervision, HSAs using RDTs and pre-referral rectal 
artesunate and implementing the integrated community case management (iCCM) in 
areas where the health facility is more than five kilometers away. [85] Despite these 
efforts, there was not an improvement in the proportion children with fever that 
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sought advice or treatment in 2017 compared to in 2014 (54% compared to 59% 
respectively). [63, 79] However, 96% of children aged less than five with recent fever 
who received an antimalarial, took an ACT in 2017 compared to 92% in 2014; and 
73% of these took it within 24 hours of being prescribed in the rural areas. [63, 79]  
5.2.5.2 Malaria prevention using vector control 
Vector control with either insecticide treated mosquito nets (ITN) or (IRS is effective 
for the prevention and reduction of malaria transmission. ITNs act as both a physical 
and a chemical barrier against mosquitoes therefore reducing the vector population, 
[86] [87] whereby IRS involves spraying interior surfaces of dwellings with a WHO pre-
approved residual insecticide, to kill or repel mosquitoes. [87] Although evidence 
suggesting that one core vector control intervention is more superior to the other is 
conflicting, studies report that if coverage of either is high enough within a specific 
area, population wide protection will be conferred across the community. [87, 88] WHO 
recommends that the selection of vector control intervention should be based on 
factors specific to the local context. [87] Despite the emergence and spread of mosquito 
resistance to pyrethroids, ITNs continue to provide a substantial level of protection in 
most settings. [71, 89] In 2018, about half of all people at risk of malaria in Africa were 
protected by an ITN, compared to 29% in 2010. [60]  
 
The government of Malawi prioritizes vector control and effective case management 
as an effective prevention intervention for malaria. According to the Malawi Vector 
Control Strategy 2015-2019, ITN use is the primary malaria vector control 
intervention in Malawi. [90] However, plans and targets for IRS implementation in the 
country have been included as an option. [77]  
MoH adopted the subsidized ITN policy in 2001. ITNs are distributed free of charge 
through routine ANC and EPI clinics to expectant women and under-five children 
through mass distribution campaigns every two to three years. Between 2012 and 
2016, NMCP with support from other partners has conducted four nationwide mass 
distribution of ITNs. [64, 90] The ITN ownership (ownership of at least one ITN per 
household) has increased from 55% in 2012 to 70% in 2014 and to 82% in 2017. [3] 
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The current 2017-2022 Malaria Strategic Plan (MSP), has targeted to cover 95% of all 
households with at least one ITN by the year 2022. [84] Currently, 42% of households 
have achieved universal coverage of ITNs (ownership of at least one ITN per 2 people 
in the household) from 30% in 2014. [78, 91]  
In Malawi, IRS programmes were initially limited to private spraying in urban centers 
or sugar plantations since the 1990s. [71] In 2007, MoH launched a nationwide IRS 
programme in one high transmission district which was later scaled up to 5 additional 
districts. [71] In a 2010 survey, it was estimated that 83% of houses in the pilot district 
and less than 2% of the households in the whole country had been sprayed within the 
previous 12 months. [79] Due to growing pyrethroid resistance, logistical difficulties 
and financial constraints, funding was suspended in 2012 and the programme was 
scaled down. [92] In the 2014 MIS, 9% of households reported to have been treated 
with IRS in the previous year. [79] In its current 2017-2022 MSP, MoH is planning for 
IRS implementation in selected epidemiological areas, in line with international 
standards. [84]  
5.2.5.3 Prevention through use of antimalarials in high risk populations 
Implementation of preventive malaria control strategies, such as intermittent 
preventive treatment of malaria (IPT), have substantially reduced malaria transmission 
and burden among vulnerable groups such as pregnant women and children under five 
because they are at highest risk of repeated and severe infection and consequently 
death in Africa. IPT is the administration of full therapeutic doses of antimalarial 
medicine to pregnant women (IPTp), infants (IPTi), children (IPTc) under five years 
and seasonally to children (SMC). [93] IPT is effective for malaria prevention by 
clearing existing parasitemia, providing a prophylactic effect and preventing 
complications of malaria such as anemia and death. WHO currently recommends use 
of IPTp, IPti and SMC as context-specific preventive interventions against falciparum 
malaria. [61]  
WHO’s recommended package for prevention and treatment of malaria among 
pregnant women includes; promotion of ITNs, IPTp with SP (IPTp-SP) and prompt 
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and effective treatment of malaria infection. IPTp-SP has shown to significantly 
reduce adverse maternal and neonatal outcomes including maternal malaria episodes, 
maternal and fetal anemia, placental parasitemia, low birth weight, and neonatal 
mortality. [94, 95] For pregnant women living in moderate to high transmission areas in 
Africa, WHO recommends administration of up to three or more doses of SP during  
antenatal care (ANC) starting as early as possible after the first trimester, with at least 
1 month between doses until the time of delivery. [96] Currently there are 36 countries 
that have adopted this IPTp-SP policy into their ANC package. [59] 
 
It is estimated that in 2018, 31% of eligible pregnant women received at least three or 
more doses of SP. Although this is large increase than the 22% in 2017 and 18% in 
2015, the proportion still remains below full coverage. [59] About 20% of pregnant 
women did not attend ANC and of those that did attend, 18% did not receive IPTp. 
This is worrying considering it is a missed opportunity to improve coverage. [59, 60]  
IPTp with at least two doses of SP has been recommended in Malawi as part of the 
three-pronged strategy for malaria prevention and treatment among pregnant women 
since 1993. [77, 97] In 2016, the MoH adopted the 2012 WHO IPTp-SP policy of 
administration of at least three-monthly doses of SP soon after the first trimester. [94, 96] 
It is estimated that in 2017, the proportion of pregnant women receiving at least one 
dose of SP increased to 92% from 90% in 2014 and 77% in 2012 and 41 % of 
pregnant women received three or more doses of SP in 2017 compared to 13 % in 
2014. [63, 79] This is a commendable increase in uptake probably attributed to the 
adoption of the new IPTp-SP policy. 
5.2.5.4 IPT among children  
In addition to the four key interventions for malaria control; vector control using ITNs 
and IRS, prompt and effective treatment of malaria and IPTp, the WHO also 
recommends intermittent preventive treatment among infants IPTi and SMC among 
children under five years. [98] 
Similar to IPTp, IPTi is the administration of full treatment courses of malaria 
medication to infants less than one year old at risk of malaria; delivered at pre-
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specified times of routine vaccinations through the Expanded Programme of 
Immunization (EPI). [98] IPTi with SP provides protection against clinical malaria, 
anemia and hospital admissions in areas of moderate to high malaria transmission. [98] 
Not to detract from the key malaria control interventions, IPTi is considered as an 
additional strategy which can be delivered through an effective and existing system. 
Although infants (under 6 months of age) have been considered to be relatively 
protected against malaria, the burden of the disease in Malawian infants is substantial, 
with 10% of children under 5 years of age hospitalized with malaria being under 6 
months of age. [64, 99] However, Malawi MoH does not include IPTi as part of their 
malaria strategic plan. [84] 
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5.3 Anemia  
5.3.1 Anemia Burden and impact 
Anemia is defined as a reduction in the amount of circulating red blood cells (RBCs) 
which causes insufficient oxygen carrying capacity to meet the body’s physiological 
needs. [52] Although other hematological assessments can be made to diagnose anemia 
the most commonly used clinical indicator of anemia is a low hemoglobin 
concentration (Hb) of <11g/dl. [100] The WHO Hb cutoffs for children aged < 5 years 
categorize anemia as mild (Hb < 11g/dl), moderate (Hb < 9g/dl) and severe (Hb < 
7g/dl). [101] Moderate and severe anemia are major public health problems associated 
with increased child morbidity and mortality, increased susceptibility to infection and 
have negative consequences on cognitive development and physical growth. [101-105] 
 
WHO estimated that 1.6 billion people are affected by anemia with the global 
prevalence at 24.8% of which, sub-Saharan Africa suffers the highest prevalence 
(67.6%) with a slower decline over time than any other region. [106, 107] Children are at 
highest risk with over 293 million affected globally of which 47.4% are aged less than 
five years. [104, 106, 108] In Malawi the prevalence of anemia among children is 63% of 
which 6% have an Hb<8g/dl. [35] Similar to other reports, in 2015 anemia was to be 
more prevalent among children aged less than 24 months than among older children, 
with a peak prevalence of 91% observed among children age 9-11 months. [35, 109] 
Overall, more than 6 in 10 children (63%) suffered from some degree of anemia: 27 % 
were classified as mildly anemic, 34 percent were moderately anemic, and 2 percent 
were severely anemic, [35] and the prevalence of decreased with age from 87% among 
children age 6-11 months to 48% among children age 48-59 months. [35] 
 
5.3.2 Pathophysiology of anemia 
Anemia develops when there is an imbalance between loss and production of RBCs 
caused by ineffective or insufficient erythropoiesis such nutritional deficiencies, 
and/or excessive loss of erythrocytes due to hemolysis or blood loss or both. There are 
multiple causes of anemia and its classification is usually based on either the 
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biological mechanism of the cause such as iron deficiency (ID) and/or RBC 
morphology.  
 
5.3.3 Determinant factors for anemia 
Anemia is pathophysiologically diverse and often multifactorial. Figure 1 is a 
conceptual framework of factors for anemia depicting how distal factors such as 
socioeconomic status contributes to the proximal determinants of anemia such as 
infections. Although these determinants are interrelated, global analyses of anemia 
burden between 1990 and 2010 have reported that the most proximal risk factors for 
anemia are genetic Hb disorders, nutritional deficiencies and infections. [110, 111] 
 
 
Figure 1. Conceptual framework model of the distal and proximal determinants of anemia among children (Adapted from 
refs. [110-112]) 
Figure 2 summarizes the major causes of anemia in SSA. Nutritional anemias result 
from insufficiencies in nutrients that favor adequate hematopoietic nutrient 
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concentrations for RBC production and maintenance. [104] Inadequate dietary intake, 
increased nutrient losses from blood loss, poor nutrient absorption and poor nutrient 
metabolism lead to reduced bioavailability of nutrients necessary for RBC production. 
[104] Although iron deficiency is the most important cause of anemia, nutritional 
deficiencies in vitamin A and vitamin B [Riboflavins, Pyridoxine (B6), Cobalamin 
(B12) and folate] also play a vital role in nutritional anemia. While vitamin A is 
important for erythropoiesis, immune function and have a role in iron metabolism, [113] 
B vitamins are also involved in Hb synthesis and iron metabolism. Their absence 
affects DNA synthesis and cell division in the bone marrow. [114] However, the extent 
to which deficiencies in these nutrients contribute to the global burden of anemia has 
varying epidemiologic characteristics and not very clear. [113] 
Iron deficiency anemia occurs when dietary iron intakes are insufficient to meet iron 
needs particularly at the time of high demand such as in growing infants and during 
pregnancy. Iron deficiency is reported to affect 1.9 billion people and  attributed to 
nearly half of all cases of anemia and the most common cause of anemia globally. [115] 
Iron deficiency has serious health consequences particularly in children’s 
psychomotor development and cognitive function as well as increased risk of 
mortality. [116] The Malawi micronutrient survey (MNS) of 2015-2016 reported that 
22% of children aged less than five years had iron deficiency but supplementation still 
remains low. [117] In many countries iron deficiency is aggravated by infectious 
diseases such as worm infestations and malaria.  
Globally, many primary diseases such as hookworm, schistosomiasis and malaria are 
also associated with anemia by causing blood loss, increased hemolysis and reduced 
RBC production. [110] Chronic infections and diseases cause anemia by altering iron 
metabolism and increased cytokine proliferation which reduces the production and 
lifespan of RBCs. [118] An analysis of 16 population-based surveys reported that high 
infection countries with poor water, sanitation, and hygiene (WASH), high prevalence 
of malaria, diarrhea, and schistosomiasis; inflammation [measured by high C- reactive 
protein (CRP)] was associated with anemia prevalence. [112] 
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Soil transmitted helminths and schistosomiasis are parasitic infections that are very 
common in SSA. Although their association with anemia is dependent on parasite 
species, intensity of infection and co-infection with other parasites; they cause chronic 
anemia by attaching to the enteric and bladder mucosa, leading to blood and iron loss 
over a period of time. [109] Other infections such as Malaria and Human 
immunodeficiency virus (HIV) which are very common in SSA have a huge impact 
on anemia prevalence. [99, 102] Persons living with HIV have a persistent chronic and 
immune response phase that causes impaired iron metabolism as well as risk of 
opportunistic infections which significantly contribute to the risk of chronic anemia. 
[105]  
 
Figure 2. Causes of anemia in low-medium income countries (adapted from Boele van Hensbroek et al 2010 )[119] 
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Malaria is a parasitic infection that often exists in settings with high ID prevalence. 
The malaria parasite requires iron for growth which in turn disturbs iron metabolism 
and distribution. [111] The pathophysiology of malarial anemia is complex but 
comprises of increased hemolysis of infected RBCs, impaired RBC production, 
reduced iron absorption and increased clearance by the spleen. [120] A single episode of 
malaria or repeated episodes due to reinfection or failure to clear parasitemia may 
result in life threatening anemia. [103] 
5.3.4 Strategies for prevention and control of anemia 
Causes of anemia are multifactorial and therefore strategies for prevention and control 
require a multi-dimensional and comprehensive approach in public health and 
nutrition. WHO developed comprehensive packages of public health measure to 
address different aspects of micronutrient deficiencies and anemia. The package can 
be implemented in countries with different levels of iron deficiency, anemia, malaria, 
helminth infections and schistosomiasis. [121, 122] The different interventions in this 
package aim to 1) increase iron intake, 2) control infectious and parasitic diseases .3) 
improve nutritional status. 
 
5.3.4.1 Nutritional strategies 
5.3.4.1.1 Iron supplementation 
Increasing iron uptake and stores is important for preventing and treating iron 
deficiency. Iron supplementation is recommended by WHO as a public health 
intervention for children beginning at six months who are at risk of anemia or iron 
deficiency. [122] Although the safety of iron supplementation in malaria endemic 
countries has been put in question due the association with increased malaria 
morbidity and mortality, iron supplementation has been found to be beneficial for 
improving Hb when other malaria control interventions such as ITNs are utilized. [123, 
124] 
 
Under the Malawi National Nutrition Policy Strategic plan (NNPSP) 2007-2012, 
prevention and control of micronutrient disorders was one of the interventions 
prioritized to promote optimal infant and young child nutrition status in Malawi. [40] 
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Routine supplementation with vitamin A, iron and folic acid and deworming are 
provided through under five clinics or routine child health campaigns. [42] In Malawi, 
Iron supplements were given to 15.2% of children aged less than 59 months in 2015, 
[35] which is far less than the 22% of children who are reportedly iron deficient. [125]  
 
5.3.4.1.2 Improvement of nutritional status 
Provision of high nutrient diets to infants and young children is key for good 
nutritional status and prevention of nutritional deficiencies. Low cost interventions 
such as fortifying flour with iron and folic acid, diet diversification and 
supplementation of micronutrients such as vitamin A as well as have been 
recommended by WHO as steps to improve anemic status among children. [126] 
In Malawi, routine supplementation with vitamin A is implemented through the 
expanded package of immunization (EPI) but programmes for ensuring a more 
adequate dietary requirements are lacking. [42, 127] In 2015, mothers reported that 79% 
of children aged 6- 59 months ate foods that were rich in vitamin A and 62.2% 
children had received vitamin A supplements. [35]  
 
5.3.4.2 Infection control 
Infectious and parasitic diseases are some of the contributing factors to anemia risk. 
These diseases are often preventable but still contribute significantly to childhood 
deaths globally. [18, 112] Interventions for preventable child deaths from infectious 
diseases include, but are not limited to; improving access to professional health care, 
improving access to nutrition and micronutrients and childhood immunizations. [128] 
Infection prevention and treatment strategies such as immunization and control 
programmes for malaria, hookworm and schistosomiasis are key to prevent and 
control anemia among children. [121] Immunization protects children from common 
childhood diseases such as community acquired pneumonia and diarrhea therefore 
leading to improved nutrition, general health and reduced anemia. [21]  
 
Severe anemia in Malawian children: Risk factors, mortality and malaria chemoprevention 
Thandile Nkosi PhD thesis  
34 
5.3.4.2.1 Deworming for helminth infestations 
Poor sanitation practices including human waste disposal increases risk for intestinal 
infections such as hookworm and Trichuris in many developing countries. [129] In 
Malawi, antihelminth medication is distributed for free to young children by the 
government through deworming campaigns in the community to prevent anemia. In 
2015, 53.4% of children aged less than five years received deworming medication. [35]  
 
5.3.4.2.2 Malaria control 
Findings from malaria intervention studies have shown compelling evidence that 
malaria contributes substantially to anemia in endemic regions. [120] A recent 
systematic review of 29 community-based studies of insecticide- treated nets (ITNs), 
antimalarial chemoprophylaxis, and insecticide residual spraying found that among 
children aged less than five years old exposed to between one and two years of any of 
the malaria control interventions, the mean Hb increase was by 0.76 g/dL compared to 
those who did not use any malaria control measures. [108] As part of malaria control 
strategies, WHO recommends provision of ITNs and IPTi to infants and children for 
malaria prevention which in turn reduces malaria incidence and prevalence. [87] In 
Malawi, ITNs are provided to under-five children at birth or at the first contact with 
the health facility. [90]
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5.4 Severe anemia 
5.4.1 Burden of severe anemia 
Severe anemia is characterized by hemoglobin concentration level that is less than 
7g/dL or hematocrit below 15% by WHO. [130] Severe anemia is a major public health 
problem that affects over 10 million children globally and significantly contributes to 
morbidity and mortality in Sub-Saharan Africa (SSA). [106, 131] In Malawi, the 
prevalence of severe anemia from a survey in 2015 was 3%. [35] However, scarcity 
and inconsistency of collecting routine in-patient data may underestimate the  
number of cases of severe anemia that present to hospital.  
 
5.4.2 Impact of severe anemia 
In addition to the negative consequences on cognitive development and physical 
growth that severe anemia has on children [132], the mortality risk persists for several 
months after the acute phase in the hospital. [131-134] While in-hospital mortality rate 
of 6% has been reported in Malawi and mortality rates as high as 53% have been 
reported in other settings, limited studies have examined the mortality risk that 
persists in the long term among under-five children with severe anemia. [5]  
 
One longitudinal study in Malawi found that children admitted to hospital with 
severe anemia died within 6 months after discharge compared to 1.6% community 
controls without severe anemia. [4, 5] In addition, 5.9% severely anemic children were 
re-admitted with severe anemia compared to 0.5% of those without severe anemia. [4, 
5] [5] Similar post-discharge morbidity and mortality has been reported in Kenya and 
in Uganda. [131, 135] 
 
5.4.3 Etiological factors for severe anemia 
There are limited studies on the etiology of severe anemia. Factors such as vitamin A 
and vitamin B12 deficiencies, bacterial infections, hookworm, and parasitic 
infections such as malaria; are common among children with severe anemia. [4, 136] 
However, unlike in mild or moderate anemia, deficiencies in iron and folic acid are 
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negatively associated. [4, 119] Hemolysis, blood loss and red cell production failure 
have been found to be the main mechanisms that lead to severe anemia and the above 
etiological factors contribute. [119] 
 
5.4.4 Malaria and severe anemia 
Malaria has been attributed as a major risk factor for severe anemia in high 
transmission areas. In severe falciparum malaria infection, there is a decline in 
hematocrit due to multiple of factors that cause severe anemia by two mechanisms; 
increased RBC destruction and reduced RBC production. [120, 137-139] Increased 
erythrocytes destruction results from several mechanisms including; 1) rupture of 
parasitized RBCs, 2) increased removal of parasitized and non-parasitized RBCs 3) 
increased RBC clearance by the spleen and 4) intra- and extravascular  hemolysis. On 
the other hand, RBC production is affected by recurrent and frequent falciparum 
malaria which cause; 1) defective and underdevelopment of RBCs, 2) reduction in 
cell signaling proteins and RBC producing hormones, and 3) interactions with other 
ongoing infections. [139] 
 
5.4.4.1 Treatment strategies for severe anemia 
In most parts of SSA, treatment for severe anemia aims to prevent and treat the 
underlying malaria infection as well as to correct the decline in hemoglobin. [121] The 
standard treatment for severe anemia is hospital admission to hospital with a blood 
transfusion given at 20 mL per kilogram, combined with presumptive parenteral 
artesunate; and antibiotics if bacterial infections are suspected. [140] Once the child is 
stable and able to eat, treatment is completed with a short course of oral artemisinin-
based combination therapy, [19] usually artemether-lumefantrine (AL) for three days. 
[140] Children are often discharged to go home with a short course of iron and folate 
and typically with no scheduled follow-up. 
 
5.4.4.2 Malaria as a cause of post-discharge severe anemia and mortality 
After an episode of malaria-related anemia, it takes about six weeks for 
hematological recovery to occur [119, 141] Observational studies in Kenya and Malawi 
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found that among other factors, malaria infection during the recovery period among 
under-five children hospitalized with severe anemia was a significant contributor to 
the slow hematological recovery in high malaria transmission settings. [5, 142] After the 
initial rise in hemoglobin achieved by a blood transfusion; these children experience 
new or recrudescent malaria infections combined with the delayed hemolysis that 
occurs due to artesunate treatment which may prolong hematological revival leading 
to recurrence of severe anemia and death. [131, 143-145] 
 
5.4.4.3 Control strategies for malaria-associated severe anemia 
In addition to vector control strategies; ITN use and IRS, WHO recommended 
strategies for malaria prevention and control include intermittent preventive therapy 
(IPT) among pregnant women (IPTp) or infants aged between 6-24 months (IPTi) in 
areas with high malaria transmission and seasonal malaria chemoprevention (SMC) 
among children in areas that experience seasonal transmission. [94, 98, 146] IPT is a 
malaria control strategy that calls for administration of full treatment courses of long 
acting antimalarials at pre-defined intervals irrespective of the individuals’ malaria 
status. [96] Currently there are no control strategies for the high-risk recovery period 
for under-five children previously treated for severe anemia in malaria endemic 
countries.  
 
In addition of IPT clearing existing malaria parasitemia or providing prolonged 
protection against new malaria infections, it has been shown to have a beneficial 
effect on anemia [96, 120] Antimalarials can be used to create a prophylactic window 
period after an episode of severe malarial anemia to allow time for the bone marrow 
to recover, resulting in a more sustained recovery. A recent randomized trial in 
Malawi found that provision of malaria chemoprevention with full treatment courses 
of artemether-lumefantrine (AL) to under-five children hospitalized with severe 
anemia, given in-hospital and at one and two months after discharge, prevented 31% 
of deaths and/or re-hospitalization due to severe anemia or severe malaria by six 
months and 41% by three months after discharge in addition to the standard treatment 
course and protective effect of ITNs. [147]  
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Similar protective effects were reported in The Gambia, where provision of monthly 
IPT with SP or weekly pyrimethamine-dapsone targeted during the malaria 
transmission season reduced the rate of clinical malaria by half and 78% reduction in 
all-cause hospital readmission in one setting and 78% reduction in severe anemia in 
another. [148, 149] These findings suggest that provision of complete, rather than 
intermittent post-discharge malaria chemoprevention (PMC) with long-acting ACTs 
during recovery is a promising strategy for managing under-five children who were 
hospitalized with severe anemia. [150] 
 
5.4.4.4 Current delivery approaches of malaria interventions 
An effective delivery system is described as one that is accessible to the target 
population, offered correctly by the provider and given in the right regimen. [151] 
PMC is an intervention that could offer substantial public health gains in managing 
under-five children who are at risk of dying. Although PMC is a relatively simple 
intervention, implementation will require appropriate delivery strategies so that it 
reaches the population that need it most. However, a major concern is how it can be 
delivered in an effective and sustainable way. With the aim of achieving a malaria free 
world, the World Health Organization aims to achieve “universal coverage” of 
malaria control interventions. [61] However, a major challenge in malaria control is 
delivery of malaria interventions to the community that need it most. [152-154]  
 
In Malawi, IPTp with SP is delivered free of charge to pregnant women in early 
second trimester at antenatal clinics. [77] Despite IPTp being effective and affordable, 
the proportion of pregnant women who received three doses of SP remained at 31% in 
2015. [35] On the other hand, ITNs are delivered through two main methods; 1) at the 
health facility to pregnant women and under five children and 2) through mass 
distribution in the communities. [78] Utilizing these two delivery approaches, the 
number of ITNs in each household significantly increased from 71% in 2014 to 82% 
in 2017, of which 72% of ITNs were obtained from mass distribution campaigns 
compared to 9% from ANC and only 4% obtained for newborns at birth. [63]  
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Whereas other IPT strategies such as IPTp have established delivery systems, PMC 
targets a specific group of children who have come in contact with the health system 
but there are no guidelines for follow up care. In the Sahel region, WHO recommends 
provision of seasonal malaria chemoprevention (SMC) previously known as IPT in 
children (IPTc), to children aged less than five years during the high malaria 
transmission season for malaria incidence reduction and improvement of anemia 
status. [146] However, WHO does not specify the programming aspects of SMC except 
that it should be given using existing community platforms. [146] Utilizing community-
delivered models for malaria control and elimination are promising approaches to the 
management of this infection in areas where access to treatment is difficult [153, 155, 156] 
However, the first consideration for sustainability is whether it is possible to achieve 
effective delivery through routine delivery systems.  
 
Multiple studies have shown that community delivery of malaria interventions is 
effective for increased coverage, adherence as well as more cost-effective that facility-
based delivery. One cluster-randomized trial in 12,000 children in The Gambia, 
reported that village health workers (VHWs) achieved significantly higher coverage 
of IPTc than delivery through mobile nurse-led clinics and that this was also more 
cost-effective and equitable. [157] Another randomized clinical trial in Ghana found 
that both community delivery of SMC through village volunteers and delivery at 
clinics through health workers achieved high coverage for lower levels of adherence 
but coverage reduced for adherence to all four courses in both delivery arms. [151]  
 
Whereas in Mali, door to door delivery of SMC achieved higher coverage compared 
to fixed- point delivery in the community. [158] Another trial in Ghana also found that 
VHWs achieve higher coverage and adherence at lower costs than facility-based 
nurses at health centers or outreach clinics. [159] In contrast, community delivery of 
IPTp was explored in 12 villages in southern Malawi and they found that community 
delivery achieved better coverage but consequentially antenatal clinic attendance 
lowered thus affected pregnancy outcomes compared to routine delivery at the health 
centers. [160] Given the different settings and nature of interventions, a combination of 
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methods may have to be utilized in each unique setting. In the case of PMC, which 
targets a specific group of children a tailored approach of delivery will need to be 
explored.  
6 Context of the research 
6.1 Malawi: the country 
Malawi is a land locked country in Southern Africa. It shares borders with Tanzania in 
the north, Zambia in the northwest and Mozambique in the east, south and southeast. It 
has a land coverage area of about 118,500 square kilometers of which 94,276 square 
kilometers is land, and a quarter of the surface area is covered by Lake Malawi (Fig 2). 
The country is divided into three regions (North, Centre and South), with a total of 28 
administrative districts; six in the Northern Region, nine in the Central Region and 
thirteen in the Southern Region. 
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Figure 3. Map of Malawi  
With an estimated population of 18 million people Malawi is considered as one of the 
least developed countries in the world with very poor health and economic indices. 
[161] Although there has been a reduction in the proportion of Malawians living below 
the poverty line from 52% in 2004 to 39%, it is still ranked 172 out of 189 countries 
on the Human Development Index and has the world´s sixth lowest Gross Domestic 
Product (GDP) per capita. [39, 162]  
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6.2 Health service system in Malawi 
The Malawi health service delivery system is pyramidal, consisting of tertiary, 
secondary and primary care levels. Secondary care health services account for 9.5% of 
all health care facilities and are provided at district and Christian Health Association 
of Malawi (CHAM) facilities. They provide outpatient and inpatient services for the 
community as well as referral services to health centers and community hospitals. The 
tertiary level of health services is intended for provision of specialist health care and 
they are provided at Central hospitals. However; in reality, up to 70% of the health 
care services they provide are either primary or secondary level services due to 
leniency in the control systems. [70, 163] 
 
Primary care is delivered through clinics and health centers where curative, maternity, 
and preventive services are offered. Malawi adopted the integrated management of 
childhood illnesses (IMCI) approach for comprehensive and integrated management 
of common childhood illnesses. Nearly 70% of health facilities offer basic child health 
interventions using IMCI approach. At community level, childhood illnesses are 
managed through the integrated community case management (iCCM) approach in 
more than 3,500 village health clinics (VHCs). The iCCM strategy targets rural 
communities who have challenges with access to health care and is aimed at 
community health workers (CHWs) providing timely diagnosis, treatment and referral 
services for the three common childhood illnesses; malaria, pneumonia and diarrhea. 
[164]  
 
A total of 30 countries have adopted iCCM as a strategy to increase access and 
coverage of treatment interventions for childhood illnesses. Despite the iCCM 
programme being rolled out in Malawi in 2007, several national-level evaluations 
between 2013 and 2017 have reported that iCCM has had minimal impact on under-
five mortality. Malawi continues to experience a high burden of infectious disease, in 
particular HIV/AIDS, respiratory infections, malaria, diarrheal diseases and perinatal 
conditions. [165, 166] However, the coverage of most childhood interventions has always 
been high, with the national immunization coverage at 85%. [163]  
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6.3 Community health workers in Malawi 
Use of community-based programs are effective at reducing mortality low- and 
medium-income countries (LMCI) such as SSA. [156] In Malawi access to quality 
health care is limited and this is a major challenge. It is estimated that only 54% of the 
Malawian population resides within 5 kilometres radius of a health facility and even 
patients who do reach a health facility, encounter a shortage of health care services. 
[164, 167] There are approximately 7 doctors/clinicians and 37 qualified nurses per 
100,000 population; signifying the need for minimally trained health personnel like 
HSAs. [163), 168] They have greatly contributed to the delivery of preventive health 
services in rural areas. [156, 169-171] In Malawi where 17 % of the population are 
children, CHWs are crucial in achieving healthy communities. [78] 
In Malawi, iCCM is provided by CHWs known as Health Surveillance Assistants 
(HSAs). HSAs were initially recruited and trained by the Ministry of Health (MoH) as 
CHWs for smallpox vaccinations in 1960s and they create a link between the health 
care system and the community. [70, 164] [172] It was in 2008 that the government of 
Malawi with support from United Nations children’s fund (UNICEF) established a 
programme to train this existing cadre of CHWs to provide iCCM in hard-to-reach 
areas with limited access to health facilities. HSAs have at least 2 years of  Malawi 
secondary school education with no formal medical training. They receive a 12-week 
training course enables them to diagnose and treat the most common childhood 
illnesses such as malaria, pneumonia and diarrhoea.  
The job description of HSAs is broad and their roles and responsibilities HSA have 
evolved over time. In addition to iCCM, HSAs provide health promotion and 
prevention services, work as environmental health monitors, data collectors and 
researchers with the duties of nurses being increasingly imparted to them. [169] [173] 
Apart from this multitude of tasks, HSAs are also required to reside within the 
community which they serve. [167] The major strengths reported for the motivation as 
reported by HSAs in communities are team spirit and cooperation, knowledge of local 
culture, language and environment. [174]  
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There are many reported technical and social constraints that affect the motivation and 
job satisfaction of HSAs. They have limited opportunities, limited supervision, limited 
training, low remuneration, lack of transport and housing to name a few. [169] These 
have been cited as the major reasons that they are unable to conduct their assigned 
tasks effectively. [173] Additionally, HSAs are often overloaded with work. There are 
instances where one HSA oversees a catchment area of an estimated 2364 people 
instead of the prescribed 1000. [169] Additionally, HSAs have limited training and are 
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7 Problem statement and rationale of thesis 
Severe anemia is major global health problem that causes of morbidity and mortality 
among under-five children in low-medium income countries. Severe anemia has been 
reported to cause up to 12% mortality rates and 6 % readmission within 6 months after 
discharge from hospital in Africa. [5] However, after standard in-hospital treatment 
with a blood transfusion and antimalarials there is no further scheduled follow up. [140]  
Causes of severe anemia are multifactorial but the major causes in developing 
countries are infections, malaria and poor nutrition. Malaria, anemia and malnutrition 
contribute substantially to childhood morbidity in Sub-Saharan Africa, and their 
respective roles and interactions are complex. [137, 176]  
 
Malnutrition on its own is the underlying cause of poor health in children with nearly 
144 million children and nearly half of all deaths in under-five children attributable to 
undernutrition. [31] All children with severe anemia have some form of malnutrition. 
[177] On the other hand, falciparum malaria is the major cause of malaria complicated 
by severe anemia and provision of malaria chemoprevention has been found to reduce 
the risk of death by 31% among children hospitalized with severe anemia. [147] 
 
With this background, it was important to investigate the added risk of death among 
severely anemic children who also have severe acute anemia as it may be a treatable 
factor associated with high mortality. Moreover, given that malaria chemoprevention 
may provide substantial protection to children recovering from severe anemia during 
the post-discharge period, it was important to identify a strategy that will deliver this 
intervention most effectively to the children that need it most. Furthermore, it was 
important to assess if community delivery of this intervention is acceptable and 
feasible from the provider point of view.
 




8.1 General objective 
To investigate the mortality risk and the delivery of malaria chemoprevention among 
under-five children with severe anemia in Malawi. 
8.2 Specific objectives 
1. To investigate the risk of mortality among children with severe anemia and 
moderate to severe acute malnutrition. 
2. To determine the optimum delivery method of post discharge malaria 
chemoprevention among children recovering from severe anemia. 
3. To determine the feasibility of utilizing community health workers in delivery 
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9 Methodology 
9.1 Study setting, design and population 
9.1.1 Study setting 
All three studies were conducted in the Southern region of Malawi. Paper I was 
conducted at Queen Elizabeth Central Hospital (QECH) in the city of Blantyre 
and Chikhwawa district Hospital in rural Chikhwawa district. The 1000 bed, 
urban QECH is the largest tertiary hospital in the country. It is located in the 
southern region of the country and it is the main teaching and training hospital 
for the medical, clinical and nursing colleges. Chikhwawa district hospital on 
the other hand is in rural Chikhwawa district and caters for the 437,892 people 
who reside there.  
The PMC trial for Papers II and III was conducted in Zomba District. Zomba 
District (former capital city of Malawi) is in the southern region of the 
Republic of Malawi and covers 3% of the total land area of Malawi. The 
District has a total population of 583,167. Health services are provided mainly 
at health posts in the community, 29 health centers and three tertiary hospitals. 
In addition, medical treatment is also provided by traditional practitioners and 
traditional birth attendants. The infant mortality rate in Zomba is 48 
deaths/1,000 live births and child mortality is 14.4%, which is among the 
highest in the country. [161] There is a total of 630 HSAs, who report to the 
health facilities under the DHO. The PMC trial recruited children from the 
Zomba central hospital, which is the referral hospital for all health centers and 
neighboring districts. 
9.1.2 Study design 
For this thesis, the study designs, population and data collection for each paper 
have been summarized in Table 1. Paper I was a cohort analysis of data 
collected from the severe anemia (SEVANA) study in Malawi while Papers II 
and III were research studies that formed part of the major activities (MAs) of a 
GLOBVAC funded mixed-methods research project entitled “ Post-discharge 
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Table 1. A summary of the study designs and participants for studies in this thesis. 
Papers Study design Participants 
A cohort analysis of survival and outcomes 
in severely anaemic children with 
moderate to severe acute malnutrition in 
Malawi 
(Paper I) 
Cohort study 330 under-5 children with severe 
anemia from SEVANA study cohort 
Adherence to community versus facility-
based delivery of monthly malaria 
chemoprevention with 
dihydroartemesinin-piperaquine for the 
post-discharge management (PMC) of 
severe anemia in Malawian children: A 




375 under-5 children with severe 
anemia at Zomba Central Hospital 
Introducing post-discharge malaria 
chemoprevention (PMC) severe anemia in 
Malawian children: a qualitative study of 
community health workers’ perceptions 
and motivation (Paper III) 
Qualitative in-
depth interviews 
and focus group 
discussions 
39 Health Surveillance assistants 
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9.1.2.1 Summary of the PMC project 
This PMC consortium was collaboration between University of Bergen, 
University of Malawi, University of Indiana, Liverpool School of Tropical 
Medicine, the Kenya Medical Research Institute (KEMRI), University of 
Amsterdam and Makerere University. Through five MAs, the project aimed to 
improve the health of under-five children suffering from severe anemia by 
providing malaria chemoprevention during the post-discharge period in areas 
with high prevalence of malaria. Papers II and III were under major activity 2. 
MA2 was a cluster randomized trial that was conducted in Zomba, Southern 
Malawi.  
 
9.1.2.2 Summary of the SEVANA project 
The SEVANA project that was a collaboration funded by the Wellcome Trust 
and University of Amsterdam. The aim of this project was to investigate the 
aetiologies, pathogenesis and long term outcomes among under-five children 
with severe anemia in Blantyre and Chikhwawa districts in Malawi. This was a 
long-term follow up study of severely anaemic children in rural and urban 
Malawi. Severely anaemic children aged less than five years old were enrolled 
after correction of their anemia at Queen Elizabeth Central Hospital and 
Chikhwawa district Hospital. For each child enrolled, one child admitted to 
hospital with another condition and another child from the community were 
also enrolled as controls.  
 
The primary end-point for this study was the incidence of the first episode of 
severe anemia within the follow-up period. The 18 months follow-up period 
was both active and passive. During the active surveillance, follow up visits 
either at the study clinic or at the child’s home were conducted at 1, 3, 6, 12, 
and 18 months after enrolment and the passive surveillance system entailed that 
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9.1.2.3 Study Design and data for Paper I 
Paper I, was a prospective study from the SEVANA study in Southern Malawi. 
We assessed the risk of death, re-hospitalization and recurrence of severe 
anemia among severely anemic children who also had moderate to severe acute 
malnutrition. Anonymized data of severely anemic children who had a 
recorded weight, height , age, hemoglobin concentration and outcome status 
during the 18-month follow up period was included. We collected baseline 
information on the socio-demographic characteristics , medical and dietary 
history and physical examination findings. 
 
Anthropometric measurements were used to calculate z-scores from the median 
height for weight of the WHO child growth standards. Children who were 
equal to or below minus two standard deviations from median height for 
weight, met the WHO definition of moderate to severe malnutrition. Children 
with a weight for height above minus two were the comparison group. We 
collected clinical as well as laboratory information for all the scheduled and 
sick visits up until the last follow up date. 
 
9.1.2.4 Study design and data for Paper II 
In paper II, we conducted a five-arm, open label cluster-randomized trial 
among children aged less than five years with severe anemia (hemoglobin 
concentration less than 5g/dL) who were admitted to Zomba central hospital’s 
pediatric ward. These children were screened and included if they were aged 
less than 59 months, weight above 5kg and were stable and discharged to go 
home after receiving the standard in-hospital care; which included blood 
transfusion, intravenous artesunate, and antibiotics for suspected bacterial 
infections. Children with other specific causes of anemia such as trauma, sickle 
cell disease, heart disease and those who residing out of the catchment area 
were excluded. Information on socio-demographic characteristics, medical 
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We allocated children to each trial arm depending on which village they 
resided. All villages within Zomba district were randomized to each of the to 
receive monthly dihydroartemesinin-piperaquine as follows: 1) community-
based delivery without an SMS reminder (Com-SMS); 2) community with an 
SMS reminder (Com+SMS); 3) community-based delivery with an HSA 
reminder instead of SMS reminder (Com+HSA); 4) facility-based delivery 
without SMS reminder (Fac-SMS); or 5) facility-based delivery with SMS 
reminder (Fac+SMS). Detailed descriptions of the methods have been provided 
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All three monthly, co-formulated dispersible tablets containing 20 mg dihydro-
artemisinin and 160 mg piperaquine was given in standard treatment doses 
according to weight over three days. Caregivers were given instructions to 
administer three full monthly treatment courses at two (PMC-1), six (PMC-2) 
and ten weeks (PMC-3). The maximum number of doses that could be 
administered was nine. Standardized verbal instructions about administration 
and frequency were given to the primary caregiver and specific dates of 
administration were documented in the child’s health book. The drug blister 
pack also contained administration instructions in Chichewa. All the caregivers 
regardless of assigned arm were requested to come back to the study clinic for 
the end of study assessment at 14-15 weeks after enrolment. After enrolment, 
the study participants were traced to their home to collect GPRS positions for 
follow up and ascertain distance from the hospital. 
To measure our primary outcome, full adherence; field workers made 
unannounced home visits to participants’ homes collect blister packs and assess 
if study medication was indeed given to the child participating in the trial. If 
the caregiver was not at home, they were contacted and visits were made when 
they were at home. The number of tablets remaining in the blister packs was 
recorded and if none were remaining “0” was recorded. If the blister pack was 
missing, the field worker probed to assess if the medicine was given to the 
child or not. In addition, assessment for adverse events was made and children 
were referred to the nearest health facility if they were sick.  
We collected a blood sample from a finger prick to check hemoglobin levels 
using the Hemocue 301 and peripheral slides for malaria microscopy after 
enrollment, at every sick visit and end of study visit at the study clinic. 
 
9.1.2.5 Study design for paper III 
For paper III, we used qualitative research methods to assess the acceptability 
and perceptions of health workers particularly health surveillance assistants 
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(HSAs) who were involved in the PMC trial. Children who were assigned to 
the community + HSA arm (COM+HSA) were given 3 months of PMC 
medication to take while at home and receive a monthly reminder from the 
HSA. 
Prior to commencement of the main trial we conducted training workshops 
with all HSAs who were working within the catchment area of Zomba district 
health office. [179] The workshops covered topics about severe anemia, causes, 
diagnosis and complications. We also explained their role in the PMC trial and 
the activities that they were expected to carry out during the study. On the day 
when the child was discharged from the hospital, the mother was linked to the 
HSA in their catchment area. The HSA responsible for the catchment area had 
their contact details collected and were informed about the participant’s 
participation in the trial, location and dates of medicine administration. When 
the HSA was not available the research staff contacted him/her through the 
phone or visited his/her home. One or two days prior to the scheduled date of 
drug administration, the HSA was expected go to the child’s home to remind 
the caretaker to administer the study drug. The HSAs are not compensated for 
this work and it is expected that it is undertaken on “any other duties assigned” 
basis. 
 
Utilizing interview guides, three independent research assistants conducted 
semi-structured in-depth interviews (IDIs) and focus group discussions (FGDs) 
in the local language of Chichewa . All interviews were digitally recorded, 
transcribed verbatim and translated into English by the research assistants. The 
information gathered was supplemented by ethnographic methodologies like 
observations and informal interviews from myself. Transcripts were loaded 
into NVIVO 11 for analysis. Each IDI and FGD was deductively and 
inductively coded and a coding system was developed based on the research 
objectives and the analytical framework of motivation. The coding system was 
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expanded during the coding process to capture emerging themes outside of the 
original study objectives.  
 
9.1.2.5.1 In-depth interviews 
The aim of IDIs is to uncover the perceptions and understandings of a topic as 
seen from the interviewees’ point of view. [180] The semi-structured interview 
technique is based upon set topics, but has an open-ended approach which 
allow the informant to speak at length without interruption. This was best 
suited for this study because we aimed to uncover the perceptions and 
understandings of PMC from the interviewees’ point of view. [181] In this study 
the interviewers used a list of guiding questions based on the pre-defined 
research questions. The interviewers probed when the responses were unclear 
and to seek clarity on the meanings.  
 
9.1.2.5.2 Focus group discussions 
An FGD involves a small group of participants (normally 6-12) with a 
moderator guiding the discussion with the use of a topic of discussion guide. 
[181] Although saturation was achieved with the initial IDIs that were conducted, 
the choice to conduct FGDs was made to further explore the different 
experiences and motivations between HSAs who made at least one hone visit 
and those who did not conduct any home visit and to explore further the 
findings from the analysis of the IDIs. 
 
With additional information provided by the caregivers at their last study visit, 
we were able to determine whether HSAs made the visits to the children, the 
timing of the visit, the information given to the caregiver and any other 
activities. Thereafter we invited additional HSAs who were not involved in the 
IDIs. We grouped them into two, one group who made at least one visit and the 
other who did not conduct any visit. Utilizing a topic guide, a nurse and a 
research assistant conducted the FGDs separately in Chichewa. A description 
of the participants in FGDs has been provided in table 5. 
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9.2 Sample sizes 
For Paper I, we used open EPI version 3 (www.openepi.com) to calculate the 
sample size. We calculated that we needed 201 children in each group to detect 
a two-fold risk of death among children with MAM/SAM compared to those 
without, with a 95% two-sided confidence interval and 80% power. However, 
due to the limited number of children among the MAM/SAM group and using 
the same assumptions as above with a sample size ratio of one to five 
(MAM/SAM/ no MAM/SAM); our study had a statistical power of 76.4%.  
 
For Paper II, the sample size was determined on the primary outcome of full 
adherence, which was defined by as the administration of all nine doses of 
dihydroartemesinin-piperaquine. We estimated that, in order to detect 25% 
increase from medium adherence to full adherence and allowing 10% losses to 
follow up and intra-cluster correlation of 0.1; 25 clusters (villages) with three 
children each (75 each and 375 overall) were required to give our trial 80% 
power. 
 
Given that Paper III was a qualitative study, no sample size was calculation 
was made. We purposely sampled the 39 HSAs because children under their 
care had completed the trial and this was important so as not to contaminate 
HSAs’ behavior on the on-going trial. While we achieved saturation with the 
first 20 IDIs, we added the two FGDs to explore further the findings that had 
been identified in the initial analysis of the IDIs.  
 
9.3 Statistical analysis 
Data for Papers I and II were coded and analyzed using STATA 14 and 15 
(StataCorp, College station, Texas, USA) respectively. We used appropriate 
descriptive statistics to summarize data, with mean or median (IQR) for 
continuous data, and frequencies and percentages for categorical data.  
For Paper I, we calculated mortality rates among the severely anemic children 
with moderate to severe acute malnutrition and those without. We measured 
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time to death by survival analysis, using Kaplan-Meier curves to compare the 
probability of death between the two groups over the 18-month study period. 
Significance was calculated using a log-rank test statistic.  
 
Incidence rates for other outcomes (re-hospitalization, malaria and severe 
anemia recurrence) were also calculated and compared between severely 
aneamic children with MAM/SAM and those with severe anemia alone. For the 
malaria incidence rate, 14 days was subtracted from the total time at risk for 
each episode from the child-years follow-up with each case of clinical malaria 
treated with AL. 
 
For Paper II, the primary outcome was full adherence. Our analysis was by 
intention to treat at cluster and participant levels as per the agreed statistical 
analysis plan (SAP). A factorial design analysis approach was used to 
investigate interaction between the effect of community compared to facility 
delivery and the pooled effect of SMS and interaction terms were included in 
factorial models to assess the strength of interaction. We also did several 
subgroup analyses for the primary and secondary outcomes adjusted for 
clustering, socioeconomic and demographic variables stratified by each 
intervention arm with the Facility-SMS (Fac-SMS) group as the reference 
group.  
 
For the secondary outcomes, the different levels of adherence were compared 
between the five groups. We used Poisson regression for the total number of 
doses administered. The unadjusted and adjusted incidence rate ratios (IRR) 
measuring the percentage of children receiving PMC according to schedule in 
each arm were obtained and compared between arms and the 95% CI for the 
IRR have been reported. The estimates of the IRR were adjusted for baseline 
characteristics using Poisson regression and clustering was accounted for. For 
all the measures of effect,  95% CIs were provided. The full statistical plan has 
been provided in the appendix. 
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No statistical methods or analyses were done for Paper III. However, inductive 
and deductive analysis and coding was done using NVIVO 11.  
 
9.4 Ethical considerations 
Paper I was submitted and approved by the ethics committees of the College of 
Medicine, University of Malawi and the Liverpool School of Tropical 
Medicine, United Kingdom. Papers II and III were submitted and approved by 
the research ethics committees of the College of Medicine in Malawi 
(COMREC, approval number P·02/15/1679 and the Regional Ethics 
Committee of Norway, approval number 2015/537 (REK Vest). The trial was 
registered at ClinicalTrials.gov (identifier: NCT02721420). For all studies, 
written informed consent explaining the aims and procedures of the studies was 
obtained from legal caregivers of the participating children in Papers I and II 
and from HSAs in Paper III prior to data collection. Completed data collection 
tools were kept in a secure place, only accessible to the research team.
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10 Summary of results 
10.1 Mortality among under-five children with severe anemia (Paper I) 
Our primary objective for this study was to investigate if severely anemic 
children with moderate to severe acute malnutrition were at increased risk of 
dying compared to children with severe anemia alone. We also aimed to 
determine if these children were at higher risk for re-hospitalization, malaria 
incidence and recurrence of severe anemia during the 18-month follow-up 
period. 
 
Data of a cohort of 382 under-five children with severe anemia was screened 
and 330 met the inclusion criteria. A total of 53 children had moderate to 
severe acute malnutrition (weight for height <-2 of Z-scores) and 27 did not. 
During the entire study period, a total of 51 children (15.5%) died, while 20 
were lost to follow up (6.1%) and 259 (78.5%) completed the 18-month 
follow-up period. Of the 51 deaths, 17 (5.2%) children died within one month, 
10 (3.0%) after three months and 10 (3.0%) after six months post-discharge.  
 
Out of the 51 deaths, 15 (28.3%) were children with MAM/SAM and 36 
(13.0%) children had severe anemia alone. The overall incidence of death 
among all the children was 3.0 (CI 2.2,4.0) children per 1000 child-days of 
observation. Among the children with MAM/SAM the incidence of death 5.4 
(3.0,9.8)/1000 child-days and 2.6 (1.9,3.7)/1000 child-days among children 
without. This shows that children with MAM/SAM had a twofold risk of dying 
compared to children who has severe anemia without moderate to severe 
malnutrition) RR 2.1; CI 0.9,4.2, p=0.03).  
 
In another analysis we found that severely anemic children who were 
underweight (defined as weight for age <-2 of Z scores) had 3-fold risk of 
dying compared to those with severe anemia alone (RR 2.8; CI 1.5-5.2, 
p=0.0006). This is further depicted in the Kaplan-Meier survival curves in 
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figure 3 which  show that children with severe anemia alone had a higher 
probability of survival compared to those that also had moderate to severe 
acute malnutrition. However, this was not statistically significant (log 
rank=2.9, p=0.098). 
 
We further found that more children who had severe anemia alone were 
readmitted to hospital during the follow up period compared to those with 
moderate to severe acute malnutrition (4.4% versus 3.5%), (IRR 0.8; CI 0.4-
1.7, p=0.62); but this was not statistically significant. In addition, the 
proportion of children who had a recurring episode of severe anemia was 
similarly low (1.6% each) in both groups the two groups of severely anemic 
children (IRR 1.1, CI 0.3-2.8, p=0.8) over the entire study period. The main 
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10.2 Delivery of malaria chemoprevention for post-discharge management 
of children with severe anemia (Paper II) 
We conducted this 5-arm cluster randomized to evaluate the most effective 
method of delivering malaria chemoprevention with dihydroartemisinin-
piperaquine for post-discharge management of under-five children recovering 
from severe anemia. The primary outcome was full adherence of DP (9 doses) 
during the 3 PMC courses. We screened 667 children who were admitted to 
Zomba Central Hospital with severe anemia between 24 March 2016 and 09 
October 2018. A total of 375 children were eligible, enrolled and randomized 
as follows: (Com-SMS=69; Com+SMS=75; Com+HSA=79; Fac-SMS=77; 
Fac+SMS=75).  
 
Overall, 93.6% were followed successfully until the end of the study; four 
children were withdrawn by their parents before the first home visit, four 
children died during the follow up period and twenty children were not brought 
for the end of study visit.Generally, the baseline characteristics of the children 
were similar across all the study arms. The median age and weight for all the 
participants were 29 months (IQR 19–39) and 11.3 kg (IQR 9.6–13.2), 
respectively. There were generally more males in each arm except in the 
Fac+SMS arm (48% male). A total of 99.7% of the children had malaria 
infection (confirmed by malaria rapid diagnostic test or malaria microscopy) 
and treated with intravenous or intramuscular artesunate during hospital 
admission.  
 
All the children in the study received at least one blood transfusion. However, 
only 1.6 % of the children had a recent history of severe anemia (four weeks 
prior to hospitalization) that required a blood transfusion. Over 76.5% reported 
possession and use of an insecticide-treated nets (ITN) the previous night prior 
to admission. Fever was the most common presenting symptom (98%). Out of 
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the 150 participants who were expected to receive SMS reminders, only 25 
(18.0%) reported to have received at least one SMS. 
 
Overall, we found that adherence to all the 9 doses of DP was reported in 
63.1% of the children. More children who received PMC in the community-
based reported full adherence compared to those in the facility-based arms 
(70.6% versus 52.7%, respectively). Children who received PMC in the 
community with an SMS reminder reported the highest proportion of full 
adherence (79.7%) compared to those in the community without an SMS 
reminder (63.2%), or with an HSA reminder (68.4%), and also those from the 
facility-based arm without an SMS reminder (51.3%) and with an SMS 
reminder (52.0%). Generally, when PMC was delivered through the 
community-based methods, adherence was greater than facility-based methods 
(IRR=1.24; 95%CI 1.10, 1.44 p=0.006) and this was observed in both the SMS 
recipients (IRR=1.41; 95%CI 1.21, 1·64, p<0.001) and in the non-SMS 
recipients (IRR=1.37; 95%CI 1.18, 1.61, p<0.001). 
 
10.3 Feasibility of utilizing HSAs for PMC delivery (Paper III) 
In paper III we conducted individual IDIs with 20 HSAs in December 2016 and 
two focus groups in March 2018 with 19 HSAs who had children who 
participated in the PMC trial from their catchment areas. We found that most 
HSAs conducted at least one the home visit to give reminders to the caregivers, 
and only fourteen did not conduct a single visit. Appendices 2 and 3 provide 
characteristics of the HSAs who participated in the IDIs and FGDs. 
 
All HSAs reported that that they were intrinsically motivated to take part in 
PMC because it is important and beneficial intervention that saves the lives of 
children who have malaria and anemia. The main source of motivation was a 
sense of obligation and altruism towards making sure the children in their 
community were healthy and recovering from this life-threatening 
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complication of malaria. They described that the assignment to visit children in 
their homes and provide reminders was relatively easy and did not require any 
additional effort. Many also reported gave them the opportunity to conduct 
other tasks that are part of their job description such as providing information 
on good hygiene. Most of the HSAs also said that this intervention helped them 
gain new knowledge that there is medication that can prevent children from 
malaria. Many HSAs reported that they appreciated being recognized for their 
importance in PMC. Knowing the participant’s family, close distance and the 
need to maintain the trust of the community were also reported factors that 
enabled HSAs to adhere to the home visits. 
 
Despite reporting high motivation to conduct home visits, many of the HSAs 
did not conduct all three home visits. They reported that they had faced 
challenges, which hindered them from doing so. Most of them reported that 
their workload was already too much to include home visits for PMC when it is 
not even on their job description. They also reported that the training they 
received at the beginning of the project was not adequate. A one-day training 
did not give them room to get enough understanding and they would have 
preferred at least three days of training and follow up refresher trainings to 
allow them to process the information. On the other hand, others reported that 
the initial training was adequate, but they were not supervised adequately by 
the research team during the project and they were unsure that what they were 
doing was correct. Another barrier that was reported by a few of the HSAs was 
that there was a negative reception from caregivers who were worried that the 
community questioned why they were visited on multiple occasions and 
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11 Discussion 
11.1 Methodological issues 
11.1.1 Study design and sample size 
This thesis presents findings from studies among children aged less than five 
years old who were admitted to the hospital with severe anemia in Southern 
Malawi. Specifically, we explored the impact that moderate to severe acute 
malnutrition has among children with severe anemia, the different methods that 
can be employed to delivery DP for post discharge malaria chemoprevention 
during recovery and the feasibility of utilizing HSAs to provide home 
reminders to caregivers of children recovering from severe anemia. 
In paper I, we used data from a prospective cohort study among severely 
anaemic children admitted to QECH in Blantyre and Chikwawa district 
hospital in Chikwawa. [4] A cohort study is a type of non-experimental or 
observational study design where by a cohort (a group of individuals), are 
followed up over a period of time from the time of exposure to the they 
experience the outcome of interest or not. This study design is useful for 
establishing temporal associations between the exposure and outcome, 
therefore directly measuring disease incidence. [182]  
Although more expensive and time consuming compared to other observational 
designs such as case-control or cross-sectional studies, the main advantage of 
cohort studies is that it is less susceptible to bias. On the other hand, it is also 
not efficient for rare outcomes compared to case-control studies and provides 
less control for confounding factors as compared to randomized-controlled 
trails. [183] The cohort study design was appropriate for our study because we 
wanted to determine the incidence rates of death between severely anemic 
under-five children who had moderate to severe acute malnutrition compared 
to those who did not over an 18-month period. 
In paper II, we conducted a five-arm cluster randomized trial that aimed to 
assess the most effective delivery method of DP for PMC by comparing 
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community-based s and facility-based methods among children recovering 
from severe anemia. [178] A cluster-randomized trial (CRT) is a trial in which 
individuals are randomized in groups (clusters) and not individually. [184] A 
cluster is defined as a unit comprising of a group of individuals such as a 
village, a school, geographic regions etc. [185]. In a CRT, all individuals within a 
given cluster are assigned to the same arm. [186] CRTs are used when; the nature 
of the intervention dictates its application at the community level, to minimize 
contamination when community allocation is more feasible, to measure and 
improve overall impact of the intervention on the population. [184] We utilized 
the CRT study design because blinding of participants or study staff would not 
have been possible, and we wanted to make sure that children coming from the 
same village were assigned the same intervention arm to minimize 
contamination. Contamination would occur if children from the same village 
were assigned different intervention arms, there will be too much shared 
knowledge and one individual’s changing behavior can influence another 
individual assigned to a different arm. [187]  
 
Other advantages of a CRT study design are that they offer cost and time 
efficiencies, it’s appropriate for community interventions which are naturally 
applied to the cluster level and they enhance participant compliance to some 
degree. [184] Although CRTs are an efficient methodology for sampling, they 
also have a few disadvantages compared to individually randomized trials. 
They are more complex in design, they require more study participants to 
obtain the same statistical power and more complex analysis as they require 
inferences be made at the cluster level and not at the individual level. [184] 
In paper III, we conducted a qualitative study aimed at exploring the feasibility 
of HSAs to conduct home visit reminders to caregivers for PMC. Qualitative 
research is a systematic scientific inquiry which seeks to build a holistic, 
largely narrative, description to inform the researcher’s understanding of a 
social or cultural phenomenon. [181] Qualitative research is a broad term for 
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investigative methodologies. In comparison to quantitative research, qualitative 
research focuses on words rather than numbers, depth rather than breadth. [188] 
Qualitative methods are exploratory; they seek to unearth people’s opinions, 
feelings, and experiences and understand behavior. This differs from 
quantitative research, which attempts to gather data by objective methods to 
provide information about associations, test a predefined hypothesis and 
predictions. [189] There are four different types of qualitative methods, 
phenomenology, ethnography, grounded theory and case studies. [181] 
Our study was largely phenomenological in nature. A phenomenological study 
is one, which is used to study phenomena such as events, situations and 
experiences among others. [190, 191] For this we utilized three qualitative research 
techniques; in-depth interviews, focus group discussions and ethnographic 
techniques such as my observations and experiences during the field work in 
the main PMC trial.  
In-depth interviews are a data collection method that involves direct one on one 
engagement with individual participants. [192] IDIs allow the researcher to 
gather more extensive and insightful information compared to other data 
collection techniques. Additionally, the researcher can establish a rapport, ask 
follow-up questions, explore emerging ideas and able to get real opinions 
without the effect of peer pressure dynamics that might exist in FGDs. On the 
other hand, they can be time consuming and require an expert interviewer. We 
conducted the IDIs in a semi-structured approach by using an interview guide 
with preset open-ended questions to explore our respondents more 
systematically and comprehensively while staying focused on our objectives. 
[192]  
Focus group discussions involve gathering of about six to twelve people of 
similar backgrounds or experiences to discuss their knowledge, attitudes, 
experiences and perceptions of a specific topic. We conducted the two FDGs 
because they are useful for gathering in-depth information about the opinions 
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and thoughts of the community in relatively a short time and to “triangulate” 
with our findings from IDIs. While they are structured and led by an 
interviewer, the questions are set loosely to allow open and expressive 
discussions among the participants. [180] FGDs require a skilled moderator who 
does show judgement or bias based on his/her opinion or experiences.  
 
The main disadvantages of FGDs are that respondents may be reluctant to 
share the true opinions on sensitive topics because of fear of judgement or the 
opinions shared are influenced by the dynamics and set-up of the group. [190] In 
our study, both FGDs were conducted by experienced research assistants and 
myself and given that the topic was not a sensitive one, we believe that the 
opinions and experiences expressed were accurate. In addition to the above 
methods, we integrated observations and experiences from the trial staff and 
from reports from caregivers of the children who participated in trial. [190] 
 
11.1.1.1 Sample size  
A sample size is calculated to determine the number of participants that will be 
required to include in a clinical study to have enough power to adequately 
answer the research question. [193] For Paper I, we calculated the sample size 
using Open Epi (www.openepi.com) based on the findings from Malawi 
among children with severe acute malnutrition. [33] To give 80 % statistical 
power and 95 % confidence to detect a risk difference of 20% between severely 
anemic children with MAM/SAM compared to those with severe anemia alone 
, 63 children were required in each study group. However, there were only 56 
severely anemic children with moderate to severe malnutrition in the study. We 
did a post-hoc calculation to find the power of our study and found that it gave 
us a power of 74.6%. 
Paper II was a CRT, whereby villages (clusters) rather than individual children 
were randomized. For CRTs, the sample size is calculated based on the number 
and size of clusters that need to be sampled. [186] In the sample size calculation, 
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we adjusted the design effect using the coefficient of variation method that 
assumes that the clusters have variable sizes. [194, 195] We assumed an intra-
cluster correlation coefficient (ICC) of 0.1 and allowing for 20% loss-to-
follow-up or efficiency loss due to varying cluster sizes, a sample size of 125 
clusters (villages) of an average of 3 children per village (i.e. 75 children per 
arm and 375 overall), had 80% power to detect a 25% absolute increase in 
coverage from an estimated 50% in the standard  out-patient groups to 75% in 
the arms supported by mobile phone reminders (α=0.05). 
 
The ICC is the ratio of the between cluster variance to the total variance and it 
is used to quantify how much more similar outcomes are for individuals within 
clusters than for those in different clusters. [184] It has a value between 0 and 1, 
(0 indicates that individuals within clusters are no more like each other than 
individuals from different clusters (there is no between-cluster variability), 1 
indicates that individuals within the same cluster all have identical outcomes 
(there is no within-cluster variability). [196, 197] We used an ICC of 0.1 based on 
a delivery trial of SMC in the Gambia. [157] 
 
Being a qualitative study, no sample size calculation was done for paper III.  
As opposed to quantitative research methods which employ probability and 
statistical sampling, qualitative sampling is purposive and based on their 
capacity to get rich information relevant to the focus of the topic and the extent 
at which saturation (no new information given) is achieved. [198, 199] We 
conducted the IDIs to get a deeper understanding of the motivation, perceptions 
and experiences which were different and might have been unique for each 
HSAs. Although we achieved saturation with the IDIs, we found it was 
important to conduct additional FGDs based on the initial coding of the IDIs. 
11.2 Internal validity 
Internal validity refers to the extent which a research study can credibly and 
confidently establish that the findings cannot be explained by any other factors. 
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[200] Internal validity of a research study can be affected by random and 
systematic errors (bias). [193]  
Random error occurs due to chance and it can be minimized by having an 
adequate sample size or by reducing errors in measurement. Bias on the other 
hand arises from deviation in the collection, analysis, interpretation and 
publication of data leading to conclusions that systemically underestimate or 
overestimate the true relationship between an exposure and outcome under 
study. All epidemiological studies are susceptible to bias. [193] Internal validity 
of a study can be compromised by three factors; selection bias, information 
bias and confounding.  
11.2.1 Selection bias 
Selection bias results from any error in selecting study participants or those 
affecting participation. [200] This can occur when two groups are not similar in 
the response, non-response and attrition rates and therefore the group are not 
comparable. [193] The commonest source of selection bias in prospective cohort 
studies is errors in selecting study participants (recruitment bias) and loss-to-
follow up, whereby study participants are no longer available or willing to 
continue participation. Distortion occurs when there is differential loss to 
follow up with respect to both the exposure and the outcome (more losses 
among those exposed with an outcome). [193] 
11.2.1.1 Sampling strategies 
In Paper 1, we screened all the children who had severe anemia based on a 
clear entry criterion which also defined the exposure and outcome variables to 
avoid differential and non-differential misclassification. However, 13% of the 
children screened were excluded due to missing anthropometric data. This was 
a potential source of selection bias because the children who were excluded 
may have been significantly different in their exposure and outcome status 
from the children that were included (differential misclassification). [193] This 
could have led to underestimation or overestimation of the results. However, 
 
 
Thandile Nkosi Thesis V1 March 2020 74 
our result was less likely to be affected because there was 94 % response rate 
of all the children who had all data points recorded. Another major potential for 
selection bias in paper I was our sampling technique. We conveniently sampled 
children from an existing study and therefore the  exposed group (52 ) had a 
slightly low number of eligible children which would make our study 
underpowered. However, five times the required number of the unexposed 
group (277) was eligible and enrolled. This gave us a statistically relevant 
result with narrow confidence intervals.  
Similar to individually randomized trials, cluster randomized trials are also at 
risk of bias. The comparability of study groups can be challenged because 
groups of trial participants rather than individual participants are randomized. 
[201] Recruitment/selection bias can occur when individuals are recruited to the 
trial after the clusters have been randomized, as the knowledge of whether each 
cluster is an ‘intervention’ or ‘control’ cluster could affect the types of 
participants recruited. [187, 202] To minimize this potential selection bias in paper 
II, the randomization was done by the trial statistician who was not aware of 
the villages and he was not part of the data collection team at any time during 
the trial. In addition, screening and enrolment of study participants was done 
by the clinical team while the allocation was done by the data officer.  
 
Once a child was enrolled, the village from which they reside was given to the 
data officer. The data officer entered the name of the village and traditional 
authority into the pre-programmed randomization list which generated the 
intervention arm the child was assigned to. The data officer was not involved in 
screening or enrolment of trial participants. It is very unlikely that selection 
bias affected our results in paper II because the allocation was revealed and 
recorded at the same time to the clinical team and manipulation of the 
assignment was avoided. [203] 
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11.2.1.2 Loss to follow up 
Loss to follow up (LTFU) refers to when research participants are no longer 
available or unwilling to continue participation in the study and it poses a threat 
to internal validity. [201] Bias results when there are different rates of losses 
between study groups and participants who are lost to follow are different from 
those that complete the study as this may reduce the statistical power of the 
study. [193]  
In paper I, the overall proportion that was lost to follow up was only 6% during 
the entire the 18-month study period. Despite the differential loss to follow up 
(3.8% in the exposed group compared to 6.5% among the unexposed) that 
could have lowered the incidence of mortality among severely anemia children 
with moderate to severe acute malnutrition, we still observed a statistically 
significant difference in mortality between these two groups. We found that 
there was no significant difference in the age, location, severity of anemia and 
death rates among those that were lost to follow up compared to those that had 
a documented outcome. 
In CRTs, differential loss of clusters is potential source of selection bias. [184] In 
paper II, we only had four children (1.1%) whose caregivers withdrew 
participation prior to the first follow up visit and 16 children (4.2%) who 
relocated and could not be traced. This was equally distributed across all five 
study arms. This represented a loss to follow up of 5.3%. This was 
considerably a small loss to follow up rate when compared to studies that have 
shown that a loss to follow up of up to 20% might not introduce bias provided 
it is similar between intervention groups and it is included when calculating the 
sample size to detect the given effect during the design stage of the trial. [182, 193, 
204] In our sample size calculation, we allowed for a 10% loss to follow up and 
therefore this not likely to affect our results. To minimize losses to follow up in 
this trial, our research nurses were well trained and experienced. They provided 
comprehensive information that emphasized the importance of adhering to the 
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follow up schedule during the informed consent process. In addition to this, 
one of our eligibility criteria was to exclude children whose permanent 
residence was outside of the catchment area. Furthermore, field workers 
exhausted all necessary avenues to contact caregivers of children when 
children did not come for their end of study visit. 
11.2.2 Information bias 
Information bias occurs when there is an error in measurement or recording of 
the exposure or the outcome variables. [193] Like all other bias in research, 
information bias produces inaccurate results and conclusions. Information bias 
is also referred to as misclassification of which there are two types. Non‐
differential misclassification occurs when the degree of misclassification of 
exposure status among those with and those without the disease is the same and 
differential misclassification occurs when the degree of misclassification of 
exposure status among those with and those without the disease is different. 
Non- differential misclassification leads to bias towards the null, therefore 
diluting the true effect while differential misclassification can bias the effect in 
either direction depending on the number misclassified. [205] 
In paper I, we minimized measurement bias by having a clear eligibility 
criterion to avoid misclassifying the exposed group (severely anemia children 
with MAM/SAM) and those who did not have MAM/SAM. We also 
minimized any type of misclassification of our health outcome status by using 
objective definitions and measurement of our key outcomes. Children were 
recorded as either died, alive or lost to follow up at the end of the study period. 
However, because we excluded children with missing outcome data and those 
that died on the same day they were recruited did not contribute time to our 
analysis, we might have underestimated the true effect. To minimize recall 
bias, all information in the main study was entered at the point of contact.  
For paper II, the potential source of misclassification was how our outcome 
(adherence) was measured. Field workers conducted home visits to do a pill 
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count and confirm if the DP was given to the child participating in the trial. 
The number of tablets remaining in the blister pack was recorded. If there was 
no evidence that the medication was given it was assumed that none of the 
tablets were administered to the child as self-reported adherence is not 
objective. [206] Although pill count is not the gold standard of measuring 
adherence to medication and is a source of potential measurement error; it is an 
objective, noninvasive and suitable alternative to therapeutic drug monitoring 
and self-reported adherence. [207]  
There are two main problems with this approach, firstly the absence of the 
tablets does not necessarily mean that the medication was given to the child in 
the trial and such this method might have overestimated the levels of 
adherence. Secondly, absence of a blister pack did not mean that the study 
medication was not given to the child. However, since these approaches were 
both applied across all trial arms, it is unlikely that there would have been 
differential misclassification that would affect our results. To further minimize 
information bias, home visits were conducted a day or two after administration 
of the last dose of DP to minimize recall bias.  
Although cluster-randomized trials are more pragmatic and the best suited 
design for our study objectives, they have challenges during analysis. [208] 
Many CRTs use incorrect methods of analysis, whereby they are analyzed as if 
individuals had been randomized and clustering is ignored when the unit of 
analysis is different from the unit of allocation (unit-of-analysis error). [209] This 
leads to artificially small p-values and this can result in false positive 
conclusions that the intervention had an effect. [184, 208] To avoid this bias, we 
included a mixed effects model taking clustering into consideration. We found 
that village did not have a significant random effect, (likelihood ratio 2.9-05, 
p=0.498) and the ICC was very small (7.56-06), indicating that there were no 
correlations between individuals coming from the same village relative to those 
form different villages. Therefore, the data was as good as individual data and 
give the same results as analysis at the individual level.. 
 
 
Thandile Nkosi Thesis V1 March 2020 78 
11.2.3 Confounding 
Confounding is a distortion of the association between an exposure that occurs 
when the study groups differ with respect to other factors that is associated 
with the outcome. Different from selection or information bias which are 
introduced by the investigator or study participants, confounding can be 
adjusted for. [193] 
A confounding factor must be associated with the exposure and the outcome, 
must be distributed unequally among the comparison groups and must not be 
on the causal pathway between an exposure and an outcome. [193] Controlling 
for confounding can be done during the design or the analysis stage. Methods 
for controlling for confounding during the design stage include randomization, 
restriction and matching and during analysis; standardization, stratification and 
multivariate analysis. 
We controlled for confounding during analysis in paper I. We used the Cochran 
Mantel-Haenszel method to calculate risk of death between severely anemia 
children with moderate to severe acute malnutrition compared to those with 
severe anemia alone. The Cochran Mantel-Haenszel is a technique that 
generates an estimate of an association between an exposure and an outcome 
after adjusting or considering confounding by stratifying data into two or more 
levels of the confounder. [210] 
In paper II, our study design was randomized by clusters (CRT). 
Randomization is a process where study participants are randomly allocated to 
intervention arms and it is a powerful method of control and prevent 
confounding. [182] This gives each participant an equal chance of being assigned 
to any intervention group and therefore likely that groups will have similar 
distribution of possible confounding factors such as age, gender and residence 
and therefore making them comparable. [193] 
During analysis of paper II, confounding was controlled for by using 
multivariable analysis statistics. [210] Our main strategy for analysis was applied 
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univariate and multivariate Poisson regression models. After univariate 
analysis, we found that common risk factors such as age and gender were 
similarly distributed across all the trial arms, and therefore we only included 
distance from the hospital and literacy in our final multivariate model as this 
was associated with adherence. 
11.3 Discussion on External validity 
External validity is the extent to which the results of a research study can be 
generalized to other populations and contexts. [182] External validity is 
influenced by internal validity. [211]  
For paper I, we conveniently sampled children who participated in a cohort 
study and followed them up for 18 months. Although our simple size was 
limited, the dropout rate was low and the follow up period was long. Therefore, 
we were able to detect statistically significant findings. On the other hand, 
children who were in the study were likely to have had more access and contact 
with health care than those outside research contexts, but this would mean that 
we might have underestimated the results. Based on this, our findings can be 
generalized to the population of under-five children with severe anemia. 
In our cluster randomized study for paper II, we randomized all the villages in 
Zomba district so that all children from that village would be assigned to the 
same intervention arm and that all villages had an equal chance of 
participating. In addition, our sample size was large enough to ensure adequate 
power with clustering considered and a low dropout rate. The major threat to 
generalizing our study findings to “real life” is that adherence might have been 
overestimated because caregivers would be influenced to administer 
medication because they were under study and received a home visit each 
month.  
However, considering that all participants in all the intervention arms received 
a home visit each month, the difference in levels of adherent would still be 
detected and can be generalized to other ecological settings which have a 
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similar health system like Malawi. 
On the other hand, the use of SMS to increase adherence was not effective but 
then only a few caregivers received at least one reminder. Therefore, this 
should be taken into consideration when interpreting our findings.  
11.4 Bias in qualitative research 
Paper III used qualitative research methods. Qualitative research is often 
criticized for lacking transparency in relation to the analytical processes 
employed, which hinders the ability of the reader to critically appraise study 
findings. [212]  
Although “internal validity” of quantitative research is crucial for interpreting 
its’ finding, the opposite is true for qualitative research. [213] Qualitative studies 
focus on explorations of phenomena to contribute to the understanding of the 
topic in question and do not make any causal inferences and each one is 
unique. [181] Despite this, it is equally important to promote rigor and ensure 
that the quality or “authenticity” of the data and the quality or 
“trustworthiness” of the analysis are valid in qualitative research. [214] This can 
be achieved by employing at least two out of the eight methods to verify 
qualitative research findings. The recommended procedures are: Prolonged 
engagement and persistent observation, triangulation, peer review or 
debriefing, negative case analysis, clarification of researcher bias (reflexivity), 
member checking, rich, thick descriptions and external audits. [213]  
For paper III, we utilized triangulation, reflexivity and prolonged engagement. 
Triangulation refers to making use of multiple and different sources of 
information to provide corroborating evidence. [214] In addition to the IDIs and 
FGDs, we used information from caregivers and research field team to 
corroborate information that the HSAs provided.  
Clarifying researcher bias also known as reflexivity; is a process in which the 
researcher is open about his or her position and assumptions from the onset of 
the study that would explain the approach and interpretation of the inquiry. [213] 
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In this paper, only one FGD was moderated by the researcher and  the 
remaining FGD and 20 IDIs were moderated by research assistants who were 
not part of the research team. 
Prolonged engagement and persistent observation refer to validating research 
by working with people for long periods of time. [198, 215] Given that the 
researchers are health workers who have regular interactions with HSAs and 
also during the PMC study, experiences and observations of the researchers 
provided the opportunity to have more insight into the different aspects of 
HSAs and their lives. 
In qualitative research, external validity can be likened to the concept of 
“transferability”, which refers to the ability of findings from one study to be 
transferred to contexts, settings and communities that are similar. [216] Given 
that our study populations’ motivation and experiences with this intervention 
was influenced by their unique culture, setting and resources among other 
things, we only interpreted our findings within the context of our study 
population. 
11.5 Discussion of main findings 
11.5.1 Mortality among severely anemic children with moderate to severe 
acute malnutrition (Paper I) 
The aim of the study for paper I was to assess the risk of mortality among 
children who have the co-morbidity of moderate-to-severe malnutrition and 
severe anaemia compared to severe anaemia alone. In this study we found that 
over a period of 18 months, severely anemic children who had moderate to 
severe acute malnutrition had a two-fold risk of dying compared to those that 
had severe anemia alone (IRR 2.2). Similar high mortality rates have been 
reported in previous studies among under-five children hospitalized with severe 
malnutrition children and anaemic children separately in other African 
countries.[55, 56, 131, 217]  
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Prior to our study we did not find any prospective study that investigated 
mortality among children who had both morbidities. High mortality rates have 
been reported among hospitalized children with severe anaemia and 
MAM/SAM separately in many African countries. One retrospective study in 
Kenya reported that among severely anemic children aged less than five years 
old, the risk of dying was higher when they also had some form of 
malnutrition. (T. Kwambai, unpublished) Our findings show a much higher 
mortality rate than that reported in studies in children with severe anaemia 
alone in Ethiopia and Nigeria. [218, 219] This higher mortality could be attributed 
to the fact that children in our study had both conditions, which independently 
are major causes of mortality in children under five years. [5, 28]  
 
There are many observational studies that have reported the prevalence of these 
two co-morbidities together in young children but there is limited data on the 
long-term the impact on survival. Our findings from this study are important  
because in the context where up to 67% of severely malnourished children also 
had severe anaemia in other African countries and East Asia, screening for 
malnutrition in this patient population is not routinely done. [103, 220-225] In our 
study alone, we excluded 28% of the 382 children who were admitted with 
severe anemia because they weight or height was not recorded and of those that 
had it recorded, 16% were found to be moderately to severely malnourished. 
Although this is lower than findings from other countries, our findings suggest 
that there is a strong association between these two co-morbidities.  
 
Although, evidence shows that the risk of mortality among children with either 
severe anemia alone or malnutrition alone is attributed to many risk factors, 
these comorbidities together have an additional burden that makes them more 
susceptible to a lowered immunity and infections. [226, 227] This suggests that 
children with these co-morbidities are likely to have more severe disease and 
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The major limitation in our study was that the number of severely anemic 
children with moderate to severe malnutrition, was lower than the minimum 
required, thus lowered the statistical power of the study. However, our findings 
were statistically significant with narrow confidence interval. This suggests  
that there is an association between the risk of death and children having severe 
anaemia and MAM/SAM. This has the implication that malnutrition may be a 
treatable factor associated with high mortality among severely anaemia 
children. 
 
11.5.2 Adherence to DP for PMC (Paper II) 
In the 5-arm, cluster randomized trial for paper II, we aimed to identify the 
optimal delivery strategy that would result in high adherence to DP for PMC 
among children recovering from severe anemia. We found that children who 
had their monthly DP delivered in the community either by caregivers or HSAs 
reminders, resulted in 24% higher adherence compared to when caregivers 
collected DP from the health facilities. 
 
Our findings are consistent with results from studies in Kenya, Uganda and 
Ghana that have found that community delivery by CHW of malaria control 
interventions such as malaria treatment, ITN ownership, IPTp, IPTi and IPTc 
or SMC result in higher coverage, access, adherence and reduced malaria 
incidence. [155, 159, 228] Similarly, in Malawi, community delivery of SP for IPTp 
by CHW improved coverage from 41.5% to 82.9%. [160] In Gambia, CHWs 
delivery of IPTc also achieved higher coverage, cost effective and reduced 
symptomatic malaria cases. [157] 
 
Although utilizing CHWs for malaria treatment and interventions has proven to 
be effective for high adherence and reduced incidence of malaria and is 
supported by WHO , the effectiveness has shown to decline for subsequent 
doses or courses. In Mali, SMC delivered through routine programmes utilizing 
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existing CHWs reduced malaria prevalence, but 84% of the targeted children 
received the first course and only 54% received four complete SMC courses. 
[229] Our findings are also similar to this. Another study in Ghana reported that 
completion of all the three doses of IPTc was similar when delivered within the 
community by community village volunteers (91.6%) compared to delivery at 
health centers (91.7%). [151] This finding is important and will pose a challenge 
for the scale up of PMC, which is supposed to be delivered at specific time 
points. 
 
Utilizing CHWs has its own challenges and requires additional resources for 
training, supervision and incentives which may be challenging for PMC 
delivery. [230] In addition, children receiving PMC would need to be scheduled 
in CHWs work plans. In our setting, it has been reported that CHWs are 
motivated to provide reminders for PMC.[231] However, even with this 
motivation, our study found that less than 50% of the HSAs conducted the 
required home visit reminders. Many of the reported challenges included, 
inability to locate the child, high existing workload, limited training, limited 
supervision and poor community acceptance. [232]  
 
Another study reported that caregivers are capable of administering the first 
dose of an anti-malarial medication to the children with basic instructions and 
supervision from the CHW. [206] However, here are no studies that examined 
adherence to medication when utilizing caregivers to administer longer-term 
interventions at home. In our study we found that community delivery utilizing 
caregivers resulted to even higher adherence without requiring CHW 
reminders. Caregivers can administer monthly doses without additional 
reminders (SMS or CHWs reminder visits) and this is important because it will 
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A qualitative study examining acceptance of PMC among caregivers in Malawi 
reported that caregivers’ preference of delivery was to be given all the 
medication to administer to their children without any additional reminder 
because HSAs and phones were unreliable and collecting medication from the 
hospital was very challenging. [233] However, the concern with this method is 
the poor storage conditions and ensuring that medication will be administered 
to the sick child and not all children considered to be at risk in a household.  
 
Use of digital technology such as mobile phones have been hailed as important 
tools to improve adherence to medication, treatment response, and outcomes in 
resource poor settings such as SSA. [234, 235] In our trial we were not able to 
establish that provision of SMS reminders had an effect on adherence. Despite 
all of the caregivers having access to a mobile phone, only 18% reported to 
have received at least one SMS. Reported factors included lack of ability to 
charge them due to electricity, loss of network and not personally owning the 
phone. These and other factors such as mobile coverage and literacy levels 
have been reported as determinants of the feasibility of utilizing mhealth 
interventions in other settings such as Kenya, Zambia and Nigeria. [236] [237] [78] 
 
Our findings show that the feasibility of utilizing SMS reminders in the 
administration of PMC may be a challenge in settings like Malawi, where the 
literacy level (ability to read or write) is less than 70%, and only 11 % of 
households having reliable electricity. [125] Similar results have been reported in 
other studies conducted in southern Malawi, where SMS reminders showed to 
have a low impact on retention of HIV positive mother in HIV clinics in one 
study [238, 239] and health worker adherence and management of common 
childhood diseases in another trial. [240, 241] In this study only 43% intended 
SMS were received compared to a similar trial in Kenya where SMS receipt 




Thandile Nkosi Thesis V1 March 2020 86 
The timing of PMC medication administration is sensitive. It would be a 
challenge for a caregiver to rely on receiving timely reminders on a personal 
phone or rely on others to receive the reminder and pass on the message. 
However, a study in Tanzania has shown that unsupervised malaria treatment 
given at home by caregivers has shown to be highly effective in malaria 
treatment in children aged less than five years without the utilization of any 
reminders. [230] Contrasting to this, a qualitative study in Malawi showed that 
caregivers have a higher preference and confidence to be given all PMC 
medication to administer at home without SMS reminders because the majority 
reported that they did not receive the SMS reminder. [233]  
 
What our study adds is that there no studies that have assessed adherence to 
PMC, which is a new intervention for managing sick children during the post-
discharge period. In addition, we investigated the effectiveness of utilizing 
caregivers who routinely administer medication and we have demonstrated that 
caregivers are effective for higher adherence among children receiving DHP 
for PMC. In this case community delivery by giving the medication to the 
caregivers may be the most successful strategy for this promising intervention. 
 
11.5.3 Feasibility of utilizing HSAs to remind caregivers to administer DP for 
PMC (Paper III) 
In this study we aimed to explore whether utilizing HSAs can be a feasible, 
practical and acceptable delivery strategy for PMC. We found that only one in 
four HSAs who were trained to incorporate PMC reminders into their normal 
duties were completely adherent. However, despite this poor level of 
adherence, the great majority of the HSAs reported that they are intrinsically 
motivated to do this work of reminding caregivers to administer DP to children 
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The main reported motivation for HSAs in PMC came from their altruism, the 
recognition that they play a major role in health service provision to the 
community and the appreciation they get from the caregivers. The HSAs’ need 
to attain and maintain the trust of the community gives them a sense of duty 
and responsibility because they have developed lasting bonds with the people 
within the community. [232, 243, 244] In our study, they wanted to maintain the 
level of power by insisting that they need to be an integral part of this 
intervention.  
 
However, when it came to conducting the duties assigned for this intervention 
this motivation was not demonstrated. Similar to other findings reported from 
other studies, they reported that the positive impact of their work and benefits 
of the intervention played a major role on motivation. [170, 179]  
Some studies have also found that financial incentives may provide a source of 
motivation, while others have observed that this can negatively influence 
motivation. [174, 194] We found that most of the HSAs do not want additional 
financial interventions to conduct home visits since they made similar visits to 
community members as part of their normal duties, but they wanted financial 
incentives in the form of lunch allowances during trainings. This suggests that 
some form of reward either financial or non-financial for the extra work is 
needed to drive their extrinsic motivation, as they genuinely want to do well in 
their communities. On the other hand, some of the HSAs stressed that lack of 
refresher training with allowances reduced their motivation to make PMC visits 
which is also consistent with findings from studies of other community-based 
interventions. [194, 243]  
 
The success of any programme is indicated by knowledge gained and 
adherence. Although awareness of the burden and impact of malaria and severe 
anemia was high among the HSAs, the question is why there was poor 
adherence to an intervention that could potentially minimize morbidity and 
mortality in the communities? In line with other studies, our study found that 
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the factors that influence HSAs motivation to carry out the PMC intervention 
activities are multilayered. [245] Professional factors allow for good intentions to 
carry out the duties but structural and community factors are a hindrance to 
them. Some of the non-adherent and partly adherent participants in this study 
referred to a high workload as one reason why they had not conducted the 
visits which has been previously reported. [169, 175] However most said the task 
was simple so perhaps in the event of a scale up there would not be this amount 
of resistance as demonstrated here. Structural barriers that existed such 
difficulty with the text messages, inability to locate the child and transportation 
challenges, mainly attributed to poor adherence. In the existing health system, 
the same is true. 
 
All HSAs received similar training but there are other factors that come into 
play because with the same training some HSAs were adherent to all the 
required visits. Limited information and knowledge about the intervention 
reported meant that the HSAs did not have a proper understanding of their role 
and expectations. In order to minimize influencing the normal behavior of the 
HSAs, the study team did not make follow up supervision visits . As such no 
additional visits were made to the HSAs. With that said, many studies have 
shown similar findings, that training improves outcomes as acquired skills and 
knowledge are lost over time. [246-249] Since the majority of the HSAs felt that 
they needed more training with follow up refresher trainings then perhaps in 
the event of an upscale, resources should be placed into conducting more 
frequent training as a way of providing additional knowledge and feedback. 
[250]  
 
Strengthening supportive supervision has also been shown to improve 
effectiveness of utilizing CHWs in similar contexts. Good supervision has been 
shown to be an effective way to boost team spirit and improve the work 
environment through a continuing dialogue in similar contexts. [251] Clarity of 
chains of command and accountability are some of the few reported sources of 
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extrinsic motivation where one fears rebuke and loss of professional respect. 
When establishing PMC reminders by HSAs, it would be important to ensure 
that the chains of commands are made clear. One of the major challenges 
during the study was that HSAs were not sure who to report to, the research 
team or the line managers. Their preference was that this intervention should be 
carried out in the existing supervision structure. 
 
Reminding caregivers to give PMC medication is reportedly simple and 
requires minimal resources in the cases when the child lives nearby, but most 
of the challenges were related to identifying the child and incorporating that 
into their routine scheduled work plans. Firstly, locating the child was a 
challenge for some and in other instances when the HSA was available; they 
were driven to the child’s home by the research team. HSAs who knew the 
child’s home did not have this challenge. However, in the event of a scale-up, 
HSAs will not be driven to the child’s home. Therefore, to address this, 
establishing and strengthening existing supportive supervision is important in 
the event of an upscale.  
 
While HSAs in this study reported having strong relationships with their 
community who depend on them for guidance and community health needs. 
Caregivers in the trial preferred to use reminders documented in the child’s 
health book rather than the HSAs reminding them. They reported that their 
HSAs were unreliable and often unavailable. [233] However, other reports have 
shown this to be opposite in that HSAs have close ties with the community and 
is an important driver for carrying out their duties. [245] Interestingly, the HSAs 
themselves report that most of the times the caregivers were capable of 
administering the medicine to their children without reminders from them. 
However, the main concern with this was that there might be misuse of the 
medication such as administering it to another child as well as  poor storage 
conditions would render the medicine ineffective. They therefore believe that 
they should be an integral part of this and work hand in hand with the 
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caregiver. This is important because PMC delivered in the community has 
shown to be more effective than facility-based delivery. 
12 Conclusions 
The conclusions of this thesis have been reported in line with main objectives 
as follows: 
Objective 1: We aimed to determine if moderate to severe malnutrition increases 
the risk of dying among hospitalized children with severe anemia. 
• Among children who were hospitalized with severe anemia, those with 
moderate to severe malnutrition were two times more at risk of dying 
compared to children with severe anemia alone. 
• Rates of hospital readmissions and recurrence of severe anemia were 
similar among severely anemic children with moderate to severe 
malnutrition and those with severe anemia alone 
 
Objective 2: We aimed to evaluate the most effective delivery method of 
dihydroartemesinin-piperaquine to under-five children with severe anemia for 
post-discharge malaria chemoprevention. 
• Adherence to DP was generally higher among children who received all 
treatment doses to take in the community compared to collect them from 
the health facility. 
• Poor adherence to DP administration was generally low among all the 
children 
• Utilizing SMS reminders to improve adherence did not have an effect on 
administration of all treatment doses of DP. 
 
Objective 3: We aimed to explore the feasibility of utilizing HSAs in the scale 
up of PMC for post-discharge management of children recovering from severe 
anemia. 
• More than half of the HSAs participating in the PMC trial conducted at 
least one home visits to the children 
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• The main motivating and enabling factors for conducting home visits for 
PMC were altruism, genuine love for the job, positive benefits of PMC, 
gaining new knowledge and knowing about the sick child. 
• The reported barriers and challenges from conducting home visits were; 
a high workload, lack of provision of transport and additional incentives, 
limited supervision and lack of information regarding the study 
medication which is not known to the HSAs. 
13 Recommendations 
13.1 Policy implications 
1. We aimed to determine if moderate to severe malnutrition increases the 
risk of dying among hospitalized children with severe anemia. 
• Children admitted to hospital with severe anemia should be 
adequately screened for malnutrition as this might be an attributable 
and treatable cause that might improve recovery and reduce poor 
health outcome. 
• Children diagnosed with moderate to severe malnutrition should be 
routinely screened for anemia in order to improve health outcomes.  
2. We aimed to evaluate the most effective delivery method of 
dihydroartemesinin-piperaquine to under-five children with severe 
anemia for post-discharge malaria chemoprevention. 
• Community delivery of DP for PMC should be incorporated as policy 
for management of under-five children recovering from severe 
anemia. 
• Text message reminders may be an effective means to improve patient 
adherence, however more studies should be conducted to ascertain 
their effectiveness in a low resource health system such as Malawi 
3. We aimed to explore the feasibility of utilizing HSAs in the scale up of 
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• The Ministry of Health should improve working conditions, continued 
professional development trainings and empowerment HSAs because 
they provide essential health services at the community level. 
 
13.2 Further research 
• A statistically well-powered, prospective study to investigate the high risk 
of death among severely anemic children with moderate to severe 
malnutrition. 
• To investigate the effect of text message reminders on adherence to 
medication, an effectiveness trial that ensures that all participants in text 
reminder arms receive them should be conducted. 
• Another statistically well-powered trial should be conducted to evaluate 
effectiveness of community delivery of PMC on clinical outcomes
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Moderate to severe acute malnutrition (SAM/MAM) and severe anaemia are important and
associated co-morbidities in children aged less than five years. Independently, these two
morbidities are responsible for high risk of in-hospital and post-discharge deaths and hospi-
tal readmissions. The primary objective of this study is to investigate the risk of death among
severely anaemic children with moderate to severe acute malnutrition compared to children
with severe anaemia alone.
Methods
This was a retrospective analysis of data collected from a large prospective study that was
investigating severe anaemia in children aged less than 5 years old. The study was con-
ducted at Queen Elizabeth Central Hospital in Blantyre and Chikhwawa district hospital in
southern Malawi. Children aged less than five years old; with severe anaemia were
screened and enrolled. Each child was followed up for eighteen months at one, three, six,
twelve and eighteen months after enrolment. Data were analysed using STATA 15.
Results
Between July 2002 and July 2004, 382 severely anaemic children were enrolled in the main
study. A total of 52 children were excluded due to missing anthropometric data. Out of the
330 included, 53 children were moderately to severely malnourished and 277 were not. At
the end of the 18-month follow period, 28.3% of children with MAM/SAM died compared to
13% of children without MAM/SAM (RR 2.1, CI 0.9–4.2, p = 0.03). Similarly, children with
moderate to severe malnutrition reported a significantly higher number of malaria infection
cases (33.9%) compared to children with severe anaemia alone (27.9%, p = 0.02).
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However, the number of hospitalizations and recurrence of severe anaemia was similar and
not statistically significant between the two groups (RR 0.8 (0.4–1.4), p = 0.6 and RR 1.1
(0.3–2.8), p = 0.8).
Conclusion
Among children with severe anaemia, those who also had moderate to severe malnutrition
had a twofold higher risk of dying compared to those who did not. It is therefore crucial to
investigate acute malnutrition among severely anaemic children, as this might be treatable
factor associated with high mortality.
Introduction
Malnutrition is a complex and multifactorial condition that results from deficiencies, excesses,
or imbalances in a person’s intake of energy and/or nutrients and presents in two broad forms;
undernutrition which includes wasting, stunting and underweight; and micronutrient defi-
ciencies and obesity [1]. Globally, it is estimated that 52 million children under five are wasted,
75% of which are in low- and middle-income countries (LMIC) [2]. The 2016 Malawi demo-
graphic and health survey (DHS) reported that 37% of children under five years of age are
stunted while 12% are underweight [3], and mortality of up to 42% has been reported among
children hospitalised with severe acute malnutrition (SAM) [4, 5]. Such high mortality rate has
been attributed to comorbidities such as infections, including HIV, as well as micronutrient
deficiencies including anaemia that often affect children with SAM [6, 7].
Severe anaemia is one of the most common causes of admissions and mortality in Sub-
Saharan Africa (SSA) and annually affects 9.6 million children globally [8, 9]. In Malawi, it was
found that children with severe anaemia alone have a tenfold risk of dying within 18 months
after the initial episode compared to children from the hospital and community who did not
have severe anaemia [10]. Similar findings have been reported in Kenya and Uganda [11, 12].
Causes of severe anaemia are multifactorial and vary in different settings. In addition to infec-
tious diseases, genetic factors and malignancies, nutritional deficiencies are a major factor
[13–16].
Severe anaemia and any form of malnutrition are common and associated co-morbidities.
Anaemia is the most common manifestation of micronutrient deficiency in malnourished
children under 5 years old [17], with up to 67% of severely malnourished children found to be
severely anaemic [18, 19]. In Malawi, up to 63% of malnourished children have some form of
anaemia signified by a Haemoglobin (Hb) level of<11.0g/dl and of these, 22% are moderate
to severely anaemic (Hb<7g/dl). On the other hand, 15.8% of severely anaemia children are
found with SAM [2].
Severe anaemia is an important co-morbidity and determinant in the recovery of children
with malnutrition, so much so that WHO recommends that children with kwashiorkor or
marasmus should be assumed to be severely anaemic [20]. Many studies have reported the in-
hospital and post-discharge mortality outcomes among children with SAM [5, 21], and chil-
dren with severe anaemia [11, 22] separately. However, the added risk of dying when a child
has both of these conditions; which we predict would be high has not previously reported. As
MAM/SAM is a potentially treatable risk factor [3]; we aimed to evaluate its impact on mortal-
ity in severely anaemic children.
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Materials andmethods
This study was approved by the ethics committees of the College of Medicine, University of
Malawi and the Liverpool School of Tropical Medicine, United Kingdom. In the SEVANA
cohort study, children with severe anaemia and aged less than five years old were enrolled
from Queen Elizabeth Central hospital and Chikhwawa district hospital in southern Malawi.
Enrolment procedures have been extensively described elsewhere [14]. In summary, 382 chil-
dren admitted with severe anaemia (defined as a haemoglobin concentration<5.0 g/dL) were
enrolled and matched with one community and one hospital control. Each child was then fol-
lowed up for 18 months.
In the present study, verbal and written informed consent was obtained from the legal
guardians and children with severe anaemia who had a recorded weight, length and met the
WHO classification of moderate to severe malnutrition defined as a child whose weight-for-
length is less than<2 of the Z-scores and weight for age less that -2 of the z-scores [23]. An
additional inclusion criterion was documented haemoglobin at enrolment and a documented
date of outcome and status (died, completed, lost-to-follow up or withdrawn).
Information about the child’s age, sex, residence, number of living and dead siblings,
24-hour dietary recall, family history of sickle cell disease (SCD), jaundice, bloody stool and
urine, blood transfusion in the last two months, being on any medication, HIV infection and
other previous medical history were obtained from the legal guardians at enrolment. Addi-
tional information included guardian’s age, occupation and education level.
Other data points collected include physical examination findings at enrolment and labora-
tory records, which included parasitology, microbiology, haematology and biochemistry.
Power calculation
We did a power calculation to evaluate the statistical power of our study due to the limited
sample size. Using open EPI version 3 (www.openepi.com), we computed the 95% two-sided
confidence interval, risk ratio (2.1) and the number of children sampled in each study group
(53 with MAM/SAM versus 275 without SAM/MAM). We found that our analysis gave us a
power of 76.4%.
Statistical analyses
Data were coded, entered and analysed using STATA 15 (StataCorp, College Station, Texas,
USA). Categorical variables have been summarized as frequencies and proportions, while con-
tinuous variables as means with standard deviations and medians with the interquartile ranges
(IQR) reported. Death was our primary outcome. We examined risk of dying by calculating
mortality rates in the children with moderate to severe acute malnutrition and those without.
We measured time to death by survival analysis, using Kaplan-Meier curves to compare the
probability of death between the two groups over the 18-month study period. Significance was
calculated with a log-rank test. Incidence rates for the composite outcomes i.e. re-hospitaliza-
tion, malaria and severe anaemia recurrence were also calculated for each group. For the
malaria incidence rate, the time at risk was calculated by subtracting 14 days from the child-
years follow-up with each case of clinical malaria treated with Lumefantrine-Artemether (AL).
P values and 95% confidence intervals have also been included.
Results
Of the 1141 under-5 children enrolled in the SEVANA study between July 2002 and July 2004,
382 were severe anaemic cases admitted to the paediatric wards of QECH and Chikhwawa
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district hospital and 759 were hospital or community controls without severe anaemia. Of the
382 children, 330 had their weight and heights measured and were included in the final analy-
sis. A total of 53 children had a weight for height z-scores -2 (moderate to severe acute mal-
nutrition) and 277 had a weight for height z-scores> -2 (not malnourished). During the
follow up period, twenty children were lost to follow up, 51 died and 259 children completed
the study (Fig 1).
The baseline characteristics and examination findings of study participants was comparable
between the two groups (Table 1). Moderate to severely malnourished children were signifi-
cantly older with mean age, 24.3 months (SD 12.1) compared to 19.5 months (SD 12.4). The
mean number of days hospitalised was not significantly different, 4.9 days (SD 8.1) compared
to 3.9 days (SD 4.1). A higher proportion of non-malnourished children resided in a rural loca-
tion, 52.4% compared to 45.3% in the malnourished group. The majority of parents of the chil-
dren had received some formal education and about half of them had employment. A total of
34.0% of malnourished children had a sibling who died compared to 28.2% among children
without (p = 0.05).
A total of 196 children (59.4%) had a positive blood smear for P. Falciparummalaria infec-
tion on admission, and of these 32 (60.4%) were children with MAM/SAM and 164 (59.2%)
were children without MAM/SAM. C-reactive protein (CRP), a common marker of inflamma-
tion was raised ( 10Mg/L) among 83% of the children with MAM/SAM compared to 82.7%
of those without MAM/SAM. A total of 27.3% of all the children had iron deficiency. A higher
proportion of children with vitamin A and vitamin B12 deficiency were those without MAM/
SAM.
Fig 1. Study flowchart.
https://doi.org/10.1371/journal.pone.0246267.g001
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During the 18-month study period, the mean observation days was 383 in the severely anae-
mic children with MAM/SAM and 456 days in the severely anaemic alone group respectively
(Fig 2 and Table 2).
The cumulative proportions of children who died during the entire 18 month study period
was 51 (15.4%) with 27 (8.2%) dying within one month of admission. Of the 51 deaths, 15
(28.3%) occurred in children with MAM/SAM compared to 36 (13.0%) who did not. The over-
all incidence rate of death with the 95% CI was 3.0 (2.2,4.0) children per 1000 person days
observed. The incidence rates for death were 5.4 (3.0,9.8) and 2.6 (1.9,3.7) among children
with MAS/SAM and those without respectively. This shows that children with MAM/SAM
had a twofold risk of dying compared to children who has severe anaemia without MAM/
SAM (RR 2.1; CI 0.9–4.2,p = 0.03). Similarly, severely anaemic children who were underweight
had almost a 3-fold risk of dying compared to those with severe anaemia alone (RR 2.8; CI
1.5–5.2, p = 0.0006).
The survival curves for the two groups showed a statistically non-significant difference in
the two mortality rates (log rank = 2.9, p = 0.098) (Fig 2). However, there was a significant
Table 1. Baseline characteristics of study participants.
Characteristic Moderate to severe malnutrition Severe anaemia alone P-value
n (%) n (%)
Age<24 months 30 (56.6) 200 (72.2) 0.02a
Mean age in months n (SD) 24.3 (12.1) 19.5 (12.4) 0.01a
Mean days in hospital n (SD) 4.9 (8.2) 3.9 (4.1) 0.18
Male gender 23 (43.4) 129 (46.6) 0.67
Rural location 24 (45.3) 145 (52.4) 0.35
One or more dead siblings 18 (34.0) 78 (28.2) 0.05a
Educated father 35 (66.0) 172 (62.1) 0.72
Teenage mother 8 (15.1) 71 (25.6) 0.15
Uneducated mother 5 (9.4) 30 (10.8) 0.03a
Jobless parent 26 (49.1) 164 (59.2) 0.03a
One dead parent 5 (9.4) 18 (6.5) 0.72
Previous blood transfusion 9 (17.0 38 (13.7) 0.53
Recent antimalarial use 31 (58.5) 175 (63.2) 0.72
History of bloody stool 6 (11.3) 19 (6.9) 0.45
History of bloody urine 1 (1.9) 5 (1.8) 0.97
Jaundiced 6 (11.3) 10 (3.6) 0.02a
Splenomegaly 33 (62.3) 178 (64.3) 0.49
Raised CRP ( 10Mg/L) 44 (83.0) 229 (82.7) 0.96
Median CRP n (IQR) 111.6 (65.2–183.2) 93.6 (37.8–150.5) 0.27
Mean Haemoglobin n (SD) 3.6 (0.8) 3.4 (1.0) 0.13
Low Vitamin B12 (<118pmol/L) 13 (24.5) 71 (25.6) 0.97
Iron deficiency 14 (26.4) 76 (27.4) 0.99
Malaria infection at enrolment 32 (60.4) 164 (59.2) 0.87
HIV infected 7 (13.2) 29 (10.5) 0.30
CMV infection 3 (1.1) 0 (0.0) 0.52
EBV infection 11 (20.8) 63 (22.7) 0.66
Bacteraemia 4 (7.6) 36 (13.0) 0.48
Sickle cell disease 1 (1.9) 3 (1.1) 0.88
a P-value which are significant at alpha = 0.05
https://doi.org/10.1371/journal.pone.0246267.t001
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difference in mortality when we compared severely anaemic children who were underweight
compared to those who were not, p = 0.001 (Fig 3).
During the follow up period, there were a total of 679 confirmed malaria cases, 16 of which
were complicated malaria. There were significantly more children who reported malaria infec-
tion among those with MAM/SAM 106 (40.8%) compared to 573 (32.3%) (p = 0.01) with
severe anaemia alone (IRR 1.3; CI 1.04–1.6, p = 0.02). There were more hospital readmissions
among children who had severe anaemia alone compared to those with moderate to severe
acute malnutrition (4.4% versus 3.5%), (IRR 0.8; CI 0.4–1.7,p = 0.62), but this was not statisti-
cally significant. In addition, the recurrence of severe anaemia was similarly low between chil-
dren with moderate to severe malnutrition compared to those who had severe anaemia alone
(IRR 1.1, CI 0.3–2.8, p = 0.8) over the entire study period.
Fig 2. KaplanMeier survival curves of severely anemic children with moderate to severe acute malnutrition compared to
those with severe anaemia alone.
https://doi.org/10.1371/journal.pone.0246267.g002
Table 2. Post-discharge morbidity and mortality among severely anaemic children with moderate to severe malnutrition compared to those with severe anaemia
alone.
Event Moderate to severe malnutrition Severe anaemia alone
Total events Incidence rate (1000 person- days) Total events Incidence rate (1000 person- days) Rate ratio p-value
n (CI)N = 53 N = 277
Deaths n (%) 15 (28.3) 5.4 36 (13.0) 2.6 2.1 (0.9, 4.2) 0.03a
Hospitalisation n (%) 9 (3.5) 1.5 76 (4.4) 1.8 0.8 (0.4, 1.7) 0.62
Malaria incidence n (%) 106 (40.8) 17.3 573 (32.3) 13.0 1.3 (1.04, 1.6) 0.02a
Severe anaemia recurrence n (%) 5 (1.6) 0.8 32 (1.6) 0.7 1.1 (0.3, 2.8) 0.81
a P-value which are significant at alpha = 0.05
https://doi.org/10.1371/journal.pone.0246267.t002
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Discussion
To our knowledge, no cohort studies investigating mortality outcomes in children with both
severe anaemia and MAM/SAM have been conducted in SSA. We found that severely anaemic
children with MAM/SAM are two times more likely to die compared to severely anaemic chil-
dren without MAM/SAM during 18 months follow-up. High mortality rates have been
reported among hospitalized children with severe anaemia and MAM/SAM separately in
other African countries [24]. However, our findings show a much higher mortality rate than
those reported in studies in children with severe anaemia in Ethiopia and Gambia [22, 25].
This higher mortality could be attributed to the fact that children included in our study had
both conditions, which independently are major causes of mortality in children.
There are few cohort studies that have investigated mortality outcomes in children with
both severe anaemia and MAM/SAM. Most of these have reported varying ranges of the bur-
den of these two co-morbidities but there is limited data on impact. One study in Ethiopia
reported that there was no significant difference in recovery among severe malnourished chil-
dren with anaemia compared to those without anaemia [26]. On the other hand another study
in Ethiopia found that children with SAM and anaemia had less chance of recovering com-
pared to those who had SAM and no anaemia [27], which was similar to findings of a study in
Kenya (Kwambai et al, Unpublished). However, this study did not have a comparison group.
These findings are important because children admitted to hospital with severe anaemia are
not routinely screened for MAM/SAM [28–30]. This has the implication that these children
will not be checked for MAM/SAM, as it may be a treatable factor associated with high
mortality.
Fig 3. KaplanMeir survival estimates comparing severely anaemic children who are underweight and those that have
severe anaemia alone.
https://doi.org/10.1371/journal.pone.0246267.g003
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The interplay between MAM/SAM, severe anaemia and the risk of mortality is multifacto-
rial. It is believed that malnutrition lowers immunity, which leads to susceptibility to infections
[31]. In addition, it is also possible that children with MAM/SAM are more likely to have
micronutrient deficiency leading to cell damage that makes infections worse and leads to poor
outcomes. Studies have attributed poor recovery outcomes in children with either MAM/SAM
or severe anaemia to many factors including infections such as malaria [32–34]. We found that
there was significantly higher malaria incidence among severely anaemic children with moder-
ate to severe acute malnutrition compared to those with severe anaemia alone. The association
between malnutrition and malaria has been inconclusive and conflicting [34]. In malaria
endemic regions, malaria infection is associated with anaemia although it may not be the pri-
mary cause of it [35]. This finding is similar to other studies in Cameroon, Ghana and Gambia,
where under-nutrition was associated with increased risk of malaria-associated mortality and
multiple malaria infections [36–38].
Compared to other studies among children with severe anaemia or malnutrition, we did not
find significant differences in hospital re admissions or recurrent severe anaemia. We had few
fewer re-hospitalisations to detect meaningful differences. Although we did not make associa-
tions with other risk factors, our findings are important for exploring interventions that may
reduce the additional burden that exists among severely anaemic children with malnutrition.
Our study had limitations. Our sample size was limited and we collected data from existing
data that are now 16 to 18 years old. This might have an effect on the findings and their inter-
pretation within the current context. Considering that mortality is a relatively rare outcome
and the number of deaths was small, the confidence intervals for the mortality risks are rela-
tively wide. However, we were able to detect significant and meaningful differences in mortal-
ity between the two groups of children.
Conclusions and recommendations
Severe anaemic children who also have moderate to severe malnutrition have a higher risk of
death than those with severe anaemia alone, even after discharge from hospital. It is therefore
crucial to carefully screen for acute malnutrition in children admitted with severe anaemia, as
this may be a treatable factor associated with high mortality. Prospective cohort studies may be
utilised to evaluate effects of interventions that may be used to reduce mortality among
severely anaemic children with moderate to severe acute malnutrition.
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Abstract 
Background: The provision of post-discharge malaria chemoprevention (PMC) in children 
recently admitted with severe anemia reduces the risk of death and re-admissions in malaria 
endemic countries. The main objective of this trial was to identify the most effective method 
of delivering dihydroartemesinin-piperaquine to children recovering from severe anemia. 
Methods: This was a 5-arm, cluster-randomized trial among under-5 children hospitalized 
with severe anemia at Zomba Central Hospital in Southern Malawi. Children were 
randomized to receive three day treatment doses of dihydroartemesinin-piperaquine 
monthly either; 1) in the community without a short text reminder; 2) in the community 
with a short message reminder; 3) in the community with a community health worker 
reminder; 4) at the facility without a short text reminder; or 5) at the facility with a short 
message reminder. The primary outcome measure was adherence to all treatment doses of 
dihydroartemesinin-piperaquine and this was assessed by pill-counts done by field workers 
during home visits. Poisson regression was utilized for analysis. 
Results: Between March 2016 and October 2018, 1460 clusters were randomized. A total of 
667 children were screened and 375 from 329 clusters were eligible and enrolled from the 
hospital.Adherence was higher in all three community-based compared to the two facility-
based delivery (156/221 [70·6%] vs. 78/150 [52·0%], IRR=1·24,95%CI 1·06-1·44, p=0·006). 
This was observed in both the SMS group (IRR=1·41,1·21-1·64, p<0·001) and in the non-SMS 
group (IRR=1·37,1·18-1·61, p<0·001). Although adherence was higher among SMS recipients 
(98/148 66·2%] vs. non-SMS 82/144 (56·9%), there was no statistical evidence that SMS 
reminders resulted in greater adherence ([IRR=1·03,0·88-1·21, p=0·68). When compared to 
the facility-based non-SMS arm (control arm), community-based delivery utilizing CHWs 
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Interpretation: Community-based delivery of dihydroartemesinin-piperaquine for post-
discharge malaria chemoprevention in children recovering from severe anemia resulted in 
higher adherence compared to facility-based methods. 
Funding: The Research Council of Norway 
Trial registration: ClinicalTrials.gov NCT02721420  
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Introduction 
Severe anaemia is defined as low hemoglobin level of less than 5mg/dl. It affects over 10 million 
children globally and is one of the leading causes of paediatric hospital admissions and mortality in 
sub-Saharan Africa (SSA).[1] Children admitted to hospital with severe anaemia are at high risk of 
dying not only during the acute phase but also after discharge from hospital.[2, 3] One prospective study 
in Malawi reported that 8% of hospitalized children with severe anaemia were re-admitted or died 
within six months after discharge compared to none of the community controls.[4] Post-discharge 
mortality rates as high as 17·9% and 36·5% have been reported in other African countries such as 
Kenya and Uganda.[3, 5] In malaria endemic African countries, malaria infection is a major contributor 
of severe anaemia and is a risk factor for slow haematological recovery that occurs in the community 
where the risk remains high.[6-9]  
Post-discharge malaria chemoprevention (PMC) is the targeted use of antimalarials in children with 
severe anaemia to create a malaria prophylactic window period post-transfusion and during 
recovery.[Kwambai, 2018 #499] Similar to seasonal malaria chemoprevention (SMC), PMC clears 
existing infections and provides prolonged prophylaxis against new infections.[10-13] A randomised 
clinical trial conducted in Malawi reported that provision of PMC to children aged less than 5 years 
with long-acting ACTs during recovery from severe anemia prevented up to 21% of deaths or hospital 
readmissions within 6 months after discharge.[Phiri, 2012 #85] More recently trials in Uganda and 
Kenya found that PMC resulted in 65% reduction in malaria incidence during the three months 
intervention period after successful treatment with blood transfusion and parenteral antimalarial 
drugs.[Kwambai, 2018 #499][Kwambai, 2020 #555] 
Utilizing community health workers (CHW) to deliver interventions for childhood diseases such as 
pneumonia and malaria has been reported to be effective in reducing childhood mortality and improved 
access.[15] Compared to facility-based delivery, provision of intermittent preventive therapy (IPT) in 
pregnant women and children by CHWs in the community, has also been shown to reduce malaria 
prevalence and incidence.[16, 17] However, this delivery strategy may have some challenges with 
sustainability due to inadequate supervision, low remuneration and irregular supplies among others.[18]  
Although facility based interventions have been effective at reducing disease complications,[16] they are 
costly and challenging to deliver for the health system.[19]  
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PMC is an intervention that could offer substantial public health gains in managing under-five children 
who are at risk of dying. Although PMC is a relatively simple intervention, implementation will require 
appropriate delivery strategies so that it reaches the population that need it most. However, a major 
concern is how it can be delivered in an effective and sustainable way.[14] However, unlike other health 
interventions delivered to children through established health systems such as the expanded programme 
on immunization, there is no existing delivery mechanism for PMC. 
The aim of this trial was to identify the most effective delivery mechanism for PMC by comparing 
community and facility-based delivery systems with and without reminders using short-text message 




The study was conducted at Zomba central hospital (ZCH), a referral government hospital with high 
paediatric admissions rates due to severe malarial anaemia located in southern Malawi with perennial 
malaria transmission. The hospital provides health services to a population of over one million and it is 
the only government health facility that provides blood transfusions and health services in Zomba 
district free of charge. Zomba Central Hospital was selected because previous related studies had been 
conducted there and is was particularly suitable for the delivery trial because of the existing linkages 
with community based health care providers and rural clinics within their catchment areas 
Study design and participants  
This was a five-arm open label cluster-randomized trial. Children aged less than five years who were 
admitted to ZCH pediatric unit  were included if they had severe anaemia (defined as a haemoglobin 
(Hb) concentration of <5g/dL with a confirmed malaria diagnosis either by rapid diagnostic test or 
microscopy) and having received the standard in-hospital care for severe anaemia which included a 
blood transfusion, intravenous artesunate and antibiotics, if  bacterial infection was suspected. Once 
stable, all children received oral lumefantrine-artemether (AL) and caregivers were provided with 
information regarding the trial procedures, medication and follow up. We excluded children with other 
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specific causes of anaemia such as trauma, those with confirmed sickle cell or heart disease and those 
who resided out of the catchment area. After obtaining informed consent in the local language of 
Chichewa from their legal guardians, we collected socio-demographic information and medical history 
using questionnaires and performed a physical examination. We collected a blood sample from a finger 
prick to check Hb using the hemocue 301 (Angelholm, Sweden) and malaria slides for microscopy. 
After enrolment, the study participants were traced to their home to collect GPRS positions for follow 
up and ascertain distance from the hospital. 
Randomization and procedures 
The unit of randomization was the village in the catchment area of the hospital. Randomization of the 
village clusters was computer-generated prior to the trial by the trial statistician. All 1460 villages 
within Zomba which were in the catchment area of ZCH were randomised, as it was not known which 
village prospective participants would reside prior to the study.  Therefore, children residing in the 
same village cluster were assigned to the same delivery arm. The villages were randomized to one of 
the following five arms: 1) community-based without an SMS reminder (Com + No SMS); 2) 
community-based with an SMS reminder (Com+SMS); 3) community-based with an HSA reminder 
instead of SMS reminder (Com+HSA); 4) facility-based delivery without SMS reminder (Fac-SMS); or 
5) facility-based delivery with SMS reminder (Fac+SMS). Detailed descriptions of the methods have 
been provided in table 1 and published elsewhere.[20] 
Text message reminder 
In the SMS arms, the text of the SMS was customised for each child with the following message 
“Remember to give (child’s name) medication starting from tomorrow for three days.” It was translated 
into the local language of Chichewa, the most widely spoken language in Malawi. The reminder was 
pre-tested on a random sample of caregivers coming with their children to the pediatric out-patient 
department prior to commencement of the trial. Considering that this was an implementation trial, we 
wanted to reflect the “real life” situation and therefore mobile phones were not provided to caregivers. 
However, for all study participants; we collected mobile phone numbers of the nearest contact person. 
Consenting caregivers were instructed to inform the owners of the mobile phone numbers that their 
child was participating in the trial Caregivers and study staff was aware of the allocation. However, the 
study statistician who performed the analyses was blinded to treatment allocation.  
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  Table 1. Detailed description of delivery methods of PMC 





PMC drugs given at discharge without SMS reminders: The guardian received all drugs 
for PMC-1, PMC-2 and PMC-3. They were instructed on how and when to give these drugs 
to the child when being discharged from the hospital.  
Com+SMS PMC drugs given at discharge with SMS reminders: The guardian received all drugs for 
PMC-1, PMC-2 and PMC-3 and was instructed on how and when to give the drugs to the 
child. Additionally, they were reminded via SMS to give the drugs to the child a day before 
each treatment course was due. 
Com+HSA PMC drugs given at discharge with HSA reminders: The guardian receives all drugs for 
PMC-1, PMC-2 and PMC-3 and was instructed on how and when to give the drugs to the 
child. Additionally, HSAs who are officially government-supported community-based 
health workers were reminded via SMS to go and remind the guardian to give the drugs to 
the child a day before each treatment course was due. 
Facility-based Fac-SMS PMC drugs collected from the hospital: At discharge, the guardian was requested to 
return to the outpatient department (OPD) of the hospital each month to collect drugs (a 
treatment course at each time) for PMC-1, PMC-2 and PMC-3. They did not receive any 
form of reminder other than what was documented in the child’s health card. 
Fac+SMS PMC drugs collected from the hospital with SMS reminders: At discharge, the guardian 
was requested to return to the OPD each month to collect drugs (a treatment course at each 
time) for PMC-1, PMC-2 and PMC-3. Additionally, they were reminded via SMS to come 
to the clinic to collect drugs a day before each treatment course was due. 
 
Study medication 
Co-formulated dihydroartemisinin-piperaquine dispersible tablets containing 20 mg dihydro-
artemesinin and 160 mg piperaquine was given as a treatment course over three days (Eurartesim®, 
Sigma-Tau, Italy). It was prescribed in standard doses according to the weight of the child 
(supplementary table 1 for specific doses). Three full monthly treatment courses were prescribed at two 
(PMC-1), six (PMC-2) and ten weeks (PMC-3) post-discharge regardless of the presence of symptoms. 
The maximum number of doses that could be administered was nine. Standardized verbal instructions 
about administration and frequency were given to the primary caregiver and specific dates of 
administration were documented in the child’s health book. The drug blister pack also contained 
administration instructions in Chichewa. All the caregivers regardless of assigned arm were requested 
to come back to the study clinic for the end of study assessment at 14-15 weeks after enrolment.  
 
One to three days after administration of the last dose of each course of medication, field workers made 
unannounced home visits to collect blister packs and assess if study medication was indeed given to the 
child participating in the trial. If the caregiver was not at home, they were contacted and visits were 
made when they were at home. The number of tablets remaining in the blister packs was recorded and 
if none were remaining “0” was recorded. If the blister pack was missing the field worker probed to 
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assess if the medicine was given to the child or not. In addition, assessment for adverse events was 
made and children were referred to the nearest health facility if they were sick. Data were entered 
directly into questionnaires in handheld tablets programmed with open data kit (ODK) electronic case 
report forms (eCRF). Stata 15 was used for analysis. 
Sample size 
The study was designed to determine whether delivery of PMC through community-based 
methods resulted in higher adherence than when delivered through facility-based methods and 
the sample size was based on this. Although a 2x2 factorial design was used, only the main 
effects of “place of delivery” and “use of mobile phone reminders” were of primary interest. 
It was estimated that each village cluster would contribute 2 to 4 children with severe anemia. 
We assumed an intra-cluster correlation coefficient (ICC) of 0.1 and allowing for 20% loss-
to-follow-up or efficiency loss due to varying cluster sizes, a sample size of 125 clusters 
(villages) of an average of 3 children per village (i.e. 75 children per arm and 375 overall), 
had 80% power to detect a 25% absolute increase in coverage from an estimated 50% in the 
standard  out-patient groups to 75% in the arms supported by mobile phone reminders 
(α=0.05). The ICC of 0.1 is slightly more conservative than the ICC in a previous trial of 
delivery approaches for IPTc in the Gambia (0.08). A statistical analysis plan (SAP) was 
written and agreed upon by all investigators before the data were analysed. However, 
additional analyses were included in the SAP during analysis to explore effects of different 
cut offs of adherence. 
Statistical considerations 
We used appropriate descriptive statistics to summarize data, with mean or median (IQR) for 
continuous data, and frequencies and percentages for categorical data. For the primary outcome, our 
analysis was by intention to treat at cluster and participant levels. We used Poisson regression for the 
total number of doses administered. The unadjusted and adjusted incidence rate ratios (IRR) measuring 
the percentage of children receiving PMC according to schedule in each arm were obtained and 
compared between arms and the 95% CI for the IRR have been reported. The estimates of the IRR 
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were adjusted for baseline characteristics using Poisson regression and accounted for clustering. 95% 
CIs are provided for all measures of effect. 
We also employed a factorial design analysis to investigate the interaction between the effects of 
community compared to facility delivery and the pooled effect of SMS; and interaction terms were 
included in models to assess the strength of interaction. We also did several subgroup analyses for the 
primary and secondary outcomes adjusted for clustering, socioeconomic and demographic variables 
stratified by each intervention arm with the Fac-SMS group as the reference group.  
Our primary outcome of the study adherence to 7 to 9 doses of the study drugs.  The secondary 
outcomes of the trial were: 1) the proportion of those with medium adherence defined as administration 
of 4 to 6 doses of the study drug; 2) the proportion of those with low adherence defined as the 
administration of less than 3 doses of the study drugs; 3) all-cause mortality and 4) all cause sick visits. 
For the secondary outcomes, the levels of adherence were compared between the five groups. Full 
details of the study design and statistical methods are provided in detail in the protocol, [20] and 
statistical analysis plan, which is available as supplementary material. 
Ethical approval 
The study was approved by the research ethics committees of the College of Medicine in Malawi 
(COMREC, approval number P·02/15/1679 and the Regional Ethics Committee of Norway, approval 
number 2015/537 (REK Vest). Written informed consent was obtained from legal guardians of the 
study participants prior to enrolment. The trial was registered at ClinicalTrials.gov (identifier: 
NCT02721420). 
Role of funding source 
The funder had no role in the design, data collection, data analysis and interpretation or writing of the 
report; and in the decision to submit the paper for publication. The corresponding author had full access 
to the data and had the final responsibility for the decision to submit for publication. 
Results 
Between 24 March 2016 and 09 October 2018, a total of 667 children hospitalized with severe anaemia 
were screened for eligibility and 375 children from 329 villages were eligible and enrolled (Com+ No 
 
10 
PMC MA2 manuscript_V1.0 
SMS=69; Com+SMS=75; Com+HSA=79; Fac-SMS=77; Fac+SMS=75) and 71 villages did not have 
children who met the legibility criteria. Overall, 351 children (93.6%) were followed successfully until 
the end of the study; caregivers of four children (1.1%) withdrew consent prior to the first home visit 
while four children died and twenty did not attend the end of study visit at 15 weeks (Figure1).  
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) flow diagram of the PMC delivery 
trial 
There was a good balance in the baseline characteristics across the arms. The overall median age and 
weight for all the participants were 29 (IQR 19–39) months and 11.3 (IQR 9.6–13.2) kg, respectively. 
There were generally more males in each arm except in the Fac+SMS arm (48% male). The proportion 
of participants with a history of having had a blood transfusion in the preceding month to recruitment 
was low (1.6%) across all the arms (Table 1). Over three quarter of children used insecticide-treated 
nets (ITN) the previous night prior to admission. None of the households had insecticide residual 
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Table 2. Baseline characteristics of trial participants 
 
Com-SMS Com+SMS Com+HSA Fac-SMS Fac+SMS Overall 
Characteristic       
 N=69 N=75 N=79 N=77 N=75 N=375 
Participant age in months, median 
(IQR) 
30 (19–40) 30 (23–38) 28 (18–39) 29 (20–38) 28 (16–38) 29 (19–39) 












Height in cm, median (IQR) 86 (78–92) 84 (79–89) 84 (75–91) 83 (77–90) 84 (77–91) 84 (77–91) 
Male, n (%) 37 (53.6) 48 (64.0) 49 (62.0) 42 (54.6) 36 (48.0) 212 (56.5) 
Previous transfusion, n (%) 1 (1.5) 2 (2.7) 0 (0.0) 1 (1.4) 2 (2.7) 6 (1.6) 
Malaria in previous month n (%) 10 (14.5) 9 (12.2) 6 (7.5) 5 (6.9) 4 (5.5) 34 (9.2) 
Slept under ITN previous night, n 
(%) 
52 (75.4) 54 (72.0) 64 (81.0) 62 (80.5) 55 (73.3) 287 (76.5) 
Diarrhoea on admission, n (%) 11 (15.9) 12 (16.2) 18 (22.7) 15 (20.6) 14 (19.2) 70 (19.0) 
Fever on admission, n (%) 63 (91.3) 69 (92.0) 74 (93.7) 60 (78.0) 69 (92.0) 335 (89.3) 
Vomiting on admission, n (%) 26 (37.7) 24 (32.4) 31 (39.2) 17 (23.3) 29 (39.7) 127 (34.5) 
Received at three doses of parenteral 
artesunate, n (%) 69 (100) 75 (100) 79 (100) 77 (100) 75 (100) 375 (100) 
Difficulty taking medication, n (%) 14 (22.2) 22 (34.4) 21 (28.7) 19 (29.7) 14 (21.5) 90 (27.4) 
Hb at enrolment in g/L, mean (Sd) 7.7 (1.3) 7.9 (1.5) 8.1 (1.6) 7.9 (1.3) 8.1 (1.3) 7.9 (1.4) 
Hb at end of study in g/L, mean (Sd) 11.3 (1.5) 11.7 (1.4) 11.6 (1.4) 11.5 (1.5) 11.3 (1.8) 11.5 (1.5) 
Guardian age in years, median 
(IQR) 28 (23–36) 26 (22–34) 27 (23–33) 27 (23–35) 27 (22–34) 27 (22–34) 
Literate legal guardian, n (%) 50 (72.5) 46 (63.0) 54 (68.4) 50 (67.6) 52 (72.6) 253 (68.8) 
Ownership of mobile phone, n (%) 28 (40.6) 28 (38.4) 28 (35.4) 29 (39.2) 33 (45.2) 146 (39.7) 
Wealthy SES, n (%) 10 (14.5) 16 (21.6) 13 (16.5) 15 (20.6) 19 (26.0) 73 (19.8) 
Distance to hospital in km, mean 
(Sd)  19.6 (8.9) 19.4 (8.9) 19.5 (10.2) 20.5 (8.5) 18.2 (9.5) 19.7 (9.2) 
Receipt of ³ 1 SMS, n (%) - 10 (14.5) - - 15 (21.4) 25 (18.0) 
 
Mobile phone ownership in the household or with a neighbour was reported in 39.7% of the caregivers, 
with the Fac+SMS arm reporting highest (45.2%). The mean distance to the hospital was similar 
among all the arms (19.7 ±SD 9.5 km). Out of the 150 participants who were expected to receive SMS 
reminders, only 25 (18.0%) reported to have received at least one SMS. 
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Adherence 
Adherence to all PMC courses was reported in 63.1% of all the children. A higher proportion of 
children in the community-based arms reported full adherence to compared to facility-based arms 
(70.6% versus 52.7%, IRR=1.24, 95% CI 1.06-1.44, p =0.006). Children receiving PMC in the 
community in the SMS arm reported the highest proportion of full adherence (79.7%) compared to 
those in the community but receiving no SMS (63.2%), Com+HSA (68.4%), Fac-SMS (51.3%) and 
Fac+SMS (52. %). The proportion that was administered at least six doses representing medium 
adherence was 22.1% among all the children and Fac-SMS arm had the highest proportion of medium 
adherence (27.6%), and Com+SMS arm (12.2%) lowest for medium adherence. On the other hand, 
only 2.9 % of the children reported very low adherence which was representing less than 30% of the 
total doses (Table2 and Figure2). 
Table 3. Levels of adherence to DHP across all the trial arms 
















Very low  
(< 30 % uptake) 
0 1 (1.5) 2 (2.7) 1 (1.3) 4 (5.3) 2 (2.7) 10 (2.7) 
1 0 (0) 0 (0) 1 (1.3) 0 (0) 0 (0) 1 (0.3) 
2 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Total 1 (1.5) 2 (2.7) 2 (2.6) 4 (5.3) 2 (2.7) 11 (2.9) 
Low  
(30% uptake) 
3 7 (10.3) 4 (5.4) 6 (7.6) 11 (14.5) 13 (17.6) 41 (11.1) 
4 0 (0) 0 (0) 0 (0) 0 (0) 0(0) 0 (0) 
5 1 (1.5) 0 (0) 0 (0) 1 (1.3) 1 (1.4) 3 (0.8) 
Total 8 (11.8) 4 (5.4) 6 (7.6) 12 (15.8) 14 (18.9) 44 (11.9) 
Medium 
(60% uptake) 
6 15 (22.1) 9 (12.2) 16 (20.3) 21 (27.6) 18 (24.3) 79 (21.3) 
7 1 (1.5) 0 (0) 0 (0) 0 (0) 1 (1.4) 2 (0.5) 
8 0 (0) 0 (0) 1 (1.3) 0 (0) 0 (0) 1 (0·3) 
Total 16 (23.5) 9 (12·2) 17 (21.5) 21 (27.6) 19 (25.7) 82 (22.1) 
Full 
(100% uptake) 
9 43 (63.2) 59 (79.7) 54 (68.4) 39 (51.3) 39 (52.7) 234 (63.1) 
Total 43 (63.2) 59 (79.7) 54 (68.4) 39 (51.3) 39 (52.7) 234 (63.1) 
Total   68 (100) 74 (100) 79 (100) 76 (100) 74 (100) 371 (100) 
When PMC was delivered through the community-based methods, adherence was greater than facility-
based methods (IRR=1.24; 95%CI 1.10, 1.44 p=0.001) and this was observed in both the SMS 
recipients (IRR=1.41; 95%CI 1.21, 1·64, p<0.001) and in the non-SMS recipients (IRR=1.37; 95%CI 
1.18, 1.61, p<0.001) (Figure 3, Tables 6). 
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Table 4. Description of the total number of doses administered for each course of PMC 













 0 15/68 (22.1) 11/74 (14.9) 10/79 (12.7) 10/76 (13.2) 10/74 (13.5) 56/371 (15.1) 
PMC 1 1 0/68 (0) 0/74 (0) 1/79 (1.3) 0/76 (0) 0/74 (0) 1/371 (0.3) 
 2 1/68 (1.5) 0/74 (0) 0/79 (0) 1/76 (1.3) 2/74 (2.7) 4/371 (1.1) 
 3 52/68 (76.5) 63/74 (85·1) 68/79 (86·1) 65/76 (85·5) 62/74 (83·8) 310/371 (83·6) 
 0 7/66 (10.6) 4/74 (5.4) 10/79 (12.7) 17/76 (22.3) 16/73 (21.6) 56/368 (15.1) 
PMC 2 1 1/66 (1.5) 0/74 (0) 0/79 (0) 0/76 (0) 0/73 (0) 1/368 (0.3) 
 2 0/66 (0) 0/74 (0) 1/79 (1·3) 0/76 (0) 0/73 (0) 1/368 (0.3) 
 3 58/66 (87.9) 70/74 (94.6) 68/79 (86.1) 59/76 (77.6) 57/73 (77.0) 312/368 (84.1) 
 0 7/66 (10.6) 8/74 (10.8) 13/79 (16.5) 29/76 (38.2) 24/73 (32.9) 81/368 (22.0) 
PMC 3 1 0/66 (0) 0/74 (0) 0/79 (0) 0/76(0) 0/73(0) 0/368 (0) 
 2 0/66 (0) 0/74 (0) 0/79 (0) 0/76(0) 0/74(0) 0/368 (0) 
 3 59/66 (89·.) 66/74 (89.2) 66/79 (83.5) 47/76(61.8) 49/73(67.2) 287/368 (78.0) 
Overall, a total of 83.6%, 84.1% and 78.0% of the children received complete courses of PMC1, PMC2 
and PMC3 respectively. Generally, most of the children who received the first dose of each PMC 
course also received the second and the third dose. A small proportion (1.3%) received the first and 
second dose but not the third dose of PMC 1, only one participant (0·3%) took only the first dose of 
PMC 2 and another one (0.3%) took only the first and second doses of PMC 2. All participants who 
took the first course of PMC 3 completed all the three doses.  













n/N (%) Overall 
 1st dose 53/68 (77.9) 63/74 (85.1) 69/79 (87.3) 66/76 (86.8) 64/74 (86.5) 
310 (83.6) PMC 1 2nd dose 53/68 (77.9) 63/74 (85.1) 68/79 (86.1) 66/76 (86.8) 64/74 (86.5) 
 3rd dose 52/68 (76.5) 63/74 (85.1) 68/79 (86.1) 65/76 (85.5) 62/74 (83.8) 
 1st dose 59/66 (89.4) 70/74 (94.6) 69/79 (87.3) 59/76 (77.6) 57/73 (77.0) 
312 (84.1) PMC 2 2nd dose 58/66 (87.9) 70/74 (94.6) 69/79 (87.3) 59/76 (77.6) 57/73 (77.0) 
 3rd dose 58/66 (87.9) 70/74 (94.6) 68/79 (86.1) 59/76 (77.6) 57/73 (77.0) 
 1st dose 59/66 (89.4) 66/74 (89.2) 66/79 (83.5) 47/76 (61.8) 49/73 (67.1) 
287 (78.0) 
PMC 3 2nd dose 59/66 (89.4) 66/74 (89.2) 66/79 (83.5) 47/76 (61.8) 49/73 (67.1) 
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 3hs dose 59/66 (89.4) 66/74 (89.2) 66/79 (83.5) 47/76 (61.8) 49.73 (67.1) 
 
Community-based delivery arms had the highest proportions of participants receiving PMC2; (86.4 to 
91.9%) and PMC3 (78.4 to 89.4%) compared to facility-based arms; who reported up to 78.7% 
receiving PMC2 and less than 70% for PMC 3. There were no significant differences in the proportion 
of participants across the arms in administration taking the PMC1 (p=0·56) and PMC2 (p=0·08) but 
administration of PMC 3 was statistically different across all the groups. 
Figure 2. Kaplan Meir curves illustrating the adherence by the total number of PMC doses that 
were administered in each trial arm 
Community delivery utilizing HSA reminders resulted in higher adherence compared to delivery in the 
health facility (IRR=1.32; 95%CI 1.14, 1.54, p<0.001). However, there was no evidence that SMS 
reminders resulted in greater adherence compare to the arms that did not receive the SMS (IRR=1.03; 
95%CI 0.88, 1.21, p=0.7) [figure3 & table6].  
Table 6. Poisson regression model excluding PMC 1 with an interaction term in factorial design 






     
 IRR (95% CI) p-value IRR (95% CI) p-value 
Pooled      
 Facility Reference - 1 - 
Community - - 1.24 (1.06, 1.44) 0.006 
No SMS Reference - 1  
SMS -  1.03 (0.88, 1.21) 0.677 
By arm      
 Fac-SMS (Ref) Reference - 1 - 
Com+ No SMS 1.33 (1.14,1.54) <0.001 1.37 (1.18,1.61) <0.001 
Com+SMS 1.37 (1.19,1.59) <0.001 1.41 (1.21,1.64) <0.001 
Com+HSA 1.29 (1.12,1.5) 0.001 1.32 (1.14,1.54) <0.001 
Fac+SMS 1.12 (0.96,1.31) 0.140 1.16 (0.99,1.37) 0.066 
There was no difference in adherence between facility-based delivery with SMS and without SMS 
(IRR=1.16; 95%CI 0.99,1.37, p=0.07) (figure 3) and there was no evidence of interaction between the 
use of SMS and delivery strategy (Facility/community) (p=0.88).  
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Figure 3. Forest plots illustrating adherence to PMC in each trial arm 
Table 7 summarizes sick visits that occurred during the follow-up period. There were total of four 
deaths (overall mortality of 1.1%); two each in the Com-SMS and Fac+SMS. Two deaths were caused 
by severe anaemia; one due to sepsis and one death caused by drowning. The total number of reported 
sick visits was 90 of which 46.7% were due to uncomplicated malaria. The lowest number of adverse 
events was observed in the Com+HSA arm. The number of deaths was too low to make meaningful 
association to adherence. 
Table 7. A summary of all sick visits 









Septicemia  1 0 2 1 1 5 
Severe anaemia  1 0 0 1 0 2 
Moderate anaemia  0 0 0 1 0 1 
Uncomplicated malaria  7 12 4 12 7 42 
Complicated malaria  1 0 1 1 0 3 
Respiratory infections 5 4 2 4 10 25 
Total 15 16 9 20 18 78 
 
Discussion 
In this study, we found that children who had their monthly DHP in the community provided by 
caregivers irrespective of reminders resulted in 24% higher adherence compared to facility-based 
delivery where caretakers were asked to return to the clinic to collect their 2nd and 3rd course of PMC. 
These findings are consistent with findings reported from other African countries. Studies in Kenya, 
Uganda and Ghana reported that malaria treatment distributed by CHWs resulted in reduced malaria 
incidence and increased access to treatment.[19, 21, 22] Similarly, in Malawi, community delivery of 
sulfadoxine-pyrimethamine (SP) for intermittent preventive therapy in pregnancy IPTp by CHWs 
improved coverage from 41.5% to 82.9% however it was noted that this led to a reduction in antenatal 
care (ANC) attendance.[23] In the Gambia, delivery of intermittent preventive therapy in children (IPTc) 
by CHWs also achieved higher coverage, cost-effectiveness and reduced symptomatic malaria cases.[17] 
Although utilizing CHWs has been supported by WHO and has proved to be effective for high 
adherence and reduced incidence of disease, the effectiveness has shown to decline for subsequent 
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doses. In Mali, seasonal malaria chemoprevention (SMC) delivered through routine programmes 
utilizing existing CHWs reduced malaria prevalence; 84% of the targeted children received the first 
course but only 54% received four complete SMC courses.[24] Another study reported that completion 
of all the three doses of IPTc was similar (91.6% versus 91.7%) in community delivery compared to 
delivery at health centres.[25] Utilizing HSAs has its own challenges and requires additional resources 
for training, supervision and incentives and this may be challenging for PMC delivery.[17, 26]  In 
addition, children receiving PMC will not be in the scheduled work plans for HSAs to incorporate. In 
our setting, it has been reported that HSAs are motivated to provide reminders for PMC.[27] However, 
despite this motivation, our study still showed that less than half of the HSAs conducted the required 
home visit reminders. Many of the reported challenges include inability to locate the child, high 
existing workload, limited training, supervision and poor community acceptance.[27, 28]  
Whereby there are limited studies that have examined adherence to medication when utilizing 
caregivers to administer longer-term malaria interventions at home, in our study, we found that 
community-delivery utilizing caregivers resulted similar adherence without requiring HSA reminders. 
One study in Sierra Leone reported that caregivers are capable of administering anti-malarial 
medication to the children with basic instructions and supervision of the first dose by the CHW.[29] 
Caregivers were able to administer monthly doses without additional reminders and this is important 
because it does not require additional resources. A qualitative study examining the acceptance of PMC 
among caregivers in Malawi reported that caregivers had a higher preference and confidence to be 
given all the medication to administer to their children without any additional reminder because HSAs 
and phones were unreliable and collecting medication from the hospital was very challenging.[30] 
However, the concern with this method is poor storage conditions, ensuring that medication will be 
only be administered as prescribed to the child and not others and possible side effects of the drugs.[30]   
Use of mobile phone reminders has been hailed as an important tool to achieve adherence, optimal 
treatment response, case management and outcomes in resource poor settings such as SSA.[31, 32] 
However, we found that SMS did not have that added effect on adherence. In rural Malawi, provision 
of SMS to health workers or mothers has been reported to not have a significant effect on adherence 
and improvement of management of common childhood illnesses with only up to 46·5% receiving 
SMSs.[33, 34] This is rather low compared to similar trials in Kenya where providing SMS was effective 
when 91% received them.[35, 36] Challenges reported with implementing mobile health (mhealth) 
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interventions in resource poor settings such as Malawi include poor network coverage, access, and 
inability to charge mobile phones, literacy and low phone ownership.[37]  
Our findings are important because PMC is a relatively new intervention in the Malawian and other 
developing countries health care system where established delivery systems currently do not exist. 
Because the timing of PMC medication administration is sensitive, it would be a challenge for a 
caregiver to rely on receiving timely reminders on a personal phone or rely on others to receive the 
reminder and pass on the message. A study in Tanzania reported that unsupervised malaria treatment 
given at home by caregivers was effective without the utilization of any reminders.[26] Contrasting to 
this, caregivers have a higher preference and confidence to be given all PMC medication to administer 
at home without any reminders.[30] In this case, community-based delivery strategies where the 
medication is given to the caregivers may be the most successful strategy for this promising 
intervention. 
Conclusion 
This is the first study to assess adherence to PMC, which is an innovative intervention for managing 
sick children during the post-discharge period. We found that using community-based strategies, 
caregivers were able to administer PMC medication to their children without additional reminders. As 
they routinely administer medication to their children at home, this may be a cost-effective strategy for 
delivery of PMC. Although utilizing HSAs has proven to be effective for improving adherence for 
other malaria interventions, adherence to subsequent doses has tended to decline and may remain 
challenging for PMC delivery utilizing HSAs reminders, which is interval sensitive. Although we 
found that SMS reminders had no effect on adherence, it must be noted that the proportion of 
caregivers that reported received the SMS reminder was very low. As such we are not able to 
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Abstract
Background: Severe malarial anaemia is one of the leading causes of paediatric hospital admissions in Malawi.
Post-discharge malaria chemoprevention (PMC) is the intermittent administration of full treatment courses of
antimalarial to children recovering from severe anaemia and findings suggest that this intervention significantly
reduces readmissions and deaths in these children. Community delivery of health interventions utilizing community
health workers (CHWs) has been successful in some programmes and not very positive in others. In Malawi, there is
an on-going cluster randomised trial that aims to find the optimum strategy for delivery of dihydroartemesinin-
piperaquine (DHP) for PMC in children with severe anaemia. Our qualitative study aimed to explore the feasibility of
utilizing CHWs also known as health surveillance assistants (HSAs) to remind caregivers to administer PMC
medication in the existing Malawian health system.
Methods: Between December 2016 and March 2018, 20 individual in-depth-interviews (IDIs) and 2 focus group
discussions (FGDs) were conducted with 39 HSAs who had the responsibility of conducting home visits to remind
caregivers of children who were prescribed PMC medication in the trial. All interviews were conducted in the local
language, transcribed verbatim, and translated into English. The transcripts were uploaded to NVIVO 11 and
analysed using the thematic framework analysis method.
Results: Although intrinsic motivation was reportedly high, adherence to the required number of home visits was
very poor with only 10 HSAs reporting full adherence. Positive factors for adherence were the knowledge and
perception of the effectiveness of PMC and the recognition from the community as well as health system. Poor
training, lack of supervision, high workload, as well as technical and structural difficulties; were reported barriers to
adherence by the HSAs.
Conclusions: Post-discharge malaria chemoprevention with DHP is perceived as a positive approach to manage children
recovering from severe anaemia by HSAs in Malawi. However, adherence to home visit reminders was very poor and the
involvement of HSAs in a scale up of this intervention may pose a challenge in the existing Malawian health system.
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Background
In sub- Saharan Africa, between 17 and 54% of malaria-at-
tributable deaths are estimated to be due to severe an-
aemia [1]. Severe anaemia is a condition in which the
number of red blood cells or their oxygen-carrying cap-
acity is insufficient to meet physiological needs. Children
with severe anaemia due to malaria are at risk of readmis-
sion and death within 6months after discharge from
hospital [2, 3]. Post-discharge malaria chemoprevention
(PMC) is the intermittent administration of full treatment
courses of antimalarial to children recovering from
severe anaemia. Findings from studies in Malawi and
other African countries suggest that PMC to children
in the post-discharge period significantly reduces hos-
pital re-admissions and deaths after discharge from
hospital [2–19]. Although PMC is a relatively simple
intervention, its implementation requires a feasible
and acceptable delivery strategy [9, 20–25].
Community health workers (CHWs) and related cadres
play a role in prevention, case management and health
promotion delivery in many poor countries [26–28]. De-
livering community-based programs using community
health workers has been shown to be effective in achieving
high coverage, improved access, and in reducing maternal,
neonatal and child mortality in some resource-poor set-
tings [9, 20–22, 29–38]. However, the global health litera-
ture has also identified a number of challenges related
to the role of CHWs in different community-based
interventions [38–42].
In the Malawian health care system, CHWs are known
as Health Surveillance Assistants (HSAs). The HSAs are
the lowest cadre in the Malawi health system and the
Ministry of Health (MoH) pays them a monthly salary.
In the villages, they work together with community
leaders in providing some basic health and environmen-
tal health services to the community and it is estimated
that each is expected to serve approximately 1000 people
in a catchment area [43]. Their role is important, since it
is estimated that only 54% of the Malawian population
resides within 5 km radius of a health facility and even
patients who do reach a health facility encounter a
shortage of health workers [29]. Furthermore, the pro-
portion of the population residing within 5 km of a
health facility equipped to provide treatment of severe
anaemia is far lower. HSAs have been reported to create
a link between the health facility and the community
and they have contributed to the delivery of health
services in rural areas [44, 45].
The literature refers to a number of factors that influ-
ence CHW activity, motivation and continuation on the
job [46–54]. Motivation can be defined as the “willing-
ness to exert and maintain an effort towards goals” and
is regarded to develop in individuals as a result of the
interaction between individual, organizational and cultural
determinants [55]. In Malawi, HSA motivation has been
found to be driven by community interactions and oppor-
tunities for increased responsibility [29]. Other reported
contributing factors to sustained motivation and job satis-
faction are altruism, need for community respect and
recognition, supportive supervision and monetary and
non-monetary incentives [45]. However, the literature also
shows that HSAs are not always conducting the activities
that are expected from them. For example, a recent study
of caregivers’ perceptions of delivery of PMC showed that
caregivers reported that HSAs were unreliable and
mothers do not prefer them as a means to receive re-
minders [56].
The main objective of this study is to assess the feasi-
bility of involving HSAs in the scaling up of PMC into
the health system by exploring perceptions, experiences
and motivation of the HSAs who were involved in an
on-going trial in Malawi [57]. The study will contribute to
the existing literature on the role of CHWs in low-income
settings, and particularly to a better understanding of the
interrelationship between motivation and structural
factors for scaling up an intervention such as PMC.
Methods
Study place
The study was conducted in Zomba District, which is
located in the southern region of the Republic of Malawi
and has a population of approximately 883,200. Public
health services in Malawi are provided mainly at village
health posts, health centres and district and central
hospitals. There are 32 health facilities in Zomba district
and a total of 630 HSAs working for the Ministry of
Health (MoH).
The design of the trial
This study is part of a trial that aims to find the
optimum strategy for delivery of PMC. A total of 375
children aged less than 5 years are given an antimalarial
medication; dihydroartemisinin-piperaquine (DP), over a
period of 3 months during the recovery from severe an-
aemia. The delivery of the medication is divided into five
different arms, of which two are facility-based and three
community-based and the protocol for the trial has been
described elsewhere [57]. This study focuses on one of
the community-based study arms where the study medi-
cation is given to the caregiver upon discharge from the
hospital, and she/he is instructed to give them to the
child at two, six and ten weeks after discharge for 3 days
at a time. The dates are noted on the child’s health card.
The PMC trial recruits children from the Zomba
central hospital (ZCH), which is the referral hospital for
all neighbouring health centres and districts. On the day
when the child is discharged, the caregiver is linked to
the HSA in their catchment area. The HSA responsible
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for the catchment area receives their contact details and
are informed about the participant and the location of
their home. In the case that the HSA is not available,
he/she is contacted by phone, or by receiving a physical
visit, with information about the participant’s details,
location and treatment procedures. One or two days
prior to the scheduled date of drug administration, the
HSA was expected to receive a short message service
(SMS) reminder on his/her phone to go to the child’s
home to remind the caregiver to administer the study
medication. The HSAs did not receive any other re-
minders or memory aids during the course of follow up
and they were not paid specifically for this work because it
was considered to be part of their regular duties. However,
they received a lunch allowance during the initial training.
Prior to commencement of the trial, community en-
gagement and briefing about the trial was conducted
with all the 7 Traditional authorities (TAs) and their
group village headmen. In Malawi, TAs are key commu-
nity leaders. In these meetings, information about the
trial objectives and methods were discussed and the
leaders were expected to disseminate this information in
their communities. In addition, 608 HSAs received a
short training about PMC as an intervention for man-
agement of children with severe anaemia. The training
included informing them about their role in the project
whereby they were requested to visit the child and
remind the caretakers to administer the study medica-
tion to the child. The HSAs were not shown the actual
study medication during the training, and there was no
formal assessment of knowledge attained.
Study participants and sampling
A total of 78 children were randomized to receive the
intervention in the arm utilizing HSAs, and 60 HSAs
participated in the trial. Of these, 21 were not inter-
viewed since they had either relocated, were unreachable
by phone, or had a child participating at the time of the
study and could not be involved in the interviews to
avoid influencing outcome measures of the trial. The
remaining 39 HSAs were invited to participate in this
study. In December 2016 we conducted 20 individual
in-depth interviews (IDIs) with HSAs, and later, in
March 2018, we conducted two focus group discussions
(FGDs) with 19 HSAs at designated health centres.
While saturation to a large degree was achieved with the
first 20 IDIs, the two FGDs gave us an opportunity ex-
plore further the findings that had been identified in the
initial analysis of the IDIs. The choice of the additional 2
FGDs was made in order to explore different experi-
ences between adherent (FGD1) and non- adherent
(FGD2) HSAs. Inclusion was not based on age or gender,
but rather by caregiver’s report at the exit visit of the
main trial.
Data collection
The semi-structured interview technique was used utilis-
ing a guide with set topics, and an open-ended approach,
which allowed the informant to speak without interrup-
tion. This was best suited for this study because we
aimed to uncover the perceptions and understandings of
PMC from the interviewees’ point of view [58]. All inter-
views were conducted in the local language; Chichewa,
by three experienced and independent research assis-
tants. The interview guides were formulated in English
and translated into Chichewa and piloted with the local
nurses to ensure that the information gathered truly
reflected the study objectives and ensured that probes
were captured precisely (Additional files 1 and 2).
Furthermore, all research assistants and the first author
were Malawians, who speak fluent Chichewa. Since the
first author is the medical researcher responsible for
conducting the trial, she took part only in the interviews
with HSAs that she did not have prior contact with to
reduce the likelihood of biased responses. The informa-
tion gathered was supplemented by her experiences and
observations throughout the trial and field notes made
during the interviews. All interviews were digitally
recorded, transcribed verbatim and translated into Eng-
lish by the research assistants. Permission to conduct
the trial was obtained from ZCH and Zomba DHO prior
to commencement and written consent was obtained
from all participants.
Data entry and analysis
The first author went through all the transcripts, obser-
vation notes and audio files for accuracy and reliability,
and read each transcript carefully to familiarise herself
with the data. The last author reviewed all the FGD
transcripts. Transcripts were loaded into NVIVO 11 and
a coding system was developed based on the research
objectives and the analytical framework of motivation.
The coding system was expanded during the coding
process to capture emerging themes outside of the ori-
ginal study objectives. The first author coded each IDI
and FGD and the last author reviewed the coding frame.
Through this process the coding was refined and both
agreed on the final themes. Thematic framework ana-
lysis was used because it is an appropriate, rigorous




A total of seven women and thirteen men were inter-
viewed in the IDIs. The HSA ages ranged from 27 to 45
years and the length of service as HSAs was between
seven and 24 years. A total of thirteen HSAs served a
health centre that was categorised as rural and seven
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were from the urban or semi-urban health centres. FGD
1 comprised of three women and six men and seven
women and three men in FGD 2 respectively. The ages
ranged between 32 and 45 years in FGD 1 and 27 and 51
in FGD 2. In FGD 1, the range of service as HSAs was
nine to twenty years and eight and seventeen years in
FGD 2. All the discussants in FGD 1 reported to a rural
health centre while six out of the ten reported to a rural
health centre in FGD2. The range of duration of each
IDI and FGD interviews was between 62 to 104 min. A
majority of all had completed secondary school and
attained a Malawi school certificate of education
(MSCE), while four possessed a junior certificate of edu-
cation (JCE), which is attained after completing 2 years
of secondary school. The HSAs reported that their catch-
ment populations ranged between 599 and 33,000. A sum-
mary of the characteristics of the IDI and FDG participants
is provided below in Tables 1 and 2 respectively.
Adherence
HSAs were required to visit the child’s home three
times, at two, six and ten weeks after discharge from
hospital. Information on adherence to home visits was
collected at the exit interview with caregivers as part of
the trial, and during IDIs and FGDs with HSAs. In FGD
1, all the nine HSAs were reported as adherent by care-
givers. Out of the 9 HSAs, 3 of them report to have
conducted at least one visit; 2 reported full adherence
and 1 had partial adherence. The ten HSAs in FDG 2, in
contrast, were reported to be non-adherent by care-
givers. However, three of them claimed that they had
made one or more visits to the child. In the IDIs, twelve
HSAs reported adherence but two differed from what
the caregiver reported. There may be several reasons
reported for this discrepancy. Firstly, the HSA may have
visited the child when the caregiver who was interviewed
for the exit interview was not at home. Second, the care-
givers or HSAs may not have reported correctly. Third,
there may have been a social desirability effect; HSAs
may have wanted to over-report their adherence. In this
paper, we refer to the HSAs self-reported adherence. Ta-
bles 1 and 2 also summarize adherence level by HSA.
We define adherence level by the number of home
visits the HSAs conducted. Those that conducted all
three home visits are termed “adherent”, those who
made at least one visit are termed “partially adherent”
and those that did not conduct any home visit are
termed “non-adherent”. Only ten HSAs, or about one in
Table 1 Characteristics of HSAs who participated in IDIs
HSA ID Gender Age Location category Population size Length of service No. Of visits Level of adherence
HSAs with self- reported adherence (N = 12)
ID1-HSA-01 Male 32 Urban 2219 9 1 Partially adherent
IDI-HSA-03 Male 40 Semi-urban 894 7 3a Fully adherent
IDI-HSA-04 Female 37 Rural 3077 10 1 Partially adherent
IDI-HSA-05 Female 45 Urban 4050 24 3 Fully adherent
IDI-HSA-06 Female 36 Semi-rural Unsure 9 2 Partially adherent
IDI-HSA-07 Male 35 Rural 3090 9 1 Partially adherent
IDI-HSA-09 Female 39 Semi-urban 1139 8 2 Partially adherent
IDI-HSA-10 Male 30 Rural 3299 10 1 Partially adherent
IDI-HSA-11 Male 39 Remote 2360 14 2 Partially adherent
IDI-HSA-14 Female 30 Semi-rural 2202 9 1 Partially adherent
IDI-HSA-17 Male 42 Semi-rural 4500 17 3 Fully adherent
IDI-HSA-18 Male 27 Urban 1160 9 1 Partially adherent
HSAs with self-reported non-adherence (N = 8)
IDI-HSA-02 Female 27 Urban 884 9 0 Not adherent
IDI-HSA-08 Female 42 Urban 599 21 0 Not adherent
IDI-HSA-12 Male 33 Semi-rural 1276 9 0 Not adherent
IDI-HSA-13 Male 32 Rural 1356 8 0 Not adherent
IDI-HSA-15 Male 32 Rural 4000 7 0 Not adherent
IDI-HSA-16 Male 38 Remote rural NA 10 0 Not adherent
IDI-HSA-19 Male 36 Remote 940 9 0 Not adherent
IDI-HSA-20 Male 40 Remote 3100 9 0 Not adherent
aThis HSA had 2 children during the course of the study and he was fully adherent to both
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four, carried out all the three required home visits. Of
the remaining three quarters of HSAs, fifteen were
non-adherent and fourteen were partially adherent. We
did not find any clear association between HSAs charac-
teristics (age, sex, population size) and adherence, but
we note that adherence was slightly higher among HSAs
in rural communities (30%) compared to those who were
based in urban areas (15%). Additionally, we noted that
male HSAs had the highest reported adherence com-
pared to female HSAs; but the sample was too small to
make any generalization. Table 3 below summarizes the
adherence levels among HSAs categorized by location.
In the following, we map out factors that appear to
have influenced HSAs’ adherence. We have categorized
these factors into three main categories: Professional
factors, structural factors, and community factors. For
each of them, we describe a number of enabling and
motivating factors reported by the HSAs. We also de-
scribe the barriers and demotivating factors that HSAs
identified for each of these categories, which reportedly
discouraged adherence.
Professional factors
The belief that PMC is important and useful, gaining
new knowledge, and opportunities to conduct other
tasks were reported as motivating factors, while the lack
of incentives was reported as a demotivating factor by
some HSAs.
The belief that PMC is important and useful
All HSAs, regardless of adherence, expressed that mal-
aria is a serious disease and is the most common cause
of death among children in their communities. Regard-
ing knowledge of severe anaemia, the HSAs explained
that it is a complication of malaria and most described
those with severe anaemia as “having white hands” and
that this condition frequently leads to death.
All HSAs, including the non-adherent, perceived PMC
as an important and beneficial intervention that will save
the lives of many children. In addition, HSAs that were
adherent to at least one visit expressed that the children
Table 2 Characteristics of HSAs participating in two FGDs
HSA ID Gender Age Location Population Length of service Number of visits
FGD 1: HSAs with full or partial-adherence as reported by the caregiver
FGD-HSA-01 F 32 Rural 982 10 2
FGD-HSA-02 M 42 Rural 3840 18 2
FGD-HSA-03 F 39 Remote 1796 20 3
FGD-HSA-04 M 35 Rural 1139 10 4
FGD-HSA-05 M 35 Rural 9808 12 3
FGD-HSA-06 M 38 Rural 2098 11 3
FGD-HSA-07 F 35 Rural 2876 10 2
FGD-HSA-08 M 34 Rural 3614 9 3
FGD-HSA-09 M 32 Rural 9300 10 2
FGD 2: HSAs with non-adherence as reported by the caregiver
FGD-HSA-10 F 27 Rural 2070 10 0
FGD-HSA-11 F 35 Semi urban 890 8 0
FGD-HSA-12 F 45 Semi urban 883 10 0
FGD-HSA-13 M 29 Urban 1896 10 1
FGD-HSA-14 F 45 Urban 1982 10 0
FGD-HSA-15 M 38 Remote 1740 10 3
FGD-HSA-16 F 31 Semi urban 2339 10 0
FGD-HSA-17 F 32 Semi urban 1038 10 0
FGD-HSA-18 M 39 Remote 1935 10 0
FGD-HSA-19 F 51 Rural 2040 17 3
Table 3 Adherence to PMC home visits by location
Location Adherence Total (%)
Rural (N = 26) ≥3 8 (30)
1–2 10 (39)
0 8 (30)
Urban (N = 13) ≥3 2 (15)
1–2 4 (30)
0 7 (54)
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who took the medication did not get sick from malaria
again:
This study has helped - the child’s frequent malaria
problems have ended. Even when the child doesn’t look
sick, the drugs are still given, to completely kill the
malaria parasite. This would benefit the nation.
(FGD1, male, 34 yrs, adherent)
Gaining new knowledge
Of the 39 participants, seven had not been part of the
initial training. Of these seven, two had received infor-
mation on the day that the child was taken home by the
research team, while the other five had heard about it
from their fellow HSAs. None of the HSAs had prior
knowledge about the fact that there is medication that
can be given to children in order to protect them from
getting malaria. This knowledge was appreciated and
considered novel by all HSAs regardless of adherence,
but it was more important to the HSAs who were adher-
ent. They said this knowledge gave them confidence in
the medication and gave them a sense of pride to know
something that even superiors at their facilities didn’t
know:
We have gained knowledge and the kids have been
helped (FGD 1, male, 34 yrs, adherent)
They also said this knowledge was beneficial to other
people than the children in the trial since they spread
this information to other community members as well
as health workers at their facilities. However, more than
half of all the HSAs reported that the information re-
ceived on the day of the initial training was too limited.
They also argued that follow-up trainings would have
been a big motivator for them because they would have
gained refreshed knowledge and up-to-date information.
Everyone knew about this study, but the information
was not clearly laid out to us. As my colleague has
already pointed out, my plea is that next time there is
a meeting, the information should be well delivered to
us, and we should have enough details. The training
should have been for a few days, or even a week. In my
case, it turned out that the client had more
information than me so it is sort of embarrassing.
(FGD 1, male, 35 yrs, adherent)
Recognition by government or NGOs
Most of the adherent HSAs reported that the fact that
they were recognised and considered to take part in
reminding caretakers is a sign of respect to them and
recognition of their importance in the health system.
They expressed that they are often not involved during
inception of similar projects and yet they are the ones
who provide health care within the community:
As HSAs, we are supposed to be part of this because
the people are ours, we live with them in the
community, and we know them in and out. When they
(hospital staff ) come here they just register and leave.
But we know their homes, how it is, what’s there, their
habits, maybe their eating habits, we visit their homes
and we know. But then the problem is when things like
these come; they involve clinicians, nurses and so when
it gets hard, that’s when they involve the HSAs at the
end. (IDI-05, female, 45 yrs Adherent)
However, many of the non-adherent HSAs were not
happy about being involved in projects organized by
NGOs and research institutions. They felt that they were
being “used” since there is no personal benefit to them:
To say the truth, I was supposed to deliver the
message. But the benefit is not there for me because
the study was just done with me, they have just used
me. So it means much benefit is gained by those
getting the support of drugs, and those doing the study.
I was just supposed to be doing my job as I do.
(IDI-12, male, 33 yrs, non-adherent)
Genuine love for the job, sense of obligation and altruism
Intrinsic motivating factors are factors that make an in-
dividual to carry out tasks without outside influence.
Many participants reported that being an HSA was a
calling and that it was their responsibility to ensure good
health in their communities. Altruism can be described
as the opposite of selfishness and it’s the inert need to
do good. Among the HSAs that conducted at least one
visit this was an emerging theme. Several reported that
the love for the job and the love for their community
enabled them to help the children get better and that
they had saved lives:
Of course, I like it because our role is to save people’s
lives. So, after you have followed up and you find that
they are getting better, you feel that you had done the
job on your own, but when the person is neglecting it
and then they die, you feel like you haven’t done your
job, like you are the one who has killed them.
(IDI-01, male, 32 yrs, partially adherent)
Many expressed that it is a calling and a privilege to
serve the communities that they are part of, but some
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were vocal that their motivation was also linked to
financial rewards.
No personal rewards
Very few of the non-adherent HSAs reported that
provision of additional incentives (other than those pro-
vided by the government as part of their job descrip-
tion), would improve their willingness to visit the
children in their homes. Many HSAs however, both
adherent and non-adherent, argued that they should get
more training (which also means a per diem), and two of
the HSAs wanted bicycles as a way to be motivated to
conduct the task. When asked what kind of incentive
that would be more motivating, the majority preferred
incentives in the form of additional training with finan-
cial allowances rather than being paid per visit to the
child, as this is not practical.
Just as my fellow HSA has said, getting these
trainings will motivate us to do the work. We
shouldn’t be given allowances every time we visit a
child but rather when we attend training.
(FGD 2, female, 45 yrs, non-adherent)
Structural factors
Structural factors are factors that are closely linked to
the practicalities of the work tasks themselves. Many of
the HSAs who were adherent reported that the task was
easy, and/or that they knew the participant. However, we
also identified a number of structural factors that were
barriers to adherence. These barriers are factors that
were reported by HSAs who were not adherent or
partially adherent. We have categorized these factors
into workload, inadequate training and lack of supervi-
sion, difficulties related to text messages, and lack of
transport. Although the scope of our study was particu-
larly expressed in the context of PMC activities, most of
the reported structural barriers are true for the HSA’s
current daily work.
Ease of the task and opportunity to conduct other activities
that are within job description
The majority of the HSAs who were adherent or par-
tially adherent reported that the task was easy, uncom-
plicated and not time-consuming:
It was simple; I didn’t spend much time, since it was
just to go and remind them and I would come back,
and continue with my work. (IDI-10, male, 30 yrs,
partially adherent)
They described that they went to the child’s home and
simply ensured that child was given medication. Most of
them said that the entire visit took less than 10 min and
was even easier than other tasks they do on a daily basis:
Since our job is mostly about visiting our people in the
community, we are able to pass through the client’s
home whilst attending to other activities.
(FGD 1, male, 35 yrs. adherent)
Moreover, more than half of them had found that ei-
ther the caregiver had already administered the medica-
tion or had already planned to do so. Although the task
was easy, they felt that their visit was very important
because it made a positive impact on the caregivers and
in turn motivated them to remember to give medication
to their children. A few also added that these visits gave
them the opportunity to conduct other activities such as
giving health counseling, nutritional assessments and
family planning counseling to the caregivers and there-
fore they were able to incorporate it into their schedule:
It is not something that is done frequently, or eats up
most of our time. When we visit the client we also
encourage them to follow healthy methods of life such
as building a toilet. Through these visits a bond is
created between the clients and us. (FGD 1, male, 42
yrs, partially adherent)
Knowing the participant, distances and transport
Adherence was highest among HSAs who knew the lo-
cation of the family that they were to visit. HSAs in this
group had either been informed or taken to the home by
the research team or they received a message from their
supervisor. Four of them made the effort to find the
location prior to the scheduled visits when they received
a message. Among these HSAs, all of them mentioned
that as a result of knowing the location or the family, it
was much easier to conduct the visits and they felt an
obligation to make the home visits.
Similarly, most of those that were non-adherent,
reported that they did not know the child or the location
when they received the message. Nearly all of them said
they did not make the effort thereafter to find the loca-
tion. However, two of the non-adherent HSAs knew the
study participants’ home, but despite this they did not
conduct the visits because they were informed to wait
for SMSs, which they didn’t receive:
Yes, I was given the client name and was told that I
will receive a phone call but I didn’t. I did not follow
up the child even though I knew him, because I was
waiting for more details. I will receive a message of
when to go, but I did not receive any, hence I didn’t
visit the child. (FGD 2, male, 39 yrs, non-adherent)
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However, most of those that eventually become aware
of the child and their home cited that the distance to the
participant was too far to go at such short notice. They
felt that they were not able to go a day or two after the
specific date because it would be too late.
Transport was reported to be a challenge also by some
of the adherent HSAs. One HSA who conducted all
three visits mentioned that the child lived very far but
he was only able to visit her because he decided to
schedule clinics in a nearby village around the dates the
PMC medication was due:
Actually, I have an outreach site close to her home. And
the dates she was given for the dosage were
corresponding to those when I was having my outreach
nearby. Hence, once I was done with my activities, I
would go visit the child. (FDG 2, male, 38 yrs, adherent)
He said this could only be achieved because he knew
the schedule. Another HSA who also conducted all the
visits reported that she would have liked to have a bi-
cycle because the child’s home was far away:
It was far. I had to go around a mountain to get to her
place. (FGD 2, female 51 yrs, adherent)
Workload, PMC not part of HSAs regular work
Although all HSAs concurred that serving their commu-
nity plays a major role in their motivation to work, most
of the HSAs that were not adherent reported that at the
time they were supposed to go to visit a child for PMC
they were already expected to perform many other tasks,
including tasks meant to be done by nurses and clini-
cians. One participant said he was aware about the child
under his care, but he “simply forgot” to go because he
had so much to do. Another HSA also said that PMC is
not on his job description, just like another on-going
project whereby they are requested to go and give vita-
min supplements. They all agreed that it is very difficult
to introduce new tasks for children aged less than 5
years, since they already entail a lot of activities such as
vaccinations and vitamin supplementation that are
scheduled on different dates.
We were all given work that does not even concern us
but we just do it. When actually, it’s not in line with
our job description. It is not there. So, they pile a lot of
work on you, yet the pay itself does not match the
given jobs. (IDI-13, male, 32 yrs, non-adherent)
Although HSAs who were adherent reported that PMC
visits were relatively simple they similarly expressed that it
increased workload, which is particularly challenging since
PMC reminders are time sensitive and therefore more
difficult to combine with other duties. Two of the HSAs
had the responsibility to remind more than one caregiver
and both of them were adherent. One of them mentioned
that although he did not find it difficult, visiting more than
one child during the same time period in the case of an
upscale of PMC would be too much work on top of the
existing assigned tasks.
Inadequate training and lack of supervision
The majority of the HSAs were dissatisfied with the
training that they received for the PMC study. They said
that the training prior to the study was too short with
too much information. In addition, the medication
instructions were not very clear. This was a reported
barrier even among those who were adherent. They
complained that there was no follow-up training follow-
ing the initial one. As a result, they had forgotten most
of the content and some even said they thought the pro-
ject was finished. They reported that they only followed
instructions as per the short message reminder they re-
ceived during the trial and not during the initial training.
A major complaint from HSAs was the fact that they
saw the medicine for the first time only with the care-
giver, because the medicine was not shown during the
training:
The work is not demanding. My only problem was that
I did not know the medicine that was administered to
the child. None the less it was simple. (FGD 2, male,
29 yr, partially adherent)
Not having seen the medication was disappointing to
the HSAs, because they did not want to look incompe-
tent in front of the caregivers. They feared losing the
confidence of the caretaker because as HSAs they are
considered highly qualified and are expected to have all
the answers. In this case, when they showed ignorance
about the medication the caregiver was unsure whether
to give the medication or not. This was expressed by
both HSAs who made the visit, as well as those that
didn’t:
You could have informed us more about the medicine
during the briefing. We had no idea how they look
like; hence it would be a surprise to see that kind of
medicine when we visit the client. We are like doctors
to the clients and if they see our ignorance about the
medicine, every guardian will question whether they
should really give the dosage to their children.
(FGD 2, female, 31 yrs, non-adherent)
Most of the HSAs reported that their supervisors were
not involved in any way during the intervention. The
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responsibility solely lied on the responsible HSA to
ensure that home visits were conducted according to
plan. They also complained that this supervision was
lacking also from the research team. Most said it should
be the supervisor who has to ensure that the work plan
of each HSA reflects all activities assigned but none of
the supervisors offered any guidance. One said the
supervisor also had limited information and as such he
was not able to go and visit the child:
I had to check with my supervisor for details. My
supervisor did not have any concrete information
about it as well; though he attended the meeting he
said the training wasn’t clear enough. (FGD 2, male,
39 yrs, non-adherent)
One HSA who did not conduct any home visit said
she was away on maternity leave at the time the child
was discharged and felt that had the supervisors been in-
volved, another HSA could have taken over reminding
the child on her behalf.
Difficulties related to text messages
Two or three days prior to drug administration, HSAs
were to receive text messages to their personal phone
from the study team with the following information
translated into the local language: “Go and remind
(child’s name) to give medicine from tomorrow for three
days”. The majority of the HSAs, both those who were
adherent and those who were not, reported that they did
not receive all the monthly text message reminders. For
some of the non-adherent, this was reported as one of
the reasons why they had not visited the child:
I did not know the date that the medicine was
supposed to be taken because the date was known by
the project team so they were supposed to call me that
the child is supposed to take the medicine tomorrow.
And then I was supposed to go and see the child in the
morning and tell them that the child is supposed to
take medicine at this particular time. How would I go
when I do not know the dates that the child is
supposed to take the medicine? (IDI-6, female, 36,
partially adherent)
Four non-adhering HSAs reported that they had been
informed during the training to only visit the child when
they received a text message, and because they did not
receive it they did not conduct a single visit:
I couldn’t do anything because we were told to wait for
the phone messages. At least if they called us, we
would have monitored the child. (FGD 2,male, 39 yrs,
non-adherent)
The few who received the text message said that hav-
ing received it was helpful, although not required. They
instead relied on a schedule they developed after finding
out the dosing schedule documented in the child’s health
book. It was reported that the content of the SMS was
adequate and clear. Only one HSA expressed that the
information on the reminder was not clear and therefore
he did not know which child to visit.
Others reported difficulties with the text message
was that the timing of the text message was very in-
convenient because it came at a time when they had
either concluded their daily activities or were away.
One HSA who conducted only one visit reported that
he received the text message once and that was the
time when he was able to go and remind the care-
taker. Another HSA decided to go even if he hadn’t
received the message:
The greatest problem I encountered was waiting to
receive a message of reminder. I did not receive the
message so I would go on my own to visit the client.
(FGD, male, 38 yrs, adherent)
Another pointed out that he is not reachable by phone
every time due to unreliable network coverage or inabil-
ity to have the phone charged all the time since he lives
in a remote village:
Maybe sometimes you have been calling me but you
couldn’t get through, it is because my phone doesn’t get
through, since the phone is a phone by name (meaning
the phone is unreliable). (IDI-07, male, 35 yrs.,
partially adherent)
The majority of the participants expressed that more
focus should be put on providing enough information
including dose schedule to HSAs because having this
information made it possible for them to incorporate it
into their scheduled work plans and also to conduct the
home visits even when text messages were missing.
Similarly, HSAs who were non-adherent reported that if
they had known the dosing schedule beforehand they
would have been able to plan ahead, but otherwise they
didn’t know what was going on:
The first time I visited the child, I took the child’s
health card to check out the dates on which the drugs
should be taken. So, I would remind the guardian on
such given date. I was motivated even more when I
would find the child has already been given the drugs.
I did not receive any message of reminder. The first
time I visited the client, I just got the dates on which I
should be reminding them. (FGD 2, male, 29 yrs,
partially adherent)
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Overall, HSAs reported that the SMS reminders were
not necessary due to their unreliability.
Community factors
In addition to professional and structural factors, factors
that were related to the HSAs relationship with the com-
munity, such as their wish to maintain community trust
was important for adherence.
Maintaining community trust
Another theme that was emerging was that all HSAs,
regardless of adherence level, argued that they had a
strong link with their villages and community members.
They expressed that the recognition by their communi-
ties as “doctors” gives them pride. As mentioned before,
we noted that adherence was highest among HSAs from
rural locations of which most live within the communi-
ties they serve. They report that there is a level of trust
and confidence that their communities hold for them
and it is important to maintain it as they conduct their
daily tasks:
To my understanding I have been able to help the
clients and in return creating a bond with them. They
will have a good perception about me and trust me
when need arises. I am appreciated for the job I have
done. (FGD 2, female, 51 yrs, adherent)
For them, going to the child’s homes for this project
was no different and maintaining the confidence moti-
vated them to go. Although those who were
non-adherent talked in a similar way, they did not see
this as a major determinant of motivation for them to
go.
Caregivers see the benefit of PMC, but neighbours may be
sceptical
When asked about community reception and attitudes
towards the intervention, most adherent HSAs reported
that caregivers of children taking PMC were generally
very receptive and had a good understanding and infor-
mation about the study medication, although some
parents did not understand the idea of giving medication
to children who are not sick or have recovered.
More than half of the HSAs reported that the care-
takers had a better understanding of PMC than them-
selves and all fully adherent HSAs reported that they
were certain that all prescribed doses were given to the
child because caregivers were determined to improve
their child’s heath.
However, some of the HSAs reported that generally,
there was a lack of information and understanding of
PMC by community members who were not directly in-
volved. Two HSAs specifically mentioned that as much
as the caretakers whose children were receiving PMC
were happy to give medication to their children, some of
the neighbours were curious and suspicious:
To some people who don’t know about this study, they
were very suspicious about it. They would ask why the
frequent visits to that house and why health officers
keep coming there. Whenever I sat outside with the
mother, some people would pretend to come greet me
while they just want to eavesdrop on what’s
happening. I asked the lady if we could go inside, as
this was irritating. The mother would feel
uncomfortable about it but I had to remind her the
importance of this study to her and the child. So, the
challenge I had was the other people had a bad
perception about the study. (FGD 1, male, 42 yrs,
partially adherent)
As a result of this, two of the HSAs reported that care-
givers feared raising unwanted suspicion among their
fellow community members as to why they were being
repeatedly visited by the HSA, which would result in
being stigmatized. One of them explained that the
caregiver avoided being at home when the HSA was
supposed to visit and he did not find her at home on
two consecutive visits. The other HSA reported the
same concerns but he simply encouraged the mother to
continue giving her child medication:
Maybe the people may be wondering, “Why are they
coming to see our children?” maybe they don’t want
you to come because of what people say. But yet in the
end they may accept it. (IDI-07, male, 35 yrs partially
adherent)
Some of the HSAs also reported that there are some
cultural and social beliefs that exist in the communities
such as that a chronic illness in a child is often attrib-
uted to witchcraft or karma and that there are no medi-
cations for it. A few of the HSAs also mentioned that
some community members believed that the medicine is
given to the children so that they should be infertile.
However, this was not presented as a major factor that
affected adherence to conduct home visits but rather an
observation that may result in caregivers not being
adherent.
They just say “you are giving these things to the
children with an aim of destroying them so that
they should not have children in future. They
should not do this and that.” This is what most
people ask and so you have to convince them that
it is not like that. (IDI-04, female, 37 yrs,partially
adherent)
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When presented with the idea that caregivers could be
in full charge of the medication, some argued that HSAs
should be central to this and that it would be better if
the medication were kept by them and not by the care-
takers to guarantee proper storage and administration:
If an HSA would be taught on how to dispense these
drugs that they receive at the central hospital, they
can be left at the facility, when the follow up date
comes the HSA will take the drugs, go and give it to
the mother and also see how the child is doing.
(IDI-10, male 30 yrs, partially adherent)
Four of the adherent HSAs however, expressed that
caregivers are capable of remembering to give medi-
cation and may not need to be reminded by HSAs
because some of the caregivers had already given the
study medication at the time when the HSA was visit-
ing. The findings of this study have been summarized
in Table 4 below.
Discussion
In this study we aimed to explore whether utilizing
HSAs can be a feasible, practical and acceptable strategy
in the delivery of PMC. We found that only one in four
HSAs who were trained to incorporate PMC re-
minders into their normal duties were adherent to all
three visits. However, despite this poor level of adher-
ence, the great majority of the HSAs report that they
are intrinsically motivated to remind caregivers to ad-
minister dihydroartemesinin-piperaquine to children
in their community without any additional financial
incentives.
We found that the main motivation for HSAs in this
intervention came from their altruism and the recognition
that they play a major role in provision of health services to
the community and the appreciation they get from the
caregivers. Kadzandira et al. and Kok et al. reported that
HSAs are a link between the community and the health
system in Malawi where their major strengths reported for
motivation are team spirit, cooperation, knowledge of local
culture, language and environment [44, 45]. The HSAs’
need to attain and maintain the trust of the community
gives them a sense of duty and responsibility because they
have developed lasting bonds with the people within
the community [51, 55, 61]. This was further outlined
in our study in that they want to maintain that level
of power by insisting that they need to be an integral
part of this intervention. However, when it came to
conducting the duties assigned for this intervention
this motivation was not demonstrated.
In addition, the experience of actually seeing the im-
pact of their work and benefits of the intervention play a
major role on motivation, which was similarly reported
by Winn et al. and Gilroy et al. in other malaria pro-
grammes [62, 63]. We found that most of the HSAs do
not expect additional financial incentives to conduct
home visits since similar visits are part of their normal
duties anyway. Some studies have reported that financial
incentives may represent a source of sustained motiv-
ation, while others have observed that they can nega-
tively influence motivation [43, 55, 64]. On the other
hand, a number of the HSAs stressed that lack of
refresher training (with allowances) reduced their motiv-
ation to make PMC visits. This is consistent with
findings reported by Mpembeni et al. and Prytherch et
al. in studies from different community-based interven-
tions [55, 64].
This suggests that some form of reward either finan-
cial or non-financial for the extra work is needed to
drive their extrinsic motivation, as they genuinely want
to do well in their communities. Financial incentives in
the form of lunch allowances during trainings would
have the added benefit of gaining new knowledge.
Table 4 Summary of findings
Enabling and motivation factors Barriers and demotivating factors
Professional factors - The belief that PMC is useful
- Gaining new knowledge
- Maintain recognition from the government and NGOs
- Genuine love for the job, altruism, sense of obligation
- Sense of PMC not being part of regular work duties
- No personal reward
- No provision of earmarked financial incentives
or other incentives like air time, bicycle or additional
training with allowances
Structural factors - Ease of the task
- Short distance to child’s home
- Knowing participant location and family
- Being able to combine with other duties in the same area
- High workload
- Not knowing participant or family location
- Long distance to child’s home, lack of transport
- Inadequate information and lack of supervision
- No refresher trainings
- Not receiving SMS/No phone
- Had not seen the study medication, fear of losing care
takers’ respect because of this
Community factors - To maintain community trust and respect as ‘doctors’
- “Love for the community”
- Care takers see the benefit for their child
- Being informed by the care taker about the dosing schedule
- Curiousness and suspicion from neighbours
- Caretakers may fear stigmatisation
- Fear that the study medicine may be harmful
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If intrinsic motivation is high then why was there such
poor adherence?
Although awareness of the burden and impact of malaria
and severe anaemia was high among the HSAs, the
question is why there was poor adherence to an inter-
vention that could potentially minimise morbidity and
mortality in the communities? In line with other studies,
our study found that the factors that influence HSAs
motivation to carry out the PMC intervention activities
are multilayered [48, 49]. Professional factors allow for
good intentions to carry out the duties because most are
interpersonal but structural and community factors are a
hindrance to them. Some of the non-adherent and partly
adherent participants in this study referred to a high
workload as one reason why they had not conducted the
visits. High workload has been reported as a barrier for
CHWs also in other studies [43–45]. However, most said
the task was simple, so perhaps in the event of a scale
up there would not be the amount of resistance as dem-
onstrated here. Moreover, in the event of an upscale,
PMC will most probably be incorporated into the regu-
lar work description of the HSAs, and will not be seen
as an additional task.
We have identified some significant structural barriers
that contributed to poor adherence: difficulties with the
text messages which meant that HSAs were not in-
formed when to visit the child, inability to locate the
child, and transportation challenges. The poor function-
ing of the SMS reminders suggests that one should not
design a system that relies on the use of this technology
in the event of an upscale in Malawi.
All HSAs received similar training, but there are other
factors that come into play because with the same train-
ing some HSAs were adherent to all the required visits.
Limited information and knowledge about the interven-
tion meant that the HSAs did not have a proper under-
standing of their role and expectations. There was no
follow up supervision because we didn’t want to affect
adherence, which is a major outcome of the main trial.
Many studies have shown similar findings, that training
improves outcomes because without retraining acquired
skills and knowledge are lost over time [43, 61, 63, 65–69].
The finding that the majority of the HSAs felt that they
needed follow-up trainings, suggests in the event of an
upscale, that resources should be placed into conducting
more frequent training as a way of providing additional
knowledge and feedback [66].
Strengthening supportive supervision has also been
shown to improve effectiveness of utilising CHWs in
similar contexts. Good supervision has been shown to
be an effective way to boost team spirit and improve the
work environment through a continuing dialogue in
similar contexts [64, 66, 68–70]. Clarity of chains of
command and accountability are reported as sources of
extrinsic motivation, since one fears rebuke and loss of
professional respect. When it comes to anchoring PMC
reminders, it would be better if there were existing
chains of command. However, introducing such lines of
command in the current study, might have had an un-
desired impact on the main trial outcomes because this
would falsely represent an existing operational system
for supervision of HSAs.
Reminding caregivers to give PMC medication is re-
portedly simple and requires minimal resources in the
cases when the child lives nearby, but most of the chal-
lenges were related to identifying the child and incorpor-
ating that into their routine scheduled work plans.
Locating the child was a challenge for some. In the cases
that the HSAs were available, they were driven to the
child’s home by the research team. However, in the event
of a scale-up, HSAs will not be driven to the child’s home.
Therefore, to address this, establishing and strengthening
existing supportive supervision is important.
HSAs in this study report having strong relationships
with their community who depend on them for guidance
and community health needs. Caregivers in the trial pre-
ferred to use reminders documented in the child’s health
book rather than the HSAs reminding them. They report
that their HSAs were unreliable and often unavailable
[56]. However, other reports have shown this to be op-
posite in that HSAs have close ties with the community
and is an important driver for carrying out their duties
[20, 49]. Interestingly, the HSAs themselves report that
most of the times the caregivers were capable of admin-
istering the medicine to their children without re-
minders from them. However, the main concern and
reason for being part of for this would be to reduce
misuse in terms of administration of the medicine to an-
other child and poor storage conditions due to the lim-
ited community understanding. They therefore believe
that they should be an integral part of this and work
hand in hand with the caregiver.
Study limitations
Our study was done in the context of a clinical trial,
which may have affected our findings in several ways.
First, some HSAs may have felt that since PMC was an
add-on to their regular work which they were not given
any extra compensation for, they were not “obliged” to
be adherent, and an integration with regular chain of
command in a national scale up might potentially im-
prove adherence. Second, and pulling in the opposite
direction, in the event of a national upscale, HSAs will
not be transported to the child’s home and adherence
may therefore be even lower than what we found. The
feasibility of sending a customized SMS with the specific
child’s name may also not be sustainable in the long run,
given the constraints facing the health system. Finally,
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the results have probably been affected by the social
desirability effect whereby the HSAs might have over-re-
ported their enthusiasm and willingness to conduct the
visits.
Conclusion
This study has explored the feasibility of delivering the
PMC intervention by utilizing HSAs to remind care-
takers in the delivery of PMC as a strategy of manage-
ment of severe anaemia during the post discharge
period. We found that HSAs in Malawi perceive PMC
with dihydroartemesinin-piperaquine as an important
intervention and that they are intrinsically motivated to
conduct home visits to remind caregivers to administer
the medication to their children. Nevertheless, adher-
ence to the visits was poor.
Difficulties with the SMS reminders, not knowing the
location of the child and/or long distances, and lack of
information about the medicine currently limits motiv-
ation, gives practical challenges and reduces adherence.
In the event of a national scale up of the intervention,
the responsibility for delivering PMC should not be an-
chored with HSAs, but HSAs can provide an additional
support to care takers as long as this is included in their
job description, and the supervision system is strength-
ened. Provision of regular trainings, which provide a
lunch allowance, may provide sustained motivation and
provide the opportunity to enhance their knowledge.
However, addressing most of these challenges will be diffi-
cult in the current health system. Unless additional re-
sources are invested, utilizing HSAs to remind caregivers
as a delivery strategy for PMC may not be feasible.
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Abstract
Background: Children initially hospitalized with severe anaemia in Africa are at high risk of readmission or death
within 6 months after discharge. No intervention strategy specifically protects children during the post-discharge
period. Recent evidence from Malawi shows that 3 months of post-discharge malaria chemoprevention (PMC) with
monthly treatment with artemether-lumefantrine in children with severe malarial anaemia prevented 31% of deaths
and readmissions. While a confirmatory multi-centre trial for PMC with dihydroartemisinin-piperaquine is on going
in Kenya and Uganda, there is a need to design and evaluate an effective delivery strategy for this promising
intervention.
Methods: This is a cluster-randomized trial with 5 arms, each representing a unique PMC delivery strategy.
Convalescent children aged less than 5 years and weighing more than 5 kg admitted with severe anaemia and
clinically stable are included. All eligible children will receive dihydroartemisinin-piperaquine at 2, 6 and 10 weeks
after discharge either: 1) in the community without an SMS reminder; 2) in the community with an SMS reminder;
3) in the community with a community health worker reminder; 4) at the hospital with an SMS reminder; or 5) at
the hospital without an SMS reminder. For community-based strategies (1, 2 and 3), mothers will be given all the
PMC doses at the time of discharge while for hospital-based strategies (4 and 5) mothers will be required to visit
the hospital each month. Each arm will consist of 25 clusters with an average of 3 children per cluster giving
approximately 75 children and will be followed up for 15 weeks. The primary outcome measure is uptake of
complete courses of PMC drugs.
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Discussion: The proposed study will help to identify the most effective, cost-effective, acceptable and feasible
strategy for delivering malaria chemoprevention for post-discharge management of severe anaemia in under-five
children in the Malawian context. This information is important for policy decision in the quest for new strategies
for malaria control in children in similar contexts.
Trial registration: ClinicalTrials.gov: NCT02721420. Protocol registered on 29 March 2016.The study was not
retrospectively registered but there was a delay between date of submission and the date it first became available
on the registry.
Keywords: Children, Severe anaemia, Post-discharge malaria chemoprevention, Malaria, Dihydroartemisinin-
piperaquine, Cluster randomised trial
Background
Severe anaemia is a reduction in haemoglobin (Hb) con-
centration below 5 g/dL or haematocrit below 15%. Glo-
bally, 43% of children have anaemia and in Africa 3.6%
have severe anaemia [1]. Severe anaemia is a leading
cause of hospital admissions contributing substantially
to paediatric mortality in Africa. Hospitalized children
with severe anaemia are particularly at risk within the
first 3 months post-discharge, mostly due to a combin-
ation of environmental, behavioural, nutritional and gen-
etic risk factors [2–6]. A case-control study in Malawian
children indicated that children aged less than 5 years
admitted with severe anaemia were not only at high risk
of dying during the acute phase in-hospital but also for
several months after discharge from the hospital. 17.2%
of children with severe anaemia experienced an all cause
mortality compared to 2% of controls without severe an-
aemia [7].
By 18 months post discharge, 10.2% of children with
severe anaemia were re-admitted with rebound severe
anaemia and 12.6% had died, which is nine times higher
than the mortality in community-based, age matched
children with mild anaemia. High rates of post-discharge
morbidity and mortality have also been reported in west-
ern Kenya and Uganda, where 36.5% of children aged
less than 5 years admitted with severe anaemia died after
18 months of follow up [3, 7].
Previous observational studies in western Kenya and a
recent intervention study in a high transmission areas in
Malawi showed that malaria in the post-discharge period
is an important contributor responsible for a slow haem-
atological recovery, rebound severe anaemia and mor-
bidity [3, 5, 7]. Many children in these areas experience
episodes of new or recrudescent malaria infections after
discharge, which negates the initial rise in haemoglobin
(Hb) achieved by blood transfusion in hospital [3, 8].
Haematological recovery from malaria-associated an-
aemia is known to take at least 6 weeks. This period
may be prolonged in those with persistent or new mal-
aria infections due to on-going red cell destruction and
red blood cell production failure [9].
Standard treatment guidelines for severe anaemia in
many countries in sub-Saharan Africa consists of a blood
transfusion combined with presumptive intravenous
anti-malarial treatment (quinine or artesunate) plus anti-
biotics if bacterial infections are suspected. Once chil-
dren have stabilized and can be switched to oral
treatment, they receive a 3-day treatment course with
artemisinin-based combination therapy (ACT), usually
artemether-lumefantrine (AL). Children are often dis-
charged with a short course of iron and folate, typically
with no scheduled follow-up [8]. Creating a prophylactic
time-window post-transfusion, is suggested to allow time
for the bone marrow to recover, resulting in a more sus-
tained haematological recovery post-discharge. Data
from a previous study in Malawi show that this process
takes 2–3 months in children with severe anaemia [3, 7].
Recently, the use of Intermittent Preventive Treatment
(IPT) in children with severe anaemia during the rainy
season reduced clinical attacks of malaria by more than
80% in areas with highly seasonal transmission [10].
PMC is a version of IPT designed to clear existing infec-
tions and provide prolonged prophylaxis against new
infections.
A study in Malawi showed that provision of 3 months
of chemoprevention with 3 full treatment courses of
artemether-lumefantrine (AL), given in-hospital for
initial malaria episode and at 1 and 2 months
post-discharge, prevented 41% of deaths or readmissions
due to severe anaemia or severe malaria during a
6 months follow-up period [2, 7, 11, 12]. These results
are consistent with studies of children with severe an-
aemia in Gambia, who received chemoprevention given
as monthly intermittent preventive therapy with SP or as
weekly prophylaxis with pyrimethamine-dapsone tar-
geted during the malaria transmission season [12]. For
these children, the rate of clinical malaria was halved
and all-cause hospital readmission was reduced by 78%
in one trial, and recurrence of severe anaemia was re-
duced by 78% in the other [12–14]. These data indicate
that IPT in the post-discharge period may potentially
provide substantial health benefits [13].
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Rationale
In the past two decades, most research on severe anaemia
and severe malaria have focused on reducing in-hospital
mortality. A major and potentially preventable component
of the disease burden occurs after discharge from hospital
and a proactive approach using PMC could offer substan-
tial public health gains [11], and is a priority area for re-
search. There is, however, no specific delivery strategy that
has been scaled up to address this high-risk post-discharge
period. Despite being a relatively simple intervention, the
implementation of PMC in African settings may face chal-
lenges due to weak healthcare systems that are unique in
different contexts. PMC requires appropriately designed
delivery strategies because treatment must be adminis-
tered for 3 days at different pre-specified intervals
post-discharge.
Delivery of PMC to the target population will require
new systems to be established that are sustainable and
cost-effective. In contrast to IPT strategies in infants
(IPTi) and pregnant women (IPTp), which are delivered
through the expanded programme on immunization
(EPI) and antenatal clinics, the delivery strategies for
PMC are not yet in place. Some evidence shows that de-
livery of IPT to children (IPTc) through community
health workers is feasible and well accepted in rural
West Africa [12]. In Malawi, the health system also in-
clude village health volunteers (VHVs) and Health Sur-
veillance Assistants (HSAs) who could deliver PMC or
schedule post-discharge visits to clinics or hospital out-
patient departments for subsequent PMC doses [14].
Since PMC targets a very high-risk group of hospitalized
children who already have contact with the health-care
system, the point of entry is already established [2, 12].
This trial is part of a larger project under the PMC con-
sortium with 5 main activities in Malawi, Kenya and
Uganda that aim to address the gaps in knowledge on
whether PMC should be recommended as a strategy for
the post-discharge management of children with severe
anaemia to the WHO. The PMC trial in Malawi specific-
ally aims to identify the most effective, acceptable and
cost-effective strategy for delivering PMC and if use of
short message service has additional benefits.
Study aims and objectives
The primary objective of the trial is to determine the
optimum PMC delivery strategy by comparing
community-based versus health facility-based strategies in
order to inform policy decision. Specifically we aim to com-
pare PMC uptake (adherence) levels and safety between
community-based versus health facility-based strategies. To
determine and compare health system and family/house-
hold costs of delivering and receiving PMC using the alter-
native proposed strategies. To assess the feasibility and
acceptability of delivering and receiving PMC in a typical
Malawi health system setting. To determine whether SMS
or Health Surveillance Assistant (HSA) reminder has add-
itional benefit on PMC uptake (adherence) levels. To esti-
mate the incremental cost-effectiveness and equity impact
of the alternative delivery strategies.
Methods
Study design
This is a single-centre open label cluster randomized clin-
ical trial with 5-arms. A cluster represents a village, which
is the smallest administrative unit and overseen by a vil-
lage headman. A total of 1387 villages in the catchment
areas of Zomba Central hospital in southern Malawi will
be involved in this study.
Trial drug
The study drug used in this trial is Eurartesim® manu-
factured by Sigma-Tau pharmaceuticals. This is a GMP
certified co-formulated artemisin-based antimalarial
combination, which contains 20 mg Dihydro-Artemesi-
nin and 160 mg Piperaquine. It is administered accord-
ing to body weight 2 (PMC-1), 6 (PMC-2) and
10 weeks (PMC-3) after discharge from hospital, each
course for three consecutive days.
Study participants
Children aged 4 to 59 months admitted to Zomba central
hospital with a diagnosis of severe anaemia either by
haemoglobin of < 5 g/dl or clinically assessed as severely
anaemic but clinically stable and have received all treat-
ments according to the hospital standard of care are
screened for inclusion in the trial at the time of discharge
from hospital. Caretakers of children who meet the eligi-
bility criteria are given general information about the trial
and those who are interested are required to give written
consent for the child to participate into the study.
Interventions
All children receive DHP and hence there are no pla-
cebo arms in this trial. However, children are random-
ized to receive PMC as follows:
Community-based arms
Arm 1
PMC drugs given at discharge without SMS reminder:
The guardian receives all drugs for PMC-1, PMC-2 and
PMC-3. They are instructed on how and when to give
these drugs to the children when being discharged from
hospital. The dates for each course are documented in
the child’s health book.
Arm 2
PMC drugs given at discharge with SMS reminders: The
guardian receives all drugs for PMC-1, PMC-2 and
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PMC-3 and is instructed on how and when to give these
drugs. Additionally they are reminded via SMS to give
the drugs to the child one day before each treatment
course is due.
Arm 3
PMC drugs at discharge with Health Surveillance Assist-
ant (HSA) reminders: The guardian receives all drugs for
PMC-1, PMC-2 and PMC-3 and is instructed on how and
when to give these drugs. Additionally, HSAs which are
part of existing networks of community-based volunteers
taking part in village health committees are reminded via
SMS to go and remind the guardian to give the drugs to
the child one day before each treatment course is due.
Hospital/facility based arms
Arm 4
PMC drugs collected from the hospital: At discharge,
the guardian is instructed to return to the outpatient
department (OPD) of the hospital each month to collect
drugs for PMC-1, PMC-2 and PMC-3. They do not re-
ceive any form of reminder other than what has been
documented in the child’s health card.
Arm 5
PMC drugs at hospital with SMS reminders: At discharge,
the guardian is requested to return to the OPD to collect
drugs for PMC-1, PMC-2 and PMC-3. Additionally they
will be reminded via SMS to come to the clinic to collect
drugs one day before each treatment course is due.
Recruitment and follow up
Figure 1 shows the study flowchart from the standard
protocol items: recommendations for interventional tri-
als (SPIRIT). Every morning, the study staff at Zomba
Central Hospital goes through all newly admitted chil-
dren’s files in order to identify and pre-screen children
who meet the study criteria. During this acute phase of
Fig. 1 Study flowchart adapted from the standard protocol items: recommendations for interventional trials (SPIRIT)
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illness, pre-study screening involves confirming the
study criteria and provision of routine standard of care
treatment. No study specific information or samples are
collected in this point of time. The role of the study
team during pre-study screening is to review the diagno-
sis and ensure that the potential study participants get
the standard quality of care for severe malarial anaemia.
Each pre-screened subject is assigned a pre-screening
number in sequential order regardless of whether they
fulfil the pre-screening eligibility criteria. After the child
has recovered sufficiently, the caretaker is approached
for further screening for eligibility. Caretakers of chil-
dren who fulfil the eligibility criteria and who agree to
participate in the research provide written informed con-
sent before enrolling into the study. The study partici-
pant’s demographic data, relevant clinical information,
including the previous and current medical history, and
laboratory information is collected simultaneously. Fur-
thermore, a physical and clinical examination is performed
and captured on the enrolment case report forms (CRFs).
Randomization and allocation methods
The unit of randomization is villages within the catchment
area of Zomba central hospital. 400 out of the 1387 villages
were randomly selected and randomized to one of the study
arms, where each arm represents a different implementation
alternative. When a child is enrolled and all study proce-
dures have been done, the study data officer enters the name
of the village where the child resides into a pre-programed
database and this automatically generates the study arm and
study identification number. The participants and the study
staff are aware of the study arm assigned. However, the study
statistician who will perform the final analyses will be
blinded to the allocated treatment arm.
Follow up procedures
Table 1 summarises the recruitment and follow up pro-
cedures for the study. Depending on the trial arm to
which the child is allocated, the caretaker is either
scheduled to return to OPD clinic for PMC drugs at
two, six and ten weeks (facility based strategies), or be
given all the courses of drugs at discharge to administer
them at home also at two, six and ten weeks (commu-
nity based strategies). This information is documented
in the child’s health book. All participants, irrespective
of arm, are visited at home shortly after the two, six and
ten scheduled PMC treatments to assess DHP uptake.
These home visits are for adherence assessment, vital
registration and health economic assessments only, and
not for clinical assessment. The PMC follow up period
Table 1 Recruitment and follow-up procedures
Enrolment Allocation Follow up














Arm 1: All PMC drugs given at discharge without monthly SMS reminder X X X
Arm2: all PMC drugs given at discharge with monthly SMS reminder X X X
Arm 3: All PMC drugs given at discharge with HAS reminder. X X X
Arm 4: PMC drugs collected monthly at the OPD with SMS reminder. X X X




Physical examination X X
Blood samples X X
Adverse event assessment X X X X X X
OUTCOMES
Adherence X
Clinical safety X X X X
Cost-effectiveness X
Acceptability and feasibility X
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ends at 15 weeks after enrolment, which is four weeks
after the third scheduled PMC course. Participants are
then requested to come to the clinic 15 weeks after en-
rolment for an end of study assessment. Transport is re-
imbursed for the study end visit. In addition, subject’s
parent or guardian are instructed to return his/her child
to the study clinic for evaluation free of charge at any
time if their condition warrants medical attention during
the 15 weeks follow-up period after discharge.
Data collection and outcome measures
Adherence outcome measures
The primary outcome is the level of uptake of PMC
drugs which will be assessed by unannounced home
visits after each course whereby pill counts will be done.
Hundred percent uptake of PMC drugs will be defined as
administration of all 3-day treatment courses (i.e. 9 doses),
given at 2, 6 and 10 weeks after discharge from hospital.
Sixty percent of PMC drugs are defined as administration
of 6 or more (but less than 9) of the daily dosages out of
the total of 9.30% of PMC drugs will be defined as adminis-
tration of 3 or more (but less than 6) of the daily dosages
out of the total of 9. Less than 30% of PMC drugs is defined
as administration of less than 3 of the daily dosages out of
the total of 9, given 2, 6 and 10 weeks after discharge.
Clinical outcomes
Study instruments include structured forms for clinical
history, physical assessment, laboratory evaluations and
clinical information collected on history of current and
previous illnesses and hospital admissions is collected in
addition to hospitalizations and mortality. For children
who are hospitalized during the follow-up period, data is
collected on the length of hospitalization, diagnosis,
treatments provided, laboratory results, and participant
outcomes. Physical examination and laboratory tests in-
clude: height, weight, mid-upper arm circumference,
malaria rapid test results, blood slide results, parasit-
aemia level, and haemoglobin concentration. This will
be used to assess all-cause mortality, incidence rate of
all-cause hospital readmissions, incidence rate of read-
missions due to severe anaemia (Hb < 5 g/dL) or severe
malaria defined by the administration of parenteral Arte-
sunate or Quinine, incidence rate of non-severe
all-cause sick-child clinic visits, specifically incidence
rate of clinic visit due to RDT/microscopy confirmed
non-severe malaria during the study period.
Cost and economic evaluation outcomes
Information about expenses, resource and time use with
open-ended fields for unanticipated findings and place
for comments will be collected. Demographic informa-
tion on children is collected including age, sex, while re-
ligion, village of residence and socioeconomic features of
their household is also recorded as well as cost informa-
tion for the economic evaluation. This will assess health
provider’s cost of delivering the PMC services, care-
takers’ cost of receiving the PMC services, incremental
cost-effectiveness ratio (ICER) of PMC delivery strategies
and equity impact by socioeconomic status of PMC de-
livery strategies on main and secondary outcomes.
Acceptability and feasibility outcomes
In addition there will be interview guides for in-depth inter-
views and focus group discussions with a selection of care-
takers and health workers who have been involved in the
PMC trial. This information will be used to assess the ac-
ceptability of PMC, adaptations to health workers’ working
practices required to implement PMC, perceptions of
implementing PMC through different delivery strategies,
and recommendations on effective implementation.
Sample size
The sample size calculation has been adjusted for the
design effect using the coefficient of variation method in
order to account for the Intra-cluster Correlations (ICC)
[15, 16]. We assumed that the cluster sizes would be uni-
formly distributed between 2 and 4 children [2, 4]. This
gives a mean cluster size of 3 children per village per year
and a standard deviation of cluster sizes of 0.58. Hence
the coefficient of variation of cluster sizes (CV) is 0.58/3
= 0.19 and CV2 = 0.036. Assuming an intra-cluster correl-
ation coefficient (ICC) of 0.1 and allowing for 10%
loss-to-follow-up, a sample size of 25 clusters (villages) of
an average of 3 children per village (75 children per arm,
N = 375 overall (for 125 clusters for the 5 arms)) has 80%
power to detect a 25% absolute increase in uptake from an
estimated 50% in the OPD and delivery at home groups to
75% in the arms supported by SMS reminders (α = 0.05).
The ICC of 0.1 is slightly more conservative than the ICC
in a previous trial of delivery approaches for IPTc in the
Gambia.
Data management and statistical analysis
Data is collected and recorded by one of the trained
study staff at the point of contact. Data is entered dir-
ectly into computer tablets that will be pre-programmed
and uploaded with electronic case report forms (eCRFs).
The eCRFs have crosschecks for verification, validation
and comply with Good Clinical Practices (GCP). These
gadgets are connected to a desktop allowing data to be
directly uploaded into a database.
The percentage of children receiving PMC according to
schedule in each arm will be obtained and compared be-
tween arms using relative risks (RR) and the 95% CI for the
RR will be reported. The estimates of the RR will be ad-
justed for prognostic factors and potential confounding fac-
tors at baseline using log binomial or Poisson regression
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with adjustment for cluster effects. Using Cox regression,
hazard ratios will be calculated for morbidity endpoints
such as incidence of severe anaemia, severe malaria and all
cause hospital re-admissions, for repeated events with ro-
bust standard error estimation methods to account for cor-
relation between episodes within children. Incidence rates
per child-year and absolute rate reductions will also be
calculated.
Discussion
This protocol describes a study in which we will deter-
mine the optimum PMC delivery mechanism in a Mala-
wian context by comparing community versus health
facility based strategies. Presently in African health sys-
tems and particularly in Malawi, post-discharge health
management systems are not in place, and there is need
to assess a number of relevant strategies for effective de-
livery of PMC in a largely rural community that would
typically benefit from this intervention.
We postulate that this post-discharge care in the form
of PMC may be delivered either in the community or at
a health facility. The most likely scenario where the
health care provider is least involved would be where
mothers are given all the PMC drugs on discharge from
hospital and allowed to administer the drugs on her own
to the child (Arm 1). In recent years there has been suc-
cessful disease control programs operationalizing more
decentralized drug delivery programs in the community
in low-income countries, making it a viable option for
PMC. However as we postulate that the mother could
forget to administer the PMC, we would like to test two
different reminder systems. The first is through the
use of SMS technology, which has been shown to be
user-friendly and acceptable from our own pilot work
(unpublished pilot study) and other current programs
in Malawi (Arm 2 and 5).
An alternate reminder system is the use of Health Sur-
veillance Assistants (HSA). HSA are Ministry of Health
(MoH) employees who are responsible for basic health
promotion activities in the community. Ideally MoH
strives to have one HSA for every 1000 people, but in
reality they often cater for much larger populations and
are usually over-burdened with many disease control
programs. In some areas in rural Malawi there are Vil-
lage Health committees, which are made up of voluntary
members of the community. They work hand in hand
with the HSA. We postulate that HSAs and where avail-
able village health volunteers (VHVs) are an option for
reminding mothers to give PMC to their child (Arm 3).
Another option for delivery of PMC is to request the
mother or caretaker to return to the health care facility
to collect the drugs for each treatment course (Arms 4
and 5). This is a plausible strategy as it is consistent with
the management of chronic illness such as TB and HIV
where drugs are routinely collected from a health facility
by the patients. This would be an alternative strategy as
part of EPI or management of other chronic illnesses e.g.
chest follow up clinic.
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PMC Study        Enrolment Visit 
Form completed by (Staff ID) 
Client’s Initials    (initials) 
Date of Visit             / / (dd/mmm/yyyy) 
 
No. Questions Categories Skip 
pattern 
 A. CHILD DEMOGRAPHIC CHARACTERISTICS  
1 Child’s date of birth / / 
(dd/mmm/yyyy) 
 
2 How old is the child Months  
3 What is the sex of the child 1=Male, 2=Female  
4 Number of siblings of the child in 
the household. (By “household”, we 
mean all the people usually living together 
in this house and sharing meals, expenses 
and living arrangements.) 
Alive dead  
5 Number of people in the household Adults (>15 Years) Children (<=15 years)  
6 Are you the main care taker of the 
child? (caretaker should be one who 
lives with the child in the same 
household) 
1=Yes, 2=No If no go to 
section  H 
Reminder to 
follow up. 
 B. PREVIOUS MEDICAL HISTORY  
7 How many times has your child 





8 Has your child been admitted to a 
hospital for malaria in the past 
year? 
1=Yes, 2=No, 3=Not Sure 
 
 
If No, go to 
Q27 
9 If Yes, how many times has your 
child been admitted due to malaria 
before the current admission? 
times  
10 Date for admission 1 / / 
(dd/mmm/yyyy) 
 
11 Date for admission 2 / / 
(dd/mmm/yyyy) 
 
12 Date for admission 3 / / 
(dd/mmm/yyyy) 
 
13 Date for admission 4 / / 
(dd/mmm/yyyy) 
 
14 Date for admission 5 / / 
(dd/mmm/yyyy) 
 
15 Has your child been admitted to a 
hospital for any other illness in the 
last three months? 
1=Yes, 2=No, 3=Not Sure 
 
 
If No, go to 
Section C 
 Severe Anaemia Study           Recruitment Form 
 
 
First name       ________________________  Study Number _____________ 
 
Surname       ________________________ 
 
Study group    1 = Severe anaemia case,  2 = Hospital controls,  3 = Community controls 
   
Consent     1 = Full consent,  2 = No consent,  3 = Only for BM,  4 = Only for HIV test 
 
HIV counsel    1 = Yes HIV results,  2 = No HIV results,  8 = Not applicable,  9 = Missing 
 
Study Centre    1 =  QECH,  2 =  CDH 
 
 
Recruitment date         
 
 






Date of birth           
 
 
Age ____________  months    (only if DOB is not known)    
   
Sex       1 = Male,  2 = Female 
 
Ethnic origin    1 = Chewa,  2 = Yao,  3 = Sena,  4 = Tumbuka,  5 = Lomwe,  6 = Ngoni 
 
   7 = Tonga,    8 = Other  Specify_______________ ,   9 = Missing/Unknown   
 
Religion     1 = Catholic,  2 = Prot-major,  3 = Prot-Adventist, 4 = Prot-Jehovah,   
  
      5 = Traditional,   6 = Muslim,   7 = others,   9 = Missing 
Age mother     Estimated Age (if unknown)  
    
Education  Mother   1 = Non / minimal (alliterate),  2 = Primary  
 Father   3 = Secondary,  4 = Tertiary,   9 =  Missing 
 
Job  Mother   1 = Unemployed,  2 =  Self employed,  3 =  Wage employed 
 Father   4 =  White collar job,  9 =  Missing 
 
Health Mother   1 = healthy, 2 = died, 3 = sick, specify________________   
 
Property no Record no of categories: Cattle,   Land,   Car/Motorbike,   bicycle,   TV,   
Radio/CD,   9=missing  
 












PREVIOUS MEDICAL HISTORY 
 
Chronic illness            1 = No,  2 = Haematologic,   3 = Cardiac,   4 = Nephrotic,   5 = Developmental
  
               6 = Multiple,  7 = Other   Specify ___________________ , 9 =Missing         
   Y / N 
Previous Admissions     If yes Specify ______________________________ 
Previous Transfusion     If yes Specify ______________________________ 
Previous Ant malarial     In last 2 months,  if yes Specify _________________  
Previous Antibiotics     In last 2 months,  if yes Specify _________________ 
Previous Haematinics     In last 2 months,  if yes Specify _________________ 
Previous Multivitamins     In last 2 months,  if yes Specify _________________ 
     
Weight loss or Failure to Thrive    1 = yes; 2 = no; 3 = less than three points on curve   
 
CURRENT MEDICAL STATUS 
 
Presenting problem 1   code and Specify   ______________________________________ 
Presenting problem 2   code and Specify   ______________________________________ 
 
    
Fever    __________ days                            
Cough   __________ days   
Vomit   __________ days   
Diarrhoea   __________ days    
Last fluid intake    __________ hrs     
  
 Y / N   
Bloody stool    Meals with meat per month    Concerning last month 
Bloody urine    Meals with fish per month    More meals/day is possible 
Jaundice history     Poor appetite in last month   1 = Yes 2 = No               
Respiratory distress    Breastfeeding             1 = Yes only BF, 2 = No 
Fitting              3 = Yes & additional feeds 



































Weight  __________ kg 
Length  __________ cm 
Temperature __________ o C (if axillary add 0.5) 
Respiratory rate __________ / min 
Pulse rate  __________ bpm 
Blood pressure __________ / mmhg 
O2 saturation __________ % 
 
 
Respiratory rhythm   1 = Regular,  2 = Irregular,  9 = Missing 
 
Respiratory amplitude   1 = Normal,  2 = Irregular,  3 = Deep,   9 = Missing 
 
     Y / N                  Y / N  
Grunting      Cold periphery        
Nasal flaring     Fitting on admission  
Chest recessions     Neck stiffness       
Anaemia       Skin changes      
Jaundice      ENT/mouth abnormalities      
Oedema      Chest signs   
Xeropthalmia     Bleeding  
Skeletal deformities     Koilonychia 
Angular stomatitis     Glossitis 
NB if any of these is confirmed please describe Abnormalities in Clinical Examination 
 
General feeding condition   1 = good, 2 = fair, 3 = poor (describe in Clinical Examination) 
Lymphadenopathy   1 = absent, 2 = regional, 3 = general 
Pallor: Conjunctiva  1 = absent, 2 = mild/moderate, 3 = severe NB Asses before Hb! 
  Palmar   1 = absent, 2 = mild/moderate, 3 = severe NB Asses before Hb!  
Dehydration                       1 = Mild,  2 = Moderate,   3 = Severe,   4 = No,   9 = Missing 
Coma score        (0-5) 
 
Spleen   __________ cm  Hb   ___________ g/dl
 
Liver    __________ cm  Malaria slide ___________ parasites/200 WBCs 
Presenting diagnose 1   code and Specify   ______________________________________ 
Presenting diagnose 2   code and Specify   ______________________________________ 
 






























   Severe Anaemia Study   Active Follow- Up Visit 
 
Initials    ______________              Study Number  __________________ 
FU visit        1 Month,  3 = 3 Months,  6 = 6 Months,  12 =12 Months,  18 =18 Months 
Date of visit          
 
Iron prophylaxis taken    1 = Yes,  2 = No,  7 = Partial,  8 = Not applicable 
History of Severe illness    1 = Yes,  2 = No   
History of hospital admission   1 = Yes,  2 = No 
 
Presenting problem     code and Specify   __________________________________ 
 
Temperature          __________ oc     (if axillary add 0.5) 
Length           __________ cm     
Weight           __________ Kg     
Spleen           __________ cm 
Hb            __________   
Malaria slide          __________  parasites/200 WBCs 
 
Presenting diagnose     code and Specify   __________________________________ 
 
Action taken       1 = Admission,  2 = Rx + extra FU,  3 = Rx +no FU,  4 = No action  
Details  






    Severe Anaemia Study        Passive Follow- Up Visit 
 
Initials             _______________________    Study Number  _______________ 
 
 
Date of visit    
  
 
Presenting problem 1   code and Specify   ______________________________________ 
Presenting problem  2   code and Specify   ______________________________________ 
 












Temperature  ___________  oc     (if axillary add 0.5 oc)   
 
 
Weight   ___________  Kg     
 
Spleen   ___________  cm 
 










Hb    ___________ g/dl   
 
Malaria slide  ___________  parasites/200 WBCs 
 
 
Presenting diagnose 1   code and Specify   ______________________________________ 
Presenting diagnose 2   code and Specify   ______________________________________ 
 
Action taken     1 = Admission,   2 = Rx + extra FU,   3 = Rx +no FU,   4 = No action,  








Severe Anaemia Study    Location 
 
First  name       ________________   Study Number _____________ 
  
Surname         ___________________________ 
Father name           ___________________________ 
Mother name        ___________________________  
 Village       ___________________________  
Compound head        ___________________________ 
GPS Position        ___________________________ 
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16 If yes, how many times has your 
child been admitted for any other 
illness in the last three months? 
Times  







18 What was the reason for admission 









19 Date of Admission 2 / / 
(dd/mmm/yyyy) 
 
20 What was the reason for admission 









21 Date of Admission 3 / / 
(dd/mmm/yyyy) 
 
22 What was the reason for admission 









23 Date of Admission 4 / / 
(dd/mmm/yyyy) 
 
24 What was the reason for admission 









25 Date of Admission 5 / / 
(dd/mmm/yyyy) 
 
26 What was the reason for admission 
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27 Did your child have a blood 
transfusion in the past four weeks?  
1=Yes, 2=No, 3=Not Sure  
 
 
If No, go to 
Section C 
28 If yes, what was the reason for 
blood transfusion 
1=severe anaemia,  
2=blood loss due to injury,  
3=leukemia,  




C. MALARIA CONTROL MEASURES  
29 Do you have mosquito nets in your 
household? 
1=Yes, 2=No If No, go to 
section D 
30 How many sleeping spaces are in 
your household? 
  
31 How many sleeping spaces in your 
household are covered by ITN? 
  
32 Did the child sleep under an ITN 
the night before admission? 
1=Yes, 2=No, 3=Not Sure If yes, go to 
Q34 
33 If no, what was the reason? 
(Tick all that apply) 
Forgot,  
Travelled away,  
Child allergic to the net, 
Net was being used by others, 
Others, specify_________________ 
 
34 At any time in the past 12 months, 
has your house been intermittently 
residual sprayed against 
mosquitoes? 
1=Yes, 2=No, 3=Not Sure 
 
If no, go to 
Section D 
35 If yes, when was your house 
sprayed? 
/ (mmm/yyyy)  
 
 
D. TREATMENT ADHERENCE  
36 Has your child been prescribed 
treatment to take at home before? 
1=Yes, 2=No, 3=Not Sure 
 
If No, go to 
section E 
37 If Yes, what measures did you put 
in place to make sure your child 
took all the prescribed doses? 
(Tick all that apply) 
Schedule drugs at meal times, 
Schedule drugs at bathing time,  
Put written reminders on the wall,  
Share information with family 
members to remind you, 
Others, specify_______________ 
 
38 Did your child vomit any of the 1=Yes, 2=No, 3=Not Sure If no ,go to 
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drugs that you gave him/her at 
home? 
40. 
39 If yes, what did you do if your child 
vomited immediately after taking 
drugs?(Tick all that apply) 
 Administered another dose, 
Did not do anything, 
Reported to the HSA, 
Others, specify_______________ 
 
40 What measures do you put in place 
to make sure your child does not 
vomit medications?(Tick all that 
apply) 
Give drugs with sweetened 
water/drink, 
Give drugs with meals,  
Breastfeed immediately after giving 
drug,  
Do nothing, 
 Others, specify_______________ 
 
  E. CURRENT MEDICAL HISTORY   
41 Which of the following symptoms 
was your child experiencing on 
admission?(Tick all that apply) 
Fever, (duration in days) 
Cough, (duration in days) 
Vomiting, (duration in days) 
Diarrhoea, (duration in days) 
Other specify ________, (duration 
in days) 
 
42 What is the diagnosis for this 
admission?  






     F. GUARDIAN DEMOGRAPHIC CHARACTERISTICS   
43 How old are you? years  
 
 
44 Is this estimated or your actual age? 1= Actual, 2=Estimated  
45 Sex 1=Male, 2=Female  







47 What religion do you practice? 1=Catholic,  
2=CCAP,  
3=Anglican,  
4=Seventh Day Adventist,   
5=Muslim, 
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50 Highest level of education 
completed by you? 
1=None,  
2=Lower primary school (1-4),  
3=Upper primary school (5-8),  
4=Lower secondary school(Form 1-2) 
5=Upper secondary school (Form 3-6) 
6=Tertiary level,  
7=Other, specify________ 
 
51 What is  main source of income of 
your household? 
1= Subsistence farming 
2=Government work  
3=Business  
4=Large scale farming,  
5=Private formal work 




52 Are you able to read? 1=yes, 2=no, 3=not sure  
53 Are you able to write? 1=yes, 2=no, 3=not sure  





If  me, go to 
Q62. 
55 How is the decision maker related 
to the child? 
 
 
1 = Sister/ Brother 
2 = Mother/ Father 
3 = Mother in law / Father in law 
4= Grandmother / grandfather 
5 = Aunt / uncle 
6 = Cousin 
17 = Does not wish to disclos 
8 = Other________________ 
 





4=Seventh Day Adventist,   
5=Muslim, 
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6 =No religion,  
7=Other, specify_________________ 
57 What is the tribe or ethnic 











58 Highest level of education 
completed by the decision maker? 
1=None,  
2=Lower primary school (1-4),  
3=Upper primary school (5-8),  
4=Lower secondary school(Form 1-2) 
5=Upper secondary school(Form 3-6) 
6=Tertiary level,  
7=Other, specify________________ 
 
59 What is the main source of income 
of the decision maker? 
 
1= Subsistence farmer  
2=Government worker  
3=Business  
4=Large scale farmer,  
5=Private formal worker, 
6=At school/university,  




60 Is the decisionmaker able to read? 1=yes, 2=no, 3=not sure  






Who is the main breadwinner? 1 = Me 
2 = Decision Maker 
3 = Someone else 
If 1 or 2, go 
to Q65. 
63 What is the main source of income 
of the main breadwinner? 
 
1= Subsistence farmer  
2=Government worker  
3=Business  
4=Large scale farmer,  
5=Private formal worker, 
6=At school/university,  




64    
 G. Household assets  
65 What is your main source of 1=Piped in dwelling  
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drinking water? 2=Communal stand piped 








11= Bottled water 
12= Other, specify 
……………………………… 
66 Where is that water source located? 1=In own dwelling,  
2= In own yard/plot,  
3=Elsewhere 
 
67 How long does it take to go there, 
to get water and come back? 
. hours/minutes  
68 Who usually fetches water? 1=Female >15 years,  
2=male >15 years  
3=Female <=15 years  
4=male <=15 years 
 
69 Do you do anything to the water to 
make it safer to drink? 
1=yes, 2=no, 3=don’t know 
 
If No, go 
to Q71. 
70 If yes, what do you do to make the 
water safer to drink? 
 
1=Boil,  
2=Add Bleach /Chlorine/Alloy  
3=Strain through a cloth,  
4= Use water filter,  
5= Solar disinfection,  
6= Let it stand and settle,  
7=Other_______ 
 
71 What type of toilet do members of 
household usually use? 
1=Flush toilet 
2=Pit latrine 
3=Dug-out pit with roof 
4=Dug-out pit without roof 
5=None 
6=Does not wish to disclose 
7=No facility, bush, outdoor 
8= Other, specify______________ 
 
 
72 Do you share this toilet with other 
households? 
1=yes, 2=No If no, go to 
Q74 
73 How many households use this households  
Screening number.                                         
Page 8 of 11 
 PMC MW Study _Enrolment visit form v3.1 11 Nov 2015 
 
toilet facility, including your own? 
74 Please indicate if your household 
owns any of the following (tick 
those that apply): 
 
Electricity  
Clock/ watch  
Radio 
 
Black and white TV  
Colour TV  
Mobile phone  




Washing machine  
Computer 
Digital camera  
Non-digital camera  
Video deck  
VCR/ DVD 
  Torch 









Battery operated Cassette player  
Plow 









75 What type of fuel does your 
household mainly use for cooking? 
1=Electricity,  
2=LPG/ natural gas,  
3=Biogas,  
4=Kerosene,  




9=Agricultural crop residue,  
10=Animal Dung,  
11=No food cooked in household  
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12=Other, specify_____________ 
76 Where is the cooking usually done? 1=Inside the house,  




77 Do you have a separate room that is 
used as a kitchen? 
 
1=yes, 2=No  
78 What is the main material the roof 
in your house is made of? 
 
1=Grass,  




6= Plastic Sheeting 
7= Does not wish to disclose 
8= Does not know 
9= Other, specify______________ 
 
79 What is the main material the main 




3=Compacted Earth (Yamdindo) 
4=Mud bricks (unfired) 




9=Does not wish to disclose 





80 What is the main material the floor 







6=Does not wish to disclose 




81 How many rooms are there in your 
house? 
number of rooms  
82 How many rooms in your house are 
used for sleeping? 
number of rooms  
Screening number.                                         
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83 Does any member of this household 




Animal drawn cart  
Car or Truck  




84 The structure you live in (house, 
flat, shack), does your household: 
1= Own the structure 
2=Pay rent/Lease 
3=No rent, with consent of owner 
4=No rent, without consent, squatting 
5=Other, specify 
 
85 The land your structure (house, flat, 
shack) sits on, does your 
household? 
 
1=Own the structure,  
2=Pay rent/ Lease  
3=No rent, with consent of owner  
4=No rent, without consent, squatting 
5=Other, specify _____________ 
 
86 Does any member of this household 
own any agricultural land? 
1=yes, 2=no If no, go to 
Q89 
87 Do you know the size of the land? 1=yes, 2=no If no, go to 
Q89 
88 How many Acres of land 
(altogether) are owned by the 





89 Does this household own any 
livestock, herds, other farm 
animals, or poultry? 
1=yes, 2=no If no, go to 
Q91 
90 How many of the following animals 
does this household own? 
 








91 Does any member of this household 
have a bank account? 
1=yes, 2=No, 3= Don’t Know  
92 What is your contact number?   
93 What is your alternative contact 
number 
  
H. CLINICAL EXAMINATION  
94 Anthropometric Measurements Weight  . kg 
Height  . cm 
 
95 Vital Signs Pulse rate               beats/min  
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Temperature          . ºC 
Respiratory rate  /min 
96 Other Signs 
(Tick all that apply) 
Chest signs,  
Chest recessions, 
Oedema, 








97 Lab Investigations  Hb Level: . g/dl 
DBS 




Is the client eligible for randomisation? 1=Yes, 2=No 
If no, what was the reason for not being eligible? _____________________ 
Village __________________________ 
TA 1. Mwambo  
                                        2. Chikowi  
 3. Malemia  
 4. Mlumbe 
 5. Kuntumanji  
 6. Sub T/A Ntholowa  
 7. Sub T/A Nkagula 
       8. Sub T/A Ngwelero 
       9. Sub T/A Mbiza 
     10. Sub T/A Nkapita 
 
Study ARM 1. Arm 1    2. Arm 2   3. Arm 3  4. Arm 4  5. Arm 5 
 
Client Identification Number (ARM 1)  
Client Identification Number (ARM 2)  
Client Identification Number (ARM 3)  
Client Identification Number (ARM 4)  
Client Identification Number (ARM 5)  
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Page 1 of 3 
   




PMC study             Drug Collection Form 
      
Form completed by (Staff ID) 
Client’s Initials  (initials) 
Visit Number  1=First, 2=Second, 3=Third 
Study Arm   1=Arm 1, 2= Arm 2, 3= Arm 3, 4=Arm 4, 5=Arm 5 
Date of visit   /  / (dd/mmm/yyyy)         
   
General information to trial staff:  
 
If the mother/guardian combines the trip to the health facility with a sick visit, the Sick Visit Form 
should also be filled out. 
No. Questions Categories Skip pattern 
 A. DRUG COLLECTION INFORMATION  
1 Is the child alive? 1=Yes, 2=No If  No, complete 
the verbal autopsy, 
STOP, end of 
form  
2 Has mother/guardian collected 
participants study drugs? 
1=Yes, 2=No If no, STOP, end 
of form 
3 Is the child sick today? 1=Yes, 2=No If yes, fill the sick 
visit form 
 B. PROVIDERS TIME INFORMATION FOR THE OPD 
VISIT 
 
4 Total time broken down by 
personnel/activity: 
- Total time spent seeing the nurse 
- Total time spent seeing the clinician 
- Total time spent in registration 









C C. PATIENT COSTS AND TIME INFORMATION FOR THIS 
OPD VISIT 
 
5 Did anyone travel with you to the 
OPD today? 
1=Yes, 2=No If no, skip to  Q7 
6 What is his/her occupation? 1= Subsistence farmer  
2=Government worker  
3=Business  
4=Large scale farmer,  
5=Private formal worker, 
6=At school/university,  
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7 How much time have you spent at the 
OPD today? 
minutes  
8 Did the person accompanying you 
spend the same amount of time? 
1 = Yes, 2 = No, If yes, go to Q9 
 If no, how much time? minutes  
9 Did you use any money at the health 
facility today or because of today’s 
OPD visit (this includes the person 
accompanying)? 
1 = Yes, 2 = No, 3=Don’t know If no, go to Q12 
10 How much money did you spend on 
each of the following: 
 
Enrolment and 



















11 How much money did you spend at 
today’s visit in total? If she doesn’t 
know details, ask her to give her best 
estimate. 
 
. Kwacha If there is a 
discrepancy please 
probe. 
12 Was there anything you should have 
spent money on, but you did not? 
1 = Yes, 2 = No If no, go to Q15 
13 If yes, specify   
14 The reason for not spending the 
money 
 1=Didn’t want to,  
2=Didn’t bring enough,  
3=Couldn’t afford it,  
4= Other______________ 
 
15 Did you have travel costs to the OPD 
today (this includes child and person 
1 = Yes, 2 = No If no, skip next 
question 
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accompanying)? 
16 How much money did you spend in 
total on travel to the health facility 
today- on the way here only (this 
includes child and person 
accompanying)? 
Kwacha  
17 What mode of transport did you use to 
the health facility today? 
Walking 
 Own bicycle 
 Bicycle taxi 
 Minibus 




18 How much time did you spend 
travelling to the health facility today – 
on the way there only? 
minutes  
19 How many days are you unable to 




Form Checked by (initials):     Date: / /  
Data Entered by (initials):                   Date: / /  
Double entered by (initials):     Date: / /  
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PMC study        Sick Visit Form  
     
Form completed by   (Staff ID) 
Client’s Initials    
Date of visit    /  /  (dd/mmm/yyyy)          
  
No. Questions Categories Skip pattern 
 A. MEDICAL HISTORY   
1 Is the child alive? 1=Yes, 2=No If  No, complete the verbal 
autopsy, STOP, end of 
form  
2 Is your child having any of the 
following symptoms 
(Tick all that apply) 
Fever, (duration in days) 
Skin problems/rashes(duration in 
days) 
 Sleep disturbance(duration in days) 
 Headache,(duration in days) 
 Dizziness,(duration in days) 
 Diarrhoea,(duration in days) 
 Abdominal pain, (duration in days)
 Vomiting, (duration in days) 
 Nausea, (Duration in days) 
 Other, specify(Duration in 
days)____________________ 
 
3 Has your child visited any health 
facility with an illness since the 
last study contact 
 Yes 
 No 
 Not sure 
If yes, complete the missed 
sick visit form as well 
4 Has your child been admitted to a 
health facility with any other 
illness since the last study contact? 
 Yes 
 No 
 Not sure 
If no, go to Q6 
5 If yes, what was the reason for 
admission? 









6 Has your child received blood 
since the last study follow up 
 Yes 
 No 
 Not sure 
 
7 Time spent by nurse: minutes 
 
 
 PHYSICAL EXAMINATION 
8 Anthropometric measurements  Weight . kg 
Height   . cm     
 
9 Vital Signs Temperature  . °C (if axillary add 
0.5 °C) 
Respiratory rate breaths/min    
    Pulse Rate beats/min 
 
10 Time spent by nurse: minutes  
11 Other signs 
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12 Time spent by clinician: minutes  
13 Are the laboratory Investigations 
done? 
1. Yes     2. No 3. N/A If no, go to Q15 
14 Laboratory Investigations HemoCue Hb check . g/d
   
Malaria Microscopy  1=Positive, 
2=Negative  
 
MRDT  1=positive, 2=negative  
 
DBS Collected     1. Yes 2. No 
Additional blood tests needed?  
 1 = Yes, 2 = No 
If yes, which tests? (Please tick) FBC 
Blood culture Urinalysis Other 
(please 
 
15 Time spent by nurse: 




16 Presenting diagnosis 1  insert diagnosis code  
17 Presenting diagnosis 2  insert diagnosis code  
18 
19 
Time spent by clinician: 




20 How many types of drugs was the 
child given? 
  
21 Drug details (anti-malarials and other non-study drugs given) 
 Drug Dose  Units(ml,g,mg,tablets and iu) Duration (days) 
    
    
    
    
 
 
22 Was the child prescribed any drugs but the drugs were not given ? 1 yes 2. No       If yes fill the table below 
Drug Dose  Units(ml,g,mg,tablets and iu) Duration (days) 
    
 
 
   
    




Time spent by nurse: 




25 Has the child been admitted to the 
hospital today? 
1 = Yes, 2 = No If yes ,Complete SAE 
form  
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C. PROVIDER’S TIME INFORMATION 
 
26 Time spent overall giving 
treatment to the patient (related to 
this disease incidence only). 
minutes  
27 Total time broken down by 
personnel/activity: 
- Total time spent by the nurse 
- Total time spent by the clinician 
-Total time spent by the lab 
technician 
-Total time spent by the 
registration (this does not include 
waiting by the patient, strictly the 









 D. PATIENTS REFERRAL COSTS  
28 Were you referred here from 
another health facility? 
1 = Yes, 2 = No, 3 = Don’t know If no, go to the next 
section 
29 If yes, how much time did 





30 How much time did you 




31 How much money did you 
spend travelling to that 
health facility? 
Kwacha  
32 How much money did you 
spend at that health facility? 
Kwacha  
 E. PATIENT COSTS AND TIME SPENT AT THE OPD   
33 Did anyone travel with you 
/visit you at the OPD? 
1=Yes, 2=No If no, skip next question 
+ question 36 and 37 
34 What is his/her occupation? 1= Subsistence farmer  
2=Government worker  
3=Business  
4=Large scale farmer,  
5=Private formal worker, 
6=At school/university,  




35 How much time did the 




36 Did the person 
accompanying you spend the 
entire time with you? 
1 = Yes, 2 = No, If yes, go to Q38 
37 If no, how much time? minutes  
38 How many days were you 
unable to work due to your 
child’s illness (this includes 
time before coming to the 
OPD)? 
days  
39 Did you use any money at 
the OPD or due to the OPD 
1=Yes, 2=No, 3=Don’t know If no, go to Q42 
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visit (this includes her, the 
person 
accompanying/visiting etc, 
but not travel costs)? 
40 How much money did you 




five care book. 
Registration  
Consultation  
Haemoglobin/Hb test  
Malaria test  
Other laboratory tests  
Mosquito net 
Medicines 
Food/drink (related to 
OPD visit) 




Total   
 
41 If she doesn’t know details, 
ask her to give her best 
estimate of the total she 
spent at today's visit: 
Kwacha If there is a discrepancy 
probe  
42 Did you have travel costs to 
the OPD? 
1 = Yes, 2 = No If no, go to Q44 
43 How much money did you 
spend in total on travel to the 
health facility - on the way 
here only (this includes 
person accompanying and 
child)? 
 Kwacha  
44 What mode of transport did 
you use to the health facility? 
Walking 
 Own bicycle 
 Bicycle taxi 
 Minibus 
 Pick up 
Other,specify_______________ 
 
45 How much money will you 
spend on travelling back 
home? 
 Kwacha  
46 How much time did you 
spend travelling to the health 
facility – on the way here 
only? 
minutes  
47 How much time will you 




 F. COSTS AS A BARRIER TO CARE   
    
   
         Client  Identification Number 
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48 When seeking treatment for 
your child, was there 
something you should have 
spent money on, but did not? 
1=Yes, 2=No, 3=Don’t know If no, skip next two 
questions 
49 If yes, please specify the 
items: 
______________________  
50 The reason for not spending 
the money 
1=Didn’t want to,  
2=Didn’t bring enough money,  
3=Couldn’t afford it,  
4= Other, specify ______________ 
 
51 Did you have to borrow 
money to seek care? 
1=Yes, 2=No, 3=Don’t know  
52 Did you have to sell any 
assets to seek care? 
1=Yes, 2=No, 3=Don’t know  
53 Since last contact with study 
staff, did you ever wish to 
seek treatment for your child, 
but could not afford to do so? 
1=Yes, 2=No, 3=Don’t know  
 G. VISIT OUTCOME 
54 Is the child admitted today 1=Yes, 2=No If no , end of form if 
yes, complete post 
admission form on 
discharge 









Form Checked by (initials):     Date: / /  
Data Entered by (initials):                   Date: / /  
Double entered by (initials):     Date: / /  
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PMC study    Missed Sick Visit Form 
       
Form completed by  (initials) 
Client’s initials  (initials) 
Date of Visit             /  /  (dd/mmm/yyyy) 
 
 Question Categories Skip Pattern 
A. MEDICAL HISTORY 
1 Is the child alive? 1=Yes, 2=No If  No, 
complete the 
verbal autopsy, 
STOP, end of 
form  
2 
When was the last 
time your child 
visited another 
health facility with 
an illness 
/ / dd/mmm/yyyy 
(insert date) 
 
3 Has your child been 
admitted to a health 
facility with any other 




 Not sure 
If no, go to Q5 
4 If yes, what was the 
reason for admission? 










What type of 
facility did you go 





Drug store/pharmacy/drug peddler 
Private laboratory for diagnosis only 
Didn't go anywhere/waited till it was over  




The last time your 
child visited 
another health 









Was the HB done? 
 
 
 1=Yes, 2= No 
 
HbLevel .  g/dl 
If no, go to 
next test  
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Was MRDT done? 
 
 1=Yes, 2= No 
 
Malaria slide: Positive  1=Yes, 2= No 
 
 1=Yes, 2= No 
 
MRDT: Positive  1=Yes, 2= No 
 
 




If no, skip the 
test 
8 
What was the 
diagnosis the last 
time your child 
visited another 
health facility? 
Diagnosis 1  Insert code 
Diagnosis 2  insert code 




Was your child 











How many types of 
other treatment was 
the child given 
  










1. ml  2. g 3. mg 4. iu 
5. tablets 
Duration (days) 
    
    
    
    
 
12 






1. ml  2. g 3. mg 4. iu 
5. tablets 
Duration (days) 
    
    
    
    
 
13 
Was your child 
admitted during 
this visit? 
 1=Yes, 2= No, 3= Not sure If no, skip to 
section C 
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B. PATIENT COSTS AND TIME SPENT for those admitted 
14 
What facility was 










Was your child 
admitted with a 
diagnosis of severe 
malarial anaemia? 
 1=Yes, 2=No, 3=Not Sure 
 
If no, go to 13 
16 
If Yes, what 
medication was 
given to your child 








Did your child have 
a blood transfusion 
during this time? 




Did anyone travel 
with you to the 
health facility? 
1=Yes, 2=No If no, go to 16 
18 
What was his/her 
occupation? 
1= Subsistence farmer  
2=Government worker  
3=Business  
4=Large scale farmer,  
5=Private formal worker, 
6=At school/university,  





How much time did 





Did the person 
accompanying you 
spend the same 
amount of time? 
1 = Yes, 2 = No, If yes, go to 19 
21 




What mode of 
transport did you 
use to the health 
facility? 
Walking 
 Own bicycle 
 Bicycle taxi 
 Minibus 
 Pick up 
 Other, specify_______________ 
 
23 
How time did you 
spend travelling to 
the health facility? 
minutes  
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24 
How much time did 




How many days 
were you unable to 
work due to your 
childs illness (this 
includes time before 





Did you use any 
money at the health 
facility or because 
of the visit (this 






1 = Yes, 2 = No,  If no, skip next two 
questions. 
27 
How much money 
did you spend on 
each of the 
following: 
 
Enrolment and health 
passport   
Registration  
Consultation  
Haemoglobin/Hb test  
Malaria test 
Other laboratory tests  
Mosquito net 
Medicines 
Food/drink (related to 
OPD visit) 
Gift for health worker  
Under-the-table payment 
Other___________ 
 Total  
 
28 
If she doesn’t 
know/remember the 
details, ask her to 
give her best 
estimate of the total 
she spent at the 
health facility: 
Kwacha 
If there is a 
discrepancy probe 
29 
How much money 
did you spend in 
total on travel to the 
health facility- on 
the way there only 
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How much time did 
you spend travelling 





C. PATIENT COSTS AND TIME SPENT FOR those not admitted 
31 
Did anyone 
travel with you 
/visit you at the 
health facility? 
1=Yes, 2=No If no, go to 28 
32 
What is his/her 
occupation? 
1= Subsistence farmer  
2=Government worker  
3=Business  
4=Large scale farmer,  
5=Private formal worker, 
6=At school/university,  





How much time 





Did the person 
accompanying 
you spend the 
same amount of 
time? 
1 = Yes, 2 = No, If yes, go to 31 
35 




How much time 
did you spend 
travelling to the 
health facility – 






How much time 






How many days 
were you unable 
to work due to 
your childs 
days  
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Did you use any 
money at the 
health facility or 
because of the 
visit (this 





1=Yes, 2=No, 3=don’t know  
40 
How much 
money did you 




Enrolment and  health 
passport   
Registration  
Consultation  
Haemoglobin/Hb test  
Malaria test 
Other laboratory tests  
Mosquito net 
Medicines 
Food/drink (related to OPD 
visit) 







money did you 
spend on the 
visit in total.If 
she doesn’t 
remember ask 
her to give her 




money did you 
spend in total on 
travel to the 
health facility - 
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43 
What mode of 
transport did 
you use to the 
health facility? 
Walking 
 Own bicycle 
 Bicycle taxi 
 Minibus 
 Pick up 












D. COSTS AS A BARRIER TO CARE 
45 
When seeking 
treatment for your 
child, was there 
something you 
should have spent 
money on, but did 
not? 
1=Yes, 2=No 3=don’t know If no, go to 41 
46 
If yes, please 




The reason for not 
spending the 
money 
1=Didn’t want to,  
2=Didn’t bring enough money,  
3=Couldn’t afford it,  
4= Other, specify ______________ 
 
48 
Did you have to 
borrow money to 
seek care? 
1=Yes, 2=No 3=don’t know  
49 
Did you have to 
sell any assets to 
seek care? 
1=Yes, 2=No 3=don’t know  
 
Form Checked by (initials):     Date: / /  
Data Entered by (initials):     Date: / /  
Double entered by (initials):     Date: / /  
HOME VISIT FORM 
 
Please Tick the applicable course  
 
PMC 1 (Week 2)   PMC 2 (Week 6)  PMC 3 (Week 10)  Unscheduled  
 
NO QUESTION CATEGORIES SKIP PATTERN 
1 Is blister pack collected? 1=Yes, 2=No If yes go to Q3 
2 If no, state the reason?   
3 Expected number of DHP tablets    
4 Actual number of DHP tablets    
 
 




FIELD WORKER ID:  1  
                               
 
 Client Identification Number    
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PMC STUDY      End of study visit form 
Form completed by  (initials) 
Client’s initials  (initials) 
Date of Completion  /  /  (dd/mmm/yyyy) 
Study Arm             1=Arm 1, 2= Arm 2, 3= Arm 3, 4=Arm 4, 5=Arm 5 
Cluster    
 
No. Questions Category Skip pattern 
A PREVIOUS MEDICAL HISTORY 
1 Is the child alive?  1=Yes, 2=No If  No, complete the 
verbal autopsy, 
STOP, end of form  
2 Did your child visit any health facility 
with an illness since last contact with 
study staff? 
1=Yes, 2=No, 3=Not Sure If yes, complete the 
missed sick visit 
form 
B MALARIA CONTROL MEASURES  
3 Do you have mosquito nets in your 
household? 
1=Yes, 2=No If No, go to section 
C 
4 How many sleeping spaces are in your 
household? 
  
5 How many sleeping spaces in your 
household are covered by ITN? 
  
6 Did the child sleep under an ITN the night 
before admission? 
1=Yes, 2=No, 3=Not Sure If yes, go to Q8 
7 If no, what was the reason? 
(Tick all that apply) 
Forgot,  
Travelled away,  
Child allergic to the net, 




8 At any time in the past 12 months, has 
your house been intermittently residual 
sprayed against mosquitoes? 
1=Yes, 2=No, 3=Not Sure 
 
If no, go to Section 
C 
9 If yes, when was your house sprayed? / (mmm/yyyy)  
C. PRESENT MEDICAL HISTORY 
10 Is your child sick today? 1=Yes, 2=No If no go to 
section D 
11 Is your child having any of the following 
symptoms (tick any that apply) 
Fever (Duration in days) 
Skin problems/rashes(Duration 
in days) 
Sleep disturbance (Duration in 
days) 
 Headache (Duration in days) 
 Dizziness (Duration in days) 
 Diarrhoea (Duration in days) 
 Abdominal pain (Duration in 
 
 Client Identification Number    
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Vomiting(Duration in days) 
 Nausea (Duration in days) 
 Other, specify(Duration in days) 
   
D CLINICAL EXAMINATION 
12 Anthropometric Measurements Weight  . kg 
Height   . cm 
 
13 Vital Signs Pulse rate beats/min 
Temperature . ºC 
Respiratory rate /min 
 
14 Other Signs 
(Tick all that apply) 
Chest signs,  
chest recessions, 
oedema, 
















HbLevel  .  g/dl 
 
Malaria Microscopy: Positive  








16 What is the current diagnosis? 






E GUARDIAN TIME AND TREATMENT COSTS  
17 Has drug administration hindered you 
from conducting other activities? 
1=Yes, 2=No, 3=Don’t know If no, skip next 
two questions. 
18 How much time, on average, do you think 
each round of drug administration (all 
three days) prevented you from 
conducting other activities? 
minutes  
19 What type of activities?  Leisure time 
 Household chores 
 Working for wages 
 Other, specify______________ 
 
20 Did you have any additional costs due to 
the malaria treatment? 
1=Yes, 2=No, 3=Don’t know If no, skip next 
question. 
21 How much in total do you think these 
additional costs were? 
Kwacha  
 Client Identification Number    
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E. COSTS AS A BARRIER TO CARE  
22 Did you ever wish to come to a health 
facility for an unscheduled visit during 
this trial, but could not because of the 
costs? 
1=Yes, 2=No  
23 When treating your child with the trial 
drugs, there something you should have 
spent money on, but did not? 
1=Yes, 2=No, 3=Don’t know If no, skip next two 
questions 
24 If yes, please specify: ______________________  
25 The reason for not spending the money 1=Didn’t want to,  
2=Didn’t bring enough money,  
3=Couldn’t afford it,  
4= Other, specify ______________ 
 
26 Did you have to borrow money during the 
time of the trial to cover treatment costs? 
1=Yes, 2=No, 3=Don’t know  
27 Did you have to sell any assets during the 
time of the trial to cover any treatment 
costs? 
1=Yes, 2=No, 3=Don’t know  
F SMS REMINDER  This only applies to 
those randomised 
into trial arm XX and 
XY. 
28 Did you receive the SMS reminder to start 
a new dose of treatment for your 
child/collect the drug at the OPD? 
1=Yes, 2=No, 3=Sometimes, 
4=Not sure 
If yes, skip next 
question 
29 If no, what was the reason? (Tick any that 
apply) 
 Did not have access to a phone 
 Did not always have access to a 
phone 
 Did not have a charged phone 
 Lost the phone that was 
registered with the study staff at 
enrolment. 
 Was embarrassing to bother 
other people. 
 
30 If yes, did you find the reminder useful?  1= yes, 2=no, 3=not sure If yes, skip the next 
question. 
31 If no or not sure, why not?  Did not need the reminder 
 Was a struggle to keep phone 
charged 
 The costs associated with 
keeping the phone charged 
outweighs the gains. 









G. COSTS OF SMS REMINDER   
32 How much money, on average, did you 
spend doing the following: 
Charging the phone: 
Kwacha  
Borrowing someone else’s phone 
 Kwacha 
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Travel to phone charging place  
 Kwacha  
33 How much time, on average, did you 
spend on the following:  
Charging the phone 
minutes 
Borrowing someone else’s phone 
minutes 
Travel to phone charging place 
minutes 
 
H. HSA VISIT  This only refers to 
trial arm XX. 
34 Were you visited by the HSA? 1. yes  2. No  If no, go to section I 
35 How many times did the HSA visit your home?  1= one, 2=two, 3=three, 4=not sure, 
5=none 
 
36 How much time did you spend (on average) with 
the HSA? 
minutes  
I. TREATMENT ADHERENCE  Applies to all trial 
arms. 
37 Of the doses that you collected at the OPD or had 
been given at discharge, did your child receive full 
doses of medication?  
1=Yes, 2=No, 3=Not Sure If yes, go to Q39 
38 If no, why not? 1=Forgot,  
2 = Lost the medication,  
3=Gave the medication to someone else,  
4 = Did not see the need as child was 
healthy, 5=Child vomited, 6=fear of side 
effects, 7=not sure how to administer drugs 
correctly 
8 = others, specify_________________ 
 
39 If Yes, what measures did you put in place to make 
sure your child took all the prescribed doses? 
(Tick all that apply) 
Schedule drugs at meal times, 
Schedule drugs at bathing time,  
Put written reminders on the wall,  
Share information with family members 
to remind you, 
Others, specify_______________ 
 
40 Did your child vomit any of the drugs that you 
gave him/her at home? 
1=Yes, 2=No, 3=Not Sure If no, go to Q42 
41 If yes, what did you do if your child vomited 
immediately after taking drugs? 
(Tick all that apply) 
 Administered another dose, 
Did not do anything, 




42 What measures do you put in place to make sure 
your child does not vomit medications? 
(Tick all that apply) 
Give drugs with sweetened water/drink, 
Give drugs with meals,  
Breastfeed immediately after giving 
drug,  
Do nothing, 
 Others, specify_______________ 
 
 
Form Checked by (initials):     Date: / /  
Data Entered by (initials):     Date: / /  
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